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This study analyzes the effects of OEF/OIF deployment (including deployment 
location, frequency of deployment, and days deployed) on the probability of being 
diagnosed with Post-Traumatic Stress Disorder (PTSD), schizophrenia and 
bipolar disorder. The authors examine active duty personnel in all four services of 
the U.S. armed services since the start of the Global War on Terrorism. 
The data are provided by the Defense Manpower Data Center (DMDC) 
and TRICARE; they include deployment, administrative, and medical information 
for all active duty service personnel between FY2001 and FY2011 
(N=2,800,999). The authors used descriptive statistics, as well as multivariate 
analysis (probit models), to assess the deployment effects.   
Results show that a deployment, especially to Iraq, is associated with an 
increased probability of being diagnosed with PTSD and that the magnitude of 
the effect is higher for deployments after 2005 for the Army. Serving in combat-
arms specialty fields is also associated with a higher probability of being 
diagnosed with PTSD among Army and Marine Corps service members. 
Deployment is associated with a lower probability of diagnosis for bipolar 
disorder. The total cases of schizophrenia among active duty service members 
are very low; thus, this condition is excluded from the multivariate analysis.  
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The United States (U.S.) armed forces have been involved in the Global 
War on Terrorism (GWOT) for over ten years. The GWOT includes ground 
combat operations in Operation Enduring Freedom (OEF) in Afghanistan, and 
Operation Iraqi Freedom (OIF) in Iraq. More than 2.3 million U.S. military service 
members have been deployed to Iraq or Afghanistan or both since 2001 
(Martinez, 2011). With the prolonged operations, the total number of military 
personnel deployed overseas has increased over the years. To meet the 
personnel demands of sustained operations, more service members have been 
sent on more frequent and longer deployments. 
During these military operations, many U.S. military personnel 
experienced prolonged psychological stress and combat-related situations. A 
large number of personnel also directly experienced blasts from improvised 
explosive devices (IED) or on the battlefield, or they indirectly experienced 
combat stress through seeing or helping dead and injured friends. These war-
related risks and stressors have led to higher prevalence rates of mental health 
conditions, such as Post-Traumatic Stress Disorder (PTSD), major depression 
and substance use disorders (Shen, Arkes, & Williams, 2012; Tanielian & 
Jaycox, 2008).  
Current studies have suggested that 10% to 18% of troops deployed to 
OEF or OIF are suffering from PTSD, a mental health disorder resulting from 
experiencing or witnessing traumatic or life-threatening events (Litz & Schlenger, 
2009). With the increased tempo of OEF and OIF between FY2003 and 2006, 
the number of PTSD cases among deployed personnel grew at an increasing 
rate across all services (Kwan & Tan, 2008). Other than PTSD, the majority of 




and substance use. There is little research done on other costly mental health 
conditions, such as schizophrenia and bipolar disorder among the OEF/OIF 
veterans. 
U.S. troops were fully withdrawn from Iraq by December 2011. The 
number of troops in Afghanistan is declining as part of the plan for withdrawal by 
2014 (White House, 2011, 2012). However, given the chronic nature associated 
with many mental health conditions, the mental health care needs of the returned 
service members will still be present long after the end of the combat operations. 
This study will use 10 years of data on all active duty service members, and 
examine the incidence of three mental health conditions (PTSD, schizophrenia 
and bipolar disorder) across the different branches of the U.S. military. This study 
will also look at how deployment, service, and demographic characteristics 
affected the probability of these mental health conditions during the GWOT era.  
B. RESEARCH QUESTIONS 
This thesis is an extension of a study by Shen, Arkes, Kwan, and Tan  
(2010). In that study, the authors examined the association of deployment and 
PTSD of active duty service members between FY2001 and FY2006 across all 
four branches of the U.S. armed services. Service members who have been 
deployed overseas were found to have higher PTSD prevalence rates.  
From FY2006 to FY2010, the U.S. military’s war efforts stepped up. The 
number of boots on the ground increased to over 170,000 in Iraq in end 2007 
and over 90,000 in Afghanistan at the close of 2010 (U.S. Library of Congress, 
2011). With the increased number of deployments from FY2006 to FY2010, this 
study will provide more updated information on the relationship between 
deployment and PTSD. This study will also examine if there is an association 
between deployment and schizophrenia or bipolar disorder. These will be 




 What is the probability of being diagnosed with PTSD, 
schizophrenia, or bipolar disorder across different branches of the 
U.S. military since the start of the Global War on Terrorism 
(GWOT)? 
 How do risk factors including being deployed and deployment 
characteristics (such as deployment location, frequency of 
deployment, and duration) affect the probability of being diagnosed 
with PTSD, schizophrenia, or bipolar disorder? 
 Is there a spike in the incidence of PTSD, schizophrenia, or bipolar 
disorder after the surge in number of military personnel deployed 
since CY2006? 
 Do the effects, if any, differ between male and female and between 
those in direct combat and those in other military specialty jobs? 
In this thesis, all active duty service members between FY2001 and 
FY2011 will be analyzed. Separate analyses will be conducted for each mental 
disorder, and for each branch of armed services (Army, Navy, Marine Corps and 
Air Force). Separate analyses for enlisted personnel and officers within each 
branch will also be conducted. 
C. STUDY OVERVIEW AND SIGNIFICANCE 
This thesis uses both descriptive statistics and multivariate analysis 
methods to study if deployment, service and demographic characteristics affect 
the probability of PTSD, schizophrenia and bipolar disorder among U.S. military 
service members.  
First, this thesis will provide a literature review of research on PTSD, 
schizophrenia and bipolar disorder. The review will focus on past studies on the 
effect of military deployment on PTSD, especially during OEF and OIF. It will also 
focus on how deployment-related situations could have an effect on 





Second, this thesis will provide multivariate analyses that address the four 
research questions stated above. Demographic, medical and deployment data 
from the Defense Manpower Data Center (DMDC) and TRICARE between 
FY2001 and FY2011 will be merged.  
 
D. ORGANIZATION OF STUDY 
This thesis is organized as follows: Chapter I provides the background on 
deployments for the GWOT and a brief summary of the association between 
PTSD and GWOT. Chapter II provides a summary of prevailing research on 
PTSD, schizophrenia and bipolar disorder. Chapter III describes the data sources 
and categories. Chapter IV describes the analytical methodology of both 
descriptive statistics and multivariate analysis models. Chapter V presents the 
descriptive analysis results regarding service, demographic and deployment 
characteristics of the population. It also includes the prevalence rates of PTSD, 
schizophrenia and bipolar disorder across different deployment characteristics of 
the four services of the U.S. military. Chapter VI presents the probit analysis of 
the effects of deployment characteristics, service characteristics and 
demographic characteristics on the probability of being diagnosed with PTSD 




II. LITERATURE REVIEW 
A. INTRODUCTION 
Since the beginning of hostilities in Afghanistan in October 2001, more 
than 1.8 million U.S. troops have served in Operation Enduring Freedom (OEF) 
in Afghanistan or Operation Iraqi Freedom (OIF) in Iraq, with at least 37% having 
deployed at least twice (Litz & Schlenger, 2009). Studies have shown that 36% of 
soldiers who have returned home from the Global War on Terrorism (GWOT) 
have sought treatment for mental health issues (Bilmes, 2007). These soldiers 
are those who have fought on the ground in Iraq or Afghanistan, and adjacent 
locations (for instance, Kuwait, which is an important staging post for Iraq). 
Among those who had sought treatment, Post-Traumatic Stress Disorder (PTSD) 
has been a leading mental health condition among military personnel and 
veterans who had served in Iraq and Afghanistan, with heavy combat typically 
cited as a leading cause of PTSD.  
Studies to date suggest that 10–18% of the combat troops serving in 
OEF/OIF have probable PTSD following deployment, and the prevalence does 
not diminish over time (Litz & Schlenger, 2009). There are, however, few 
statistics on bipolar disorder and schizophrenia among the OEF/OIF veterans. 
With the last U.S. troops having left Iraq at the end of 2011 and the projection of 
all troops to leave Afghanistan by 2014, it is thus timely to conduct a ten-year 
look back at the association between the Global War on Terrorism (GWOT) and 
these three costly mental health conditions. 
This chapter provides an overview of prevailing studies on PTSD, bipolar 
disorder and schizophrenia symptoms and their treatment costs. Section B 
defines the clinical definition, symptoms and treatment of PTSD, followed by past 
research on PTSD in Section C, which examines the prevalence and risk factors 
of PTSD. Similar-styled discussions are conducted for bipolar disorder and 
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schizophrenia from Section D to G. Section H discusses the shortcomings in 
prevailing studies while Section I summarizes and concludes the chapter.  
B. DEFINITION OF PTSD, SYMPTOMS AND TREATMENT 
PTSD is the psychiatric disorder that can result from the experience or 
witnessing of traumatic or life threatening events such as terrorist attack, violent 
crime and abuse, military combat, natural disasters, serious accidents or violent 
personal assaults (Iribarren, Prolo, Neagos, & Chiappelli, 2005). The dysphoria 
factor of PTSD symptoms includes symptoms that overlap with many disorders 
such as feelings of isolation, loss of interest in activities, irritability, and sleep 
disturbance (Simms, Watson, & Doebbeling, 2002).  
While it is normal for such events to trigger such an anxiety disorder, in 
the case of PTSD, this reaction is changed or damaged. People who have PTSD 
may feel stressed or frightened even when they are no longer in these events. 
These symptoms must persist for at least one month, and they must cause 
clinically significant distress and affect the individual’s ability to function socially, 
occupationally, or domestically (Bisson, 2007). OEF/OIF veterans who screened 
positive for PTSD were found to be more than four times as likely to report 
suicidal ideation relative to non-PTSD veterans (Jakupcak & Varra, 2010). PTSD 
is also associated with reported reductions in quality of life, which includes 
general health, energy, emotional well-being, emotional role limitation, physical 
role limitation and social functioning (Erbes, Westermeyer, Engdahl, & Johnsen, 
2007). 
According to the Diagnostic and Statistical Manual of Mental Disorders 4th 
edition (DSM IV-TR) classification by American Psychiatric Association (APA; 
2000), the person must also have experienced intense fear, helplessness, or 
horror when the event occurred. The characteristic symptoms of PTSD, adapted 




Table 1. Symptoms of PTSD as classified by DSM IV-TR 
Re-experiencing phenomena (at least one required) 
 Recurrent and intrusive distressing collections 
 Recurrent distressing dreams 
 Acting or Feeling as if the events are recurring 
 Intense psychological distress to cues 
 Physiological reactivity to cues 
Avoidance and numbing (at least three required) 
 Avoidance of thoughts, feelings and conversations 
 Avoidance of reminders 
 Psychogenic amnesia 
 Greatly reduced interest in related activities 
 Detachment or estrangement feelings 
 Restricted range of affect 
 Sense of a foreshortened future 
Increased arousal (at least two required) 
 Difficulty sleeping 
 Irritability or outbursts of anger 
 Difficulty concentrating 
 Hypervigilance 
 Exaggerated startle response 
 
According to the National Institute of Mental Health (n.d.) and the U.S. 
Department of Veterans Affairs (2007), the main treatments for people with 
PTSD are psychotherapy, medications, or both, depending on individuals. Some 
people with PTSD need to try different treatments to find what works for their 
symptoms. 
One method is Cognitive Behavioral Therapy (CBT), which is a blend of 
two therapies: Cognitive Processing Therapy (CPT) and Prolonged Exposure 
(PE) therapy. CPT is the process when the therapist helps the patient to 
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understand and change how he thinks about his trauma and its aftermath. In PE, 
the patient’s goal is to have less fear about his memories. It is based on the idea 
that people learn to fear thoughts, feelings, and situations that remind them of a 
past traumatic event. 
CBT has shown to be effective in treating mental health disorders, 
including PTSD (Butler, Chapman, Forman, & Beck, 2006; Harvey, Bryant, & 
Tarrier, 2003). Several studies have also shown CBT to be effective in reducing 
suicidal behaviors (Tarrier, Taylor, & Gooding, 2008).  
Besides CBT, other treatment methods include eye movement 
desensitization and reprocessing (EMDR). Medications have also been shown to 
be effective. A type of drug known as a selective serotonin reuptake inhibitor 
(SSRI), which is also used for depression, is effective for PTSD. 
The costs associated with PTSD can be of various forms. A study done by 
Rand Corporation listed the main cost outcomes of PTSD, which include 
treatment costs, the costs of lives lost to suicide, and costs related to lost 
productivity (including reduced employment and lower earnings) (Tanielian & 
Jaycox, 2008). There are also secondary costs to PTSD such as costs stemming 
from family stress and caregiver burden. The study used a microsimulation 
model to predict that two-year costs resulting from PTSD (and major depression) 
for the approximately 1.6 million service members who have deployed since 
2001 could range from $4.0 to $6.2 billion. These costs are taken in societal 
perspective and accrue to all members of U.S. society, which potentially include 
government agencies, service members, their families, employers, private health 
insurers, taxpayers, and others. The study also approximated the average 
treatment cost per case over two years for all returning service members with 
PTSD to be $10,298 (for cases with suicide mortality) and $5,904 (for cases 
without suicide mortality). 
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C. PAST RESEARCH ON PTSD 
Past literature covered extensively the relationship of deployment in 
combat zones and the risk of development of PTSD. Shen et al. (2010) had 
found that deployment to Iraq/Afghanistan increases the odds of developing 
PTSD substantially, with the largest effect for the Navy and the smallest effect for 
the Air Force. The tour length also matters, as a deployment lasting longer than 
180 days increases the odds of PTSD by 1.11 to 2.84 times, depending on the 
service, as compared to a short tour of less than 180 days. In their study, they 
also found that females are significantly more likely to be diagnosed with PTSD 
across all services, with odds ratio ranging from 2.96 to 6.34. In terms of Military 
Occupational Specialty (MOS), service members in combat arms are more likely 
to be diagnosed with PTSD than non-combat arms service members across all 
service branches.   
Vasterling et al. (2010) also found that military deployment to Iraq is 
associated with pre- to post-deployment increases in PTSD symptoms, from 11% 
to 29%. Non-deployed soldiers, on the other hand, did not show symptom 
increases, suggesting that pre- to post-deployment increases could not be 
attributed to nonspecific factors inherent to military life.  
Brown, Antonius, Kramer, Root, and Hirst (2010) also found that trauma 
centrality, which is the extent to which an individual integrates a traumatic event 
into their identity, and PTSD severity are positively correlated (0.58). 
Exposure to a combat situation was also found to be correlated with 
screening positive for PTSD among OIF veterans. OIF and OEF veterans also 
used inpatient and outpatient mental health services at a higher rate after 
deployment than service members who deployed to other locations (Hoge, 
Auchterlonie, & Milliken, 2006). Overall, prevalence of scoring two or more in the 
four-item primary-care PTSD scale were 9.8% for OIF, 4.7% for OEF and 2.1% 
for other locations. Their findings showed that there is a higher occurrence in 
mental health disorders deployment in OIF, followed by OEF, with deployment in 
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other locations having the least occurrence. They also found that those who 
screened positive for a mental health concern were significantly more likely to 
leave service for any reason during the year after deployment than those who 
screened negative for all deployment locations, including Iraq and Afghanistan 
(21.4% vs 16.4%). 
A study on the relationship between physical injury and PTSD was also 
conducted by MacGregor et al. (2009). They found that compared with non-battle 
injuries, those with battle injuries had a greater risk of PTSD. Those with minor 
injuries (odds ratio 2.63), moderate injuries (odds ratio 4.01), serious injuries 
(odds ratio 8.69) and severe injuries (odds ratio 8.88) were more likely to receive 
diagnosis of PTSD.  
Hoge and colleagues (2004) conducted a study that showed that exposure 
to combat was significantly greater among those who were deployed to Iraq than 
among those deployed to Afghanistan. The percentage of study subjects whose 
responses met the screening criteria for major depression, generalized anxiety or 
PTSD was significantly higher after duty in Iraq (15.6% to 17.1%) than after duty 
in Afghanistan (11.2%) or before deployment to Iraq (9.3%); the largest 
difference was in the rate in PTSD.  
Among Marine Corps personnel deployed to Iraq or Kuwait between 
January 2003 and December 2007, the rate of PTSD was higher among those 
with two deployments compared to one deployment (2.1% versus 1.2%) 
(MacGregor, Han, Dougherty, & Galameau, 2012). 
D. DEFINITION OF SCHIZOPHRENIA, SYMPTOMS AND TREATMENT 
Schizophrenia is a chronic psychological disorder that affects 
approximately 1.1% among those of age 18 and older in a given year (Regier et 
al., 1993). Symptoms can be broadly grouped into “positive” and “negative” 
symptoms. The positive symptoms involve an excess of ideas, sensory, 
experiences, or behavior, such as hallucinations, delusions, and bizarre 
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behaviors. Negative symptoms involve a decreased reactivity to the environment, 
such as blunted or flat affect (reduction in emotional expression), anhedonia 
(absence of positive emotions in normally pleasurable situations), lesser speech, 
and lack of motivation (Harvey & Walker, 1987). Based on the DSM IV 
classification, the person must have signs and symptoms of the disorder present 
for six months or more (including prodromal and residual phases), and cause 
social/occupational dysfunction. Significant mood disorder, such as depression  
or manic symptoms, general medical conditions or substance abuse that might 
lead to psychotic symptoms must not be present (APA, 2000). The characteristic 
symptoms of schizophrenia (adapted from DSM IV-TR) are summarized in  
Table 2.  
Table 2. Symptoms of schizophrenia as classified by DSM IV-TR 
Characteristic symptoms (at least two or more required for at least one month) 
 Hallucinations 
 Delusions 
 Disorganized speech (e.g., frequent derailment or incoherence) 
 Grossly disorganized or catatonic behavior 
 Negative symptoms, i.e., affective flattening, alogia, or avolition 
Additional symptoms (only one characteristic symptom required if an additional symptom 
exists) 
 Bizarre delusions 
 Hallucinated voices consist of a running commentary or of two voices conversing 
 
There are four subtypes of schizophrenia, namely paranoid, catatonic, 
disorganized, and undifferentiated. The paranoid subtype is preoccupied with 
delusions or hallucination, but there is no disorganized speech, disorganized or 
catatonic behavior, or flat or inappropriate affect. The catatonic subtype involves 
a clinical syndrome that is dominated by postural and/or movement 
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abnormalities, mutism, or echolalia. As for the disorganized subtype, all of the 
following symptoms are prominent: disorganized speech, disorganized behavior, 
and flat or inappropriate affect, but the criteria for the catatonic subtype are not 
met. The undifferentiated subtype is diagnosed when the patient does not meet 
criteria for the previous subtypes, but does meet the general criteria for 
schizophrenia (APA, 2000). 
Many studies have tried to determine the causes of schizophrenia. One of 
the findings is that the vulnerability to schizophrenia can be inherited. The risk for 
schizophrenia increases in individuals who have a biological relative with the 
disorder, and the likelihood increases if the level of genetic relatedness is closer 
(Gottesman, 1991). Findings from an adoption study by Tiernari, Wynne, Moring 
and Lahti (1994) show that genetic influences as well as environmental factors 
play a part. Genetic vulnerability was mainly expressed in association with 
disruptive adoptive environments, but the increased rate of schizophrenia was 
not detected in adoptees reared in healthy family environments. 
Studies showed that schizophrenia patients are more likely to have a 
history of obstetrical complications (OCs) (Dalman, Allebeck, Cullberg, 
Grunewald, & Koester, 1999; McNeil, Cantor-Graae, & Weinberger, 2000). 
Stressful events during pregnancy are also associated with greater risk for 
schizophrenia and other psychiatric disorders in adult offspring (Huttunen, 1989). 
One explanation is that prenatal stress triggers the release of maternal stress 
hormones which disturbs fetal neurodevelopment which influences behavior and 
cognition (Welberg & Seckl, 2001).  
Post-natal events can also play a part. Individuals who sustain head 
injuries are also shown to have heightened risk for a variety of psychiatric 
disorders, including schizophrenia. The association is stronger if the injuries 
occurred in early childhood (AbdelMalik, Husted, Chow, & Bassett, 2003). 
Research also shows that stressful events play a part. Preceding a schizophrenia 
relapse, the number of stressful life events has been found to increase (Ventura, 
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Nuechterlein, Hardesty, & Gitlin, 1992). Indirect evidence also indicates that 
stress can induce the onset of schizophrenia symptoms in vulnerable individuals. 
Children of biological mothers with schizophrenia are at greater risk for the 
disorder if their adoptive families are dysfunctional (Tienari et al., 1994). 
There are various treatments available for schizophrenia. Antipsychotic 
medications reduce dopamine activity. The commonly prescribed atypical 
antipsychotics in the United States include Risperdal (risperidone), Zyprexa 
(olanzapine), Seroquel (quetiapine), and Geodon (ziprasidone). Psychosocial 
treatment methods include family therapy which has shown to improve family 
members’ coping and knowledge about schizophrenia, which then reduces the 
risk of relapse. Cognitive behavior therapy (CBT) helps psychotic patients deal 
directly with their symptoms. It has shown to be effective in reducing 
hallucinations and delusions in medication-resistant patients, and can be a 
complement to medication (Walker, Kestler, Bollini, & Hochman, 2004). Stress 
management has also been shown to benefit individuals with schizophrenia. An 
explanation is that stress management training provides individuals with skills to 
cope with stressors effectively and reduces the intensity of symptoms (Norman et 
al., 2002). 
Schizophrenia can be very costly in terms of treatment costs and indirect 
costs. Indirect costs include loss of earnings due to unemployment of the patient, 
as well as loss of earnings for the patient’s family. In the United States, the in-
patient hospitalization cost for first-episode cases in 1986 was $2.3 billion (in 
1993 dollars) and $2 billion for relapses cases annually (Weiden & Olfson, 1995). 
Indirect costs have been estimated to be one to four times higher than the direct 
costs. Suicide rates among schizophrenia patients are more than twice those of 
the general population (Knapp, 1997). In the UK, the lifetime cost (direct and 
indirect) ranges from £1,700 to £316,000 per person (equivalent to $2,700 to 
$506,000) (Davies & Drummond, 1994). 
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E. PAST RESEARCH ON SCHIZOPHRENIA 
The literature on gender difference in risk of schizophrenia is not 
consistent. Kennedy et al. (2002) found that schizophrenia is more prevalent 
among males, while Hendrick, Altshuler, Gitlin, Delrahm, and Hammen (2000) 
found that the lifetime risk is the same for males and females. Häfner (2003) also 
reported similar lifetime risks for males and females, but the onset of 
schizophrenia is earlier for males in the early twenties to mid-thirties, while more 
females were diagnosed with schizophrenia after their mid-thirties. 
Schizophrenia has been identified as one of the comorbid psychiatric 
disorders in PTSD, but the prevalence rate differs among studies. Escobar et al. 
(1983) found that 35% of Hispanic veterans with PTSD had comorbid diagnosis 
of schizophrenia (Escobar et al., 1983). Among patients with severe mental 
illness, PTSD prevalence was reported at 28% among patients with 
schizophrenia, which is higher than the lifetime prevalence of the general 
population. However, the prevalence rate is considered low compared to other 
mental illness, such as depression and borderline personality disorder (Mueser et 
al., 1998). Resnick, Bond, and Mueser (2003) reported a lower PTSD prevalence 
rate of 12.8% among people with schizophrenia. 
F. DEFINITION OF BIPOLAR DISORDER, SYMPTOMS AND TREATMENT 
Bipolar disorder, otherwise known as manic-depressive disorder, is 
characterized by dramatic mood swings. Bipolar disorder can be mainly classified 
into Bipolar I disorder and Bipolar II disorder.  
Based on the DSM-IV classification on Bipolar I disorder, the individual 
must have at least one episode of a manic or mixed episode. There may be 
episodes of hypomania or major depression as well. As for Bipolar II disorder, the 





hypomania and an episode of major depression. The symptoms must cause 
clinically significant distress or impairment in social, occupational, or other 
important areas of functioning.  
Genetics has shown to be a strong determinant of bipolar disorder. 
Lichtenstein et al. (2009) found that first-degree relatives of individuals with 
bipolar disorder had increased risk. Adopted children with biological parents who 
had bipolar disorder had a more than four-fold risk of bipolar disorder. 
Environmental stressors also seem to play a part. Goldberg & Garno (2005) 
found that 51% of a cohort of 100 adults with bipolar disorder had a history of 
severe trauma. Bebbington et al. (1993) also found that higher rates of severe, 
independent stressors in the 6 months before onset were evident in hospitalized 
manic patients as compared to members of a normal control group.  
There are several treatment methods for bipolar disorder. 
Pharmacotherapy is one of the most common methods. Medications range from 
mood stabilizers (lithium or anticonvulsants), antipsychotics (typical 
antipsychotics or atypical antipsychotics), antidepressants, and other 
medications (Möller & Nasrallah, 2003). Psychotherapy is also found to be 
useful. Cognitive behavioral therapy has been found to be effective in lowering 
the relapse of depression (Fava et al., 2004). Bipolar patients with family-focused 
treatment (FFT) had lower relapse rate over a 12-month period than bipolar 
patients in a comparison treatment involving two family education sessions and 
follow-up crisis management (Miklowitz et al., 2000).  
Treatment costs of bipolar disorder can be significant for the U.S. military. 
In general, about two-thirds of bipolar disorder patients have been found to suffer 
at least one relapse requiring hospital admission. Among bipolar disorder 
patients, the mortality rate is two to three times greater than non-patients 
(Silverstone & Romans-Clarkson, 1989). In the U.S. military, affective disorder 
(ICD-9 code: 296), including bipolar disorder, has been found to be the third most 
common reason for hospitalization of military personnel. In FY2001, the 
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Department of Veterans Affairs spent over $3 billion for psychiatric care of 
patients with psychosis or bipolar disorder (Sajatovic, Blow, & Ignacio, 2004). 
The social cost of bipolar disorder is also high. Bipolar disorder patients were 
also found to function less well at work than non-patients. The proportion of 
bipolar disorder population employed or studying full-time was significantly lower 
than those without bipolar disorder (Shippee et al., 2011). This means that 
bipolar disorder is related to lost work productivity. 
Overall, the total annual societal cost of bipolar disorder was 
approximately £6,919 per person (equivalent to $12,000 at 1999/2000 prices) 
with bipolar disorder in the UKs. This includes treatment and hospitalization 
costs, as well as indirect societal costs such as unemployment, absenteeism 
from work and suicide (Gupta & Guest, 2002). In the United States, the present 
value lifetime cost (both direct and indirect) per person with bipolar disorder in 
1998 dollars was estimated to be from $11,720 to $624,785 (Begley et al., 2001).   
G. PAST RESEARCH ON BIPOLAR DISORDER 
In the U.S. military, Weber, Cowan, Bedno, and Niebuhr (2010) looked at 
all hospitalized military personnel (active duty and reserve component in 1997 to 
2006). They found that the incidence rate of bipolar I disorder was 0.21 for men, 
and higher, at 0.40, for women. The incidence rate of bipolar I disorder was 
higher among whites than blacks, except the manic type. There is a significant 
decrease in the incidence rate with age among men, black and white, and among 
white women. Similarly, Krishkan (2005), Kennedy et al. (2002) and Shippee et 
al. (2011) found that bipolar disorder is more prevalent among females. 
Bipolar disorder has been found to be a comorbid condition with PTSD. 
PTSD prevalence among bipolar disorder patients was at 40%, which was the 
third highest among patients with severe mental illness, following depression 
(58%) and borderline personality disorder (54%) (Mueser et al., 1998). 
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H. SHORTCOMINGS IN PREVAILING STUDIES  
One of the shortcomings in prevailing studies on the relationship between 
the military and psychosis is the limited number of studies conducted on 
schizophrenia and bipolar disorder. While there are many studies that are able to 
draw conclusions that the prevalence of PTSD increases over time and the 
exposure to combat situations and probability of developing PTSD are positively 
related, there are limited similar studies conducted to test on the relationship 
between number of deployments, length of deployment and exposure to combat 
situations, and schizophrenia and bipolar disorder.  
The other shortcoming is the quality of the data used. Most data used are 
either of a small sample size, a short duration or specific combat troops. This 
may lead to selection bias and thus provides inaccurate estimates.  
Some studies used surveys to determine the symptoms of PTSD, 
schizophrenia or bipolar disorder. The results may not be accurate as well, as 
respondents may not divulge true or personal information. Such surveys may 
also not be medically robust to correctly determine if an individual is indeed 
suffering from these three mental health disorders.      
Shen et al. (2010) did a similar study on the effect of deployment and the 
probability of being diagnosed with PTSD across all four services of the U.S. 
armed services. In defining deployment, the study looked at the effects of the last 
deployment. However, this might lead in bias as the last deployment may be 
biased toward the outcome (diagnosis of PTSD) that is being studied. 
I. SUMMARY 
Although there are many studies that find a positive relationship between 
the probability of developing PTSD and combat exposure, especially in OEF and 
OIF, there are a limited number of similar studies on schizophrenia and bipolar 
disorder. There are also few studies that used data from the entire DoD 
population, due to the sensitivity and security of the data. Nor are there many 
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studies that use data that stretch for a long duration of up to ten years. There are 
also limited studies that directly compare the possibility of developing PTSD, 
schizophrenia and bipolar disorder across the four different services.  
With these shortcomings and with GWOT coming to a close, there is a 
need to conduct a study on the possible mental health conditions for the troops 
returning from Iraq and Afghanistan. The results of this study will be able to 
accurately estimate the prevalence of the different health conditions across the 
various services. The implications for the DoD will be to ensure sufficient health 
care services are available, determine the costs of treatment, prepare for 
possible attrition after deployment, and improve the overall readiness of the U.S. 




III. DATA CATEGORIES AND SOURCES 
A. INTRODUCTION 
This chapter discusses the data sources and categories of data used for 
this thesis. Section B describes the data sources. Section C describes the 
categories of data used. Section D identifies and describes the data limitations. 
Section E provides a summary of the chapter.  
B. DATA SOURCES 
There are generally two main sources, TRICARE and Defense Manpower 
Data Center (DMDC). These two sources provide three key categories of data: 
basic demographic information, mental health disorders diagnosis information 
and deployment information.  
This thesis uses manpower data from FY2001 to FY2011. There are four 
sets of demographic data from TRICARE, one from each service. TRICARE also 
provided two inpatient and two outpatient mental health disorder diagnosis data. 
These data contain the type of mental health disorder and the date of diagnosis 
for each service member. DMDC provided deployment data and the Military 
Occupational Specialty (MOS) information for every service member. The 
datasets used and their sources are summarized in Table 3. 
Table 3. Summary of datasets used and their sources 
Datasets Source 
1 set of Army demographic data 
1 set of Marine Corps demographic data 
1 set of Navy demographic data 
1 set of Air Force demographic data 
TRICARE 
2 sets of inpatient mental health disorders diagnosis data 
2 sets of outpatient mental health disorders diagnosis data TRICARE 
1 set of deployment data 




TRICARE is the health care program serving U.S. military active duty 
service members, National Guard and Reserve members, retirees, their families, 
survivors and certain former spouses worldwide. As a major component of the 
Military Health System (MHS), TRICARE brings together the health care 
resources of the uniformed services and supplements them with networks of 
civilian health care professionals, institutions, pharmacies and suppliers to 
provide access to high-quality health care services while maintaining the 
capability to support military operations (TRICARE, 2012). Currently, TRICARE 
serves approximately 9.7 million beneficiaries worldwide.  
The data from TRICARE provided two of the three key categories of 
information as mentioned above. TRICARE’s Defense Enrollment Eligibility 
Reporting System (DEERS) provided the basic demographic information. The 
MHS provided the mental health disorders diagnosis information, which included 
Post-Traumatic Stress Disorder (PTSD), schizophrenia and bipolar disorder.   
2. Defense Manpower Data Center (DMDC) 
Defense Manpower Data Center (DMDC) is the Department of Defense’s 
(DoD) human resource information source. It currently serves as the authoritative 
source of information on over 42 million people now and previously connected to 
DoD. It provides secure services and solutions to support DoD’s mission, and is 
recognized as a world leader in identity management (DMDC, n.d.). The third 
category of information, deployment information, is obtained from DMDC’s 
Contingency Tracking System (CTS). CTS began tracking deployment 
information under Operation Iraqi Freedom (OIF) and Operation Enduring 
Freedom (OEF) missions in FY2001. It contains data on deployment 
characteristics for all active duty service personnel from the U.S. military who 
were deployed between FY2001 and FY2011.  
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C. DATA CATEGORIES 
For this thesis, the data are categorized into three key categories, namely, 
basic demographic information, mental health disorders diagnosis information 
and deployment information.     
1. Basic Demographic Information 
As mentioned earlier, DEERS is a worldwide, computerized database of 
uniformed services members (sponsors), their family members, and others who 
are eligible for military benefits, including TRICARE (TRICARE, 2011). All service 
members are automatically registered in DEERS, thus it captures all basic 
demographic information of active duty service members. 
To provide confidentiality of the members, each service member is 
represented by a unique number called an Electronic Data Interchange Person 
Number (EDIPN). No names, social security numbers or any other personal 
information are given that would allow researchers to identify specific individuals. 
EDIPN is also the key to link every member across various data sources to 
obtain mental disorder diagnosis information and deployment information. 
Key demographic variables that can be obtained from DEERS include 
gender, race, branch of service, marital status, pay grade, age and MOS. 
The entire DEERS data set consists of 2,800,999 unique EDIPN 
observations of active duty service members from all four services who had 
served from FY2001 to FY2011.  
2. Mental Health Disorders Diagnosis Information 
Mental health disorders diagnosis information is obtained from TRICARE’s 
inpatient and outpatient records, which contain four different data files: Standard 
Inpatient Data Record (SIDR), TRICARE Encounter Data—Institutional  
(TEDI), Standard Ambulatory Data Record (SADR)/Comprehensive 
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Ambulatory/Professional Encounter Record (CAPER), and TRICARE Encounter 
Data—Non-Institutional (TEDN).   
SIDR and TEDI data files contain all medical treatment records among 
personnel with mental disorders who were admitted under the inpatient setting. 
SADR/CAPER and TEDN data files contain all treatment patterns among 
personnel with mental disorders who were admitted under the outpatient setting.   
a. Inpatient Records of Mental Health Disorder 
As long as a service member is eligible for TRICARE, he is entitled 
to use the health care services in the Military Treatment Facilities (MTFs). MTFs 
are usually located on or near military bases and are facilities where TRICARE 
beneficiaries may receive care. As defined by the TRICARE Operations Manual 
(2008), inpatient care refers to care provided to a patient who has been admitted 
to a hospital or other authorized institution for bed occupancy for purposes of 
receiving necessary medical care, with the reasonable expectation that the 
patient will remain in the institution at least 24 hours, and with the registration 
and assignment of an inpatient number or designation.  
Under the DoD’s MHS, active duty service members’ treatment 
information is captured in the SIDR database. This happens as long as they seek 
medical inpatient care from MTFs and they are eligible for TRICARE. For active 
duty service members who are eligible for TRICARE but seek medical inpatient 
care from a hospital or other authorized institutional provider, their treatment 
information is captured in the TEDI database once they are given inpatient care 







(1) Standard Inpatient Data Record (SIDR) 
Out of the entire population of 2,800,999 service members, 
5,236 of them sought inpatient treatment in MTFs. Among them, 2,921 service 
members sought treatment for PTSD, 721 for schizophrenia and 1,594 for bipolar 
disorder.  
(2) TRICARE Encounter Data–Institutional (TEDI) 
Out of the population, 5,885 service members sought 
inpatient treatment in a hospital or other authorized institutional provider. 3,625 
sought treatment for PTSD, 342 for schizophrenia and 1,918 for bipolar disorder.   
b. Outpatient Records of Mental Health Disorder 
Service members who are eligible for TRICARE are also entitled to 
specialized/professional medical services or outpatient treatment in both MTFs 
and hospitals or other authorized institutional providers. Outpatient observation 
stays are those services furnished by a hospital on a hospital’s premises, 
including the use of a bed and periodic monitoring by a hospital’s nursing or other 
staff, which are reasonable and necessary to evaluate an outpatient’s condition 
or determine whether there is a need for a possible admission to the hospital as 
an inpatient. Such services are provided when ordered by a physician or other 
individual authorized by State licensure law and hospital staff bylaws to admit 
patients to the hospital or to order outpatient tests. 
Under the DoD’s Military Health System (MHS), active duty service 
members’ treatment information is captured in the SADR/CAPER database as 
long as they seek medical outpatient care from MTFs and they are eligible for 
TRICARE. SADR provided the outpatient information from FY2001 to FY2006. 
From FY2007 to FY2011, the SADR system was replaced by CAPER.  
For active duty service members who are eligible for TRICARE but 
seek specialized/professional medical services or outpatient treatment from a 
hospital or other authorized institutional provider, treatment information is 
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captured in the TEDN database. In this case, a TEDN record reflects either 
inpatient or outpatient health care services exclusive of inpatient institutional 
facility services. 
(1) Standard Ambulatory Data Record (SADR)/ 
Comprehensive Ambulatory/Professional Encounter Record (CAPER) 
Out of the population, 115,324 service members sought 
specialized/professional medical services or outpatient treatment in MTFs. This 
posted the highest source of diagnosis of mental disorders. Of those service 
members, 92,799 sought treatment for PTSD, 3,347 for schizophrenia and 
19,178 for bipolar disorder.  
(2) TRICARE Encounter Data–Non-Institutional (TEDN) 
Out of the population, 20,688 service members sought 
specialized/professional medical services or outpatient treatment in a hospital or 
other authorized institutional provider. More specifically, 14,208 sought treatment 
for PTSD, 860 for schizophrenia, and 5,620 for bipolar disorder. 
c. Trend of Records of Mental Health Disorder 
 Tables 4 and 5 show the overall breakdown of mental health 
disorder treatment in both inpatient and outpatient facilities for PTSD, 
schizophrenia and bipolar from CY2000 to CY2011, for active duty enlisted 
personnel and officers respectively. 
 Using the full-year equivalent number of active duty enlisted 
personnel as the base, the percentages of enlisted personnel diagnosed with 
PTSD, schizophrenia and bipolar disorder in each year can be observed. The 
same can be observed for the officers.  
An upward trend in the number of new PTSD cases over the years 
can be observed in both the enlisted and officer population. There is also an 
upward trend in the number of new bipolar disorder cases in the enlisted 
population. From CY2006 onward, there is a surge in the number of new cases 
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of PTSD and bipolar disorder. The most distinctive increase was in CY2007, 
where the number of new PTSD cases among enlisted personnel increased by 
1.5 times. This coincides with the period in which the U.S. military had stepped 
up its war efforts, as mentioned in Chapter I. There is no noticeable trend for new 
cases of schizophrenia.  
Table 4. Active duty enlisted personnel diagnosed with PTSD, schizophrenia 
and bipolar disorder in a hospital or other authorized institutional provider 
Year 
























CY2000* 722 0.27% 213 0.078% 429 0.16% 271,508 
CY2001 2,218 0.19% 649 0.055% 1,663 0.14% 1,180,359 
CY2002 2,189 0.17% 491 0.038% 1,999 0.16% 1,276,907 
CY2003 2,951 0.22% 480 0.036% 2,359 0.18% 1,332,065 
CY2004 5,806 0.44% 454 0.034% 2,173 0.16% 1,332,940 
CY2005 9,251 0.71% 469 0.036% 2,398 0.18% 1,302,769 
CY2006 9,639 0.75% 446 0.035% 2,978 0.23% 1,287,350 
CY2007 14,466 1.13% 494 0.039% 3,032 0.24% 1,276,381 
CY2008 17,519 1.51% 464 0.040% 3,153 0.27% 1,162,124 
CY2009 16,258 1.61% 373 0.037% 2,696 0.27% 1,009,707 
CY2010 15,140 1.76% 314 0.037% 2,211 0.26% 859,993 
CY2011* 10,838 1.97% 184 0.033% 1,374 0.25% 550,292 
* The number of active duty service members in 2000 and 2011 is lower because the DEERS 
data only captures the last quarter in CY2000 and the first three quarters in CY2011. 
# The full year equivalent number of active duty service members refers to the number of 
weighted service members. The weightage is computed based on the number of months of 
service in the particular year. For example, 12 months of service is equivalent to one service 


















Table 5. Active duty officers diagnosed with PTSD, schizophrenia and 
bipolar disorder in a hospital or other authorized institutional provider 
Year 
























CY2000* 64 0.12% 13 0.024% 63 0.12% 54,377 
CY2001 136 0.06% 37 0.016% 159 0.07% 224,958 
CY2002 164 0.07% 27 0.012% 157 0.07% 233,359 
CY2003 201 0.08% 34 0.014% 200 0.08% 241,718 
CY2004 370 0.15% 21 0.009% 174 0.07% 239,635 
CY2005 504 0.21% 19 0.008% 182 0.08% 234,997 
CY2006 601 0.26% 17 0.007% 188 0.08% 227,541 
CY2007 790 0.36% 15 0.007% 183 0.08% 218,300 
CY2008 959 0.47% 14 0.007% 155 0.08% 203,663 
CY2009 984 0.52% 13 0.007% 161 0.09% 188,523 
CY2010 1,039 0.60% 19 0.011% 125 0.07% 173,924 
CY2011* 744 0.62% 10 0.008% 98 0.08% 120,220 
* The number of active duty service members in 2000 and 2011 is lower because the DEERS 
data only captures the last quarter in CY2000 and the first three quarters in CY2011. 
# The full year equivalent number of active duty service members refers to the number of 
weighted service members. The weightage is computed based on the number of months of 
service in the particular year. For example, 12 months of service is equivalent to one service 







3. Deployment Information 
In this thesis, the focus is to study the relationship between the probability 
of being diagnosed with a mental disorder and deployment characteristics. The 
deployment characteristics include deployment location, frequency and duration 
from FY2001 to FY2011. Thus, in addition to demographic information and 
diagnosis information on mental health disorders, deployment information is 
critical to this thesis.  
Deployment information in this thesis is obtained from DMDC’s CTS. In 
the data, every service member’s history of deployment for OIF/OEF missions 
since the end of FY2001 is recorded. Information like deployment location and 
duration for each deployment from FY2001 to FY2011 can be obtained. The 
service members’ Military Occupation Specialty (MOS) is also provided in the 
data. This will help in predicting the level of risk and exposure to combat or 
stressful events during deployment.  
Based on the CTS data, there are a total of 1,223,435 servicemen who 
were deployed overseas. Descriptive statistics on overseas deployment will be 
discussed in Chapter V.  
D. DATA LIMITATIONS 
Unlike the previous study by Shen et al. (2010), data for all service 
members from all four services is available for this thesis. The completeness of 
the data means that this study can be conducted without any form of sampling. 
However, several restrictions must be taken into consideration.  
First, the datasets have missing information. For instance, some 
observations (less than 1%) do not have EDIPN and are thus being dropped from 
the study. There are also about 1–2% of the population with deployment 
information appearing earlier than it first appeared in DEERS data, and which 
therefore are omitted for this thesis.   
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Second, there are data entry errors in some observations. For example, 
some service members have different gender and race records over the years. 
These data are cleaned by classifying them according to the highest number of 
occurrence in the data set.  
Finally, the data are incomplete for service members who enlisted in 
CY2000 and before. Due to the nature of the data obtained, the service start date 
is only available for service members who enlisted in CY2001 and beyond. There 
is no service start date for those who enlisted in CY2000 and before. Thus for 
this thesis, the way the observation window is constructed for these two groups 
of service members will be different. The details on the construction of the 
observation window and how the above-mentioned limitations are dealt with will 
be discussed in detail in Chapter IV.   
E. SUMMARY 
This chapter has described the sources of the data used in this thesis, 
namely TRICARE and DMDC. From TRICARE, the demographic information is 
obtained from DEERS while the mental disorder diagnosis information is 
obtained from SIDR, SADR, TEDI and TEDN. From DMDC, the deployment 
information is obtained from the CTS.  
While managing the data set, some data has to be cleaned to overcome 
issues that are present in the data, which includes missing data and errors in 
data entry. Dropping missing observations may inevitably result in errors in the 
estimates. However, due to the small percentage of such restrictions, the 
significance of this impact should be minimal.  
The next chapter will discuss the analytical methodology and elaborate 
upon the models of this study. Following that, the subsequent chapters will 





IV. ANALYTICAL METHODOLOGY 
A. INTRODUCTION 
This chapter will describe the hypotheses and the analytical methodology 
used to examine the four research questions outlined in Chapter I. The research 
questions are: 
 What is the probability of being diagnosed with Post-Traumatic 
Stress Disorder (PTSD), schizophrenia, or bipolar disorder across 
different branches of the U.S. military since the start of the Global 
War on Terrorism (GWOT)? 
 How do risk factors (including being deployed in Operation 
Enduring Freedom (OEF)/Operation Iraqi Freedom (OIF) missions) 
and deployment characteristics (such as deployment location, 
frequency of deployment, and duration) affect the probability of 
being diagnosed with PTSD, schizophrenia, or bipolar disorder? 
 Is there a spike in the incidence of PTSD, schizophrenia, or bipolar 
disorder after the surge in the number of military personnel 
deployed in OEF/OIF missions since CY2006? 
 Do the effects, if any, differ between males and females and 
between those in direct combat and those in other military specialty 
jobs? 
The rest of this chapter will be organized as follows: Section B will lay out 
the research hypotheses for the research questions. Sections C and D will 
describe the descriptive statistics and multivariate analysis methods used to 
analyze each research question. Section E will provide a summary.  
B. RESEARCH HYPOTHESES 
The main objective is to analyze the effect of deployment characteristics 
(such as deployment location, frequency of deployment, and deployment 
duration) on the probability of being diagnosed with PTSD, schizophrenia, or 
bipolar disorder across the different branches of the U.S. military. The thesis will 
also analyze how the effects may vary based on service and demographic 
characteristics. Previous studies have examined the effect of deployment to Iraq 
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and/or Afghanistan on PTSD and found that exposure to combat situations is 
positively related to being diagnosed with PTSD (Shen et al., 2010). There have 
not been many studies examining the effect of deployment in OEF/OIF missions 
on schizophrenia and bipolar disorder. However, prior research has shown that 
environmental stressors increase the probability of schizophrenia and bipolar 
disorder (Ventura et al., 1992). PTSD and bipolar disorder are found to be more 
prevalent in females (Kennedy et al., 2002; Krishkan, 2005; Shen et al., 2010; 
Shippee et al., 2011). There may not be a gender difference in lifetime risk of 
schizophrenia, but the onset for males occurs earlier in their twenties (Häfner, 
2003; Hendrick et al., 2000).   
On the relationship between deployment characteristics and the 
probability of being diagnosed with PTSD, schizophrenia and/or bipolar disorder, 
the authors of this thesis hypothesize the following: 
 Being deployed in OEF/OIF missions will increase the probability of 
being diagnosed with PTSD, schizophrenia and/or bipolar disorder 
for all branches of the U.S. military. 
 The deployment location will have varying effects on the probability 
of being diagnosed with PTSD, schizophrenia and bipolar disorder. 
Specifically, the authors hypothesize that personnel who have been 
deployed to Iraq and/or Afghanistan will have a higher probability of 
being diagnosed with PTSD, schizophrenia and bipolar disorder, 
compared to personnel deployed to other locations who might have 
less exposure to direct combat. 
 As the number and duration of deployments to Iraq and/or 
Afghanistan increases, the probability of being diagnosed with 
PTSD, schizophrenia and/or bipolar disorder will increase for all 
branches of the U.S. military. 
 The probability of being diagnosed with PTSD, schizophrenia 
and/or bipolar disorder is higher for service members whose first 
deployment in OEF/OIF missions is on or after CY2006, as 
compared to those whose first deployment in OEF/OIF missions is 
before CY2006. From Chapter III, an upward trend of new PTSD 
cases is observed from CY2006. This could imply that post-surge 
troops have a higher chance of witnessing combat/stressful events. 
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 Whether the effect of deployment in OEF/OIF missions on the 
probability of being diagnosed with PTSD, schizophrenia and/or 
bipolar disorder is stronger or weaker for those in the combat arms 
specialty category is an empirical question. On one hand, due to 
the job nature, service members in combat arms during 
deployments in OEF/OIF missions are more likely to be exposed to 
high-stress events and war trauma than deployed service members 
in non-combat arms. On the other hand, those who chose to work 
in a combat arms specialty fields might be better prepared mentally 
for combat situations than those who self-select themselves into 
specialty fields that are not generally involved in direct combat 
situations. 
 Based on prior literature (Häfner, 2003; Hendrick et al., 2000; 
Kennedy et al., 2002; Krishkan, 2005; Shen et al., 2010; Shippee et 
al., 2011), the authors hypothesize that females have a higher 
probability of being diagnosed with PTSD and bipolar disorder, 
while males have a higher probability of being diagnosed with 
schizophrenia. The gender effect is magnified during deployment in 
OEF/OIF missions. 
C. PREVALENCE OF PTSD, SCHIZOPHRENIA AND BIPOLAR 
DISORDER IN THE ACTIVE DUTY U.S. ARMED SERVICES 
This thesis first aims to examine the probability of being diagnosed with 
PTSD, schizophrenia and bipolar disorder in the active duty U.S. armed services. 
As mentioned in Chapter III, linked data from the TRICARE and DMDC are used 
in this thesis. For the first research question, the authors will implement 
descriptive analysis to provide a summary of service and demographic 
characteristics, as well as deployment information across all four services. The 
descriptive analysis will also show the probability of being diagnosed with PTSD, 
schizophrenia and bipolar disorder based on deployment characteristics.  
D. EFFECT OF DEPLOYMENT INTENSITY ON THE PROBABILITY OF 
BEING DIAGNOSED WITH PTSD, SCHIZOPHRENIA AND BIPOLAR 
DISORDER 
Separate multivariate analysis models are used to examine the effect of 
deployment intensity on the probability of being diagnosed with PTSD, 
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schizophrenia and bipolar disorder. The sample includes all active duty service 
members from FY2001 to FY2011.  
1. Theoretical Model 
An observation window approach is used for analysis. This approach 
allows uniformed reference point(s) across all populations in observing 
independent variables (deployment, service and demographic characteristics). 
This approach also ensures that deployment characteristics are independent of 
the outcomes of interest (PTSD, schizophrenia and bipolar disorder). For 
example, a service member is considered to have been deployed in OEF/OIF 
missions if at least one deployment starts within the observation window.   
Without this observation window approach to observe all personnel for the 
same amount of time, regardless of their mental health outcomes, there is a risk 
of the following self-selection problem:  Holding all other factors constant, those 
who stay in the military longer tend to be healthier (and therefore would be 
deployed in OEF/OIF missions more during their career) than those who have 
serious mental health conditions (and would be discharged early in their career). 
Without the observation window approach described below, there will be a bias in 
the direction of longer and more frequent deployments being associated with 
lower incidences of mental health problems, because those who stay and remain 
healthy will have more opportunities to be deployed in OEF/OIF missions.    
Due to limitations of the DEERS data on the start date of service, the 
observation window period varies among the following two groups: 
a. In-Service On or After CY2001 
All active duty service members are observed between their 8th to 
48th month of service or the last date of service, whichever is earlier, for 
deployment characteristics. The 8th to 48th month period is chosen because 
newly enlisted personnel would undergo training during the initial months of 
enlistment, and the majority of deployments in OEF/OIF missions have been 
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observed to occur during this time interval1. The first date of entry of records in 
the DEERS data is used as the start date of service for all service members in-
service on or after 2001. The start date of service is then used to identify the 
observation window period.  
Service members who entered the service on or after 1 September 
2007 are excluded because DEERS data provided records up to FY2011 (i.e., up 
to September 2011). This does not allow them to be observed for the full 
observation window. 
b. In-Service Before CY2001 
The earliest date of entry of records in the DEERS data is 1 
September 2000, which is an inaccurate start date of service for those who were 
already in service before 2001. Service members who have the earliest date of 
entry of records (DEERS data) in CY2000 but medical records prior to CY2000 
are identified as having entered the military before CY2000. Unlike the newly 
enlisted group described above, this group tends to be more heterogeneous with 
wide distribution in terms of their length of service and ranks. Since the majority 
of this group would not be newly enlisted personnel who need to undergo basic 
training, their observation window is from their earliest date of entry from records 
in the DEERS data to 48 months later or the last date of service, whichever is 
earlier.  
All service members who have an earliest date of entry from 
DEERS records in CY2000 and no TRICARE records prior to CY2000 are 
assumed to have entered the military in CY2000 as newly enlisted or 
commissioned. This group will be observed from the 8th to 48th month of service 
or the last date of service, whichever is earlier, based on the earliest date of entry 
of records.  
                                            
1 Based on authors’ tabulations of DEERS/CTS data. 
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2. Dependent Variable 
The dependent variable is a binary variable on whether a service member 
is diagnosed with the respective mental health disorder (PTSD, schizophrenia or 
bipolar disorder). The mental health disorder diagnosis information is available 
from the SIDR, TEDI, SADR/CAPER and TEDN. ICD-9 codes are used to 
classify the diagnosis information (i.e., 309.81 for PTSD; 295 for schizophrenia; 
and 296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8 and 296.89 for bipolar 
disorder). The dependent variable takes the value of one if the person is 
diagnosed with the mental health disorder after the observation window begins, 
until the end of FY2011, and takes the value of zero otherwise. 
As the dependent variable is dichotomous, probit models are used in this 
thesis. Linear probability models (LPM) are not ideal, as LPMs do not constrain 
the dependent variable to be between zero and one. Probit models constrain the 
dependent variable to be between zero and one, so it is used to estimate the 
effect of deployment intensity on the probability of being diagnosed with PTSD, 
schizophrenia, and bipolar disorder.  
3. Independent Variables 
The base model for the multivariate analysis is described below: 
P(y = 1 | x) = β0 + β1X1 + β2X2 + u 
where X1 = deployment characteristics 
X2 = service and demographic characteristics 
The vector X1 contains the main variables of interest for the probit model. 
These key variables are based on deployment information from the CTS data. 
During the deployment period, service members may be physically sent to 
certain locations (for example Iraq, Afghanistan) or engaged in training 
elsewhere. For this study, deployment is defined as being deployed to the 
specific country or theater. Depending on the model, the key variables include 
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deployment location, deployment frequency and deployment duration. The 
specific key variables of interest for each respective probit model are described 
in a later section of this chapter. 
The vector X2 contains the control variables, namely the service and 
demographic characteristics, and year dummy variables. The same control 
variables are used in all probit models. Control variables that may change over 
time (such as Military Occupation Specialty (MOS), pay grade, marital status, 
age, and year dummy variables) are observed at the start of the observation 
window. The control variables are described below. 
Service Characteristics 
(1) Military Occupation Specialty (MOS) Codes.    The 
MOS Code is provided in the CTS and DEERS data. The four service branches 
use different sets of MOS codes. The Army and Marine Corps use a MOS code, 
while the Air Force uses Air Force Specialty Codes (AFSC) and the Navy uses a 
system of naval ratings and designators along with the Naval Enlisted 
Classification (NEC) system. Using the different sets of military occupation 
codes, all observations are categorized into six military occupation categories 
using binary variables. The six categories are combat arms, combat service, 
service support, aviation, medical and other MOS. Observations with missing 
MOS information are grouped under “others.” See the Appendix for the six MOS 
categories and corresponding codes. Due to the job nature, the “combat arms” 
category is expected to have the largest effect on the probability of being 
diagnosed with PTSD, schizophrenia and bipolar disorder. The reference group 
used in all models is the “combat arms” category.  
(2) Pay Grade. The pay grade information is provided in 
the DEERS data. All observations are categorized into the following pay grade 
categories using binary variables: W1 to W5, O1 to O2, O3, O4, O5, O6, O7 to 
O10 for officers; and E1 to E2, E3 to E5, E6 to E9 for enlisted personnel. Each 
service member is assigned the pay grade they were in at the beginning of their 
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observation window. Observations with missing pay grade information will be 
categorized with the most junior pay grade category. The most junior pay grade 
category is used as the reference group. This means that “W1 to W5” is used as 
the reference group used for the officer population in the Army, Marine Corps 
and Navy. “O1 to O2” is the reference group for the Air Force as there are no 
warrant officers in the Air Force. “E1 to E2” is the reference group for all enlisted 
populations. 
(3) Shore/Ship Deployment. This is only applicable to 
Navy personnel. All deployments are categorized as a binary variable “shore,” 
depending on whether the deployments were on shore or on ship. The binary 
variable “shore” takes on a value of one if the deployment was on shore, zero 
otherwise. 
Demographic Characteristics 
(1) Gender. The gender information is provided by 
the DEERS data. Observations with missing gender information are grouped 
under “male.” A binary variable “female” is used where it takes on a value of one 
if the gender is female, and zero otherwise. The reference group used is male, as 
the majority of the military personnel are male. 
(2) Race. The race information is provided by the 
DEERS data and encoded into binary variables for each of the five racial/ethnic 
categories: White, Black, Hispanic, Asian, and other race. Observations with 
missing race information are grouped under “other race.” The race variables take 
on a value of one if the service member belongs to the race category, and zero 
otherwise. The reference group used is “White.” 
(3) Marital Status. The marital status information is 
provided in the DEERS data and encoded into a binary variable “married.” It 
takes on a value of one if the marital status is married at the start of the 




(4) Age. The age and date of birth are provided in the 
DEERS data. The age variable is a continuous variable and reflects the age of 
the personnel at the start of the observation window. Observations with missing 
age information take on the average value of the non-missing ages. 
Year Dummy Variables 
Binary variables for each calendar year (CY2001 to CY2008) are 
included in the models to capture cohort changes across the years. The year 
dummy variables take the value of one if the observation window starts in the 
respective calendar year, or zero if otherwise. The reference year used is 
CY2000. 
4. Base Model Specification  
A total of eight probit models built on four base models are set up to test 
the hypotheses and estimate the effect of deployment characteristics on the 
probability of being diagnosed with PTSD, schizophrenia and bipolar disorder. 
The service and demographic variables are held constant in all models. The 
reference groups for all eight models are made up of the personnel with no 
deployment in OEF/OIF missions during the observation window. 
The four base models and their respective key variables of interest are 
described below.  
a. Model 1–Overall Effect of Deployment 
The first base model examines the effect of deployment in OEF/OIF 
missions on the probability of being diagnosed with PTSD, schizophrenia and 
bipolar disorder. The key variable of interest is whether the person was deployed 
in OEF/OIF missions within the observation window. A deployment variable is 
encoded as a binary variable. It takes the value of one if at least one deployment 
occurred during the observation window, or zero if otherwise.  
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b. Model 2–Effect of Deployment Location 
The second base model examines the effect of the deployment 
location on the probability of being diagnosed with PTSD, schizophrenia and 
bipolar disorder. The deployment effect is indicated by a deployment variable in 
Model 1 Unlike Model 1, Model 2 uses deployment location variables as an 
indicator for deployment in OEF/OIF missions. Deployment locations are 
categorized into four binary variables: (1) Afghanistan; (2) Iraq; (3) Classified or 
unknown countries, and; (4) Other countries under OEF/OIF missions. Each 
variable takes the value of one if the service member has been deployed to the 
location during the observation window, or zero if otherwise. Any persons who 
were deployed twice to two separate locations would have the value of one on 
both location indicators. A non-deployed service member would have the value of 
zero for all location indicators.  
c. Model 3–Effect of Deployment Location and Frequency 
The third base model examines the effect of the deployment 
location and frequency on the probability of being diagnosed with PTSD, 
schizophrenia or bipolar disorder. Similar to Model 2, Model 3 also uses 
deployment location variables to indicate whether a service member has been 
deployed in OEF/OIF missions. The majority of the deployed population were 
only deployed in OEF/OIF missions once during the observation window. 
Therefore, deployment frequency is encoded as a binary variable that takes the 
value of one if there is more than one deployment during the observation 
window, or zero if otherwise.  
d. Model 4–Effect of Deployment Location and Duration 
The fourth base model examines the effect of the deployment 
location and duration on the probability of being diagnosed with PTSD, 
schizophrenia or bipolar disorder. Based on the empirical distribution of deployed 
days, the total deployment duration (in days) during the observation window is 
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differentiated into three categories: (1) Short (less than 120 days); (2) Medium 
(120 to 180 days), and (3) Long (more than 180 days). Each variable takes the 
value of one if the deployment duration is as per the category description, or zero 
if otherwise.  
5. Interaction Models’ Specifications 
Modifications are made to Models 1 and 2 to study how the interactions 
between various independent variables affect the probability of developing 
PTSD, schizophrenia or bipolar disorder. Four interaction models are used. The 
interaction models and their respective key variables of interest are described 
below.  
a. Model 5–Effect of Deployment and Deployment Period 
As described in the beginning of the chapter, one of the research 
questions examines whether there is a differential effect between the beginning 
of the GWOT and the later part (the “surge” period).The first base model is 
modified to examine the interactive effect of deployment period on the probability 
of being diagnosed with PTSD, schizophrenia or bipolar disorder. Service 
members who have been deployed in OEF/OIF missions are categorized into 
“CY 2005 and prior” and “CY2006 and after” deployment periods, based on their 
first deployment start dates. A dummy variable is created for each of the two 
periods to replace the deployment variable. Each dummy variable takes the 
value of one if the first deployment start date occurs during the time frame, or 
zero if otherwise.  
b. Model 6–Effect of Deployment Location and Period 
The second base model is modified to examine the effect of 
deployment location and period on the probability of being diagnosed with PTSD, 
schizophrenia or bipolar disorder. For each location, service members who have 
been deployed to the location are categorized into “CY2005 and prior” and 
40 
 
“CY2006 and after” deployment periods, based on their first deployment start 
date to that location. A dummy variable is created for each of the two periods to 
replace the original deployment location variables. Each dummy variable takes 
the value of one if the first deployment start date of the respective location occurs 
during the time frame, or zero if otherwise. For example, a service member who 
was first deployed to Iraq in CY2005 would be indicated as “1” under the dummy 
variable of “Deployed to Iraq in CY2005 and prior.” A total of eight dummy 
variables (two for each location) are included in the model.  
c. Model 7–Interaction Effect between Deployment and 
MOS 
The first base model is expanded to examine the effect of 
deployment in OEF/OIF missions, as well as the interaction effect of deployment 
in OEF/OIF missions and MOS on the probability of being diagnosed with PTSD, 
schizophrenia and bipolar disorder. To study the effect of combat arms versus 
other types of MOS, we grouped all non-combat arms MOSs to generate the 
interaction variable included in the model. The interaction variable takes the 
value of one if the service member was deployed in OEF/OIF missions during the 
observation window and the MOS is not combat arms, or zero if otherwise.  
d. Model 8–Interaction Effect between Deployment and 
Gender 
The first base model is expanded to examine the effect of 
deployment in OEF/OIF missions, as well as the interaction effect of deployment 
in OEF/OIF missions and gender on the probability of being diagnosed with 
PTSD, schizophrenia and bipolar disorder. An interaction variable between 
deployment in OEF/OIF missions and the female variable is included in the 
model. The interaction variable takes the value of one if the service member was 
deployed in OEF/OIF missions during the observation window and female, or 




This chapter describes the analytical methodology and approaches used 
to examine the key research objectives in this thesis. A combination of 
descriptive and multivariate analyses is used to examine the effect of deployment 
intensity on the probability of being diagnosed with PTSD, schizophrenia or 
bipolar disorder. The results of the descriptive statistics and multivariate analysis 










V. DESCRIPTIVE RESULTS 
A. INTRODUCTION 
This chapter presents the descriptive analysis results of this thesis. 
Detailed tables of descriptive analysis results are produced using the data from 
the Defense Enrollment Eligibility Reporting System (DEERS) and TRICARE. 
These tables will provide comprehensive background information regarding the 
service and demographic breakdown of the entire population, and deployment 
characteristics of the enlisted and officer populations. The tables will also include 
information on mental health disorder diagnosis with respect to different 
deployments in Operation Enduring Freedom (OEF)/Operation Iraqi Freedom 
(OIF) missions.  
The information used is based on each service member’s observation 
window, which varied depending on his enlistment date. As described in Chapter 
IV, the observation window approach is used for analysis as this approach allows 
unformed reference point(s) across the entire population in observing 
independent variables (deployment, service and demographic characteristics). 
This approach also ensures that deployment characteristics are independent of 
the outcomes of interest (PTSD, schizophrenia and bipolar disorder). For active 
duty service members who were in service in or after CY2001, they are observed 
between their 8th to 48th month of service or the last date of service, whichever 
is earlier, for deployment characteristics. For active duty service members who 
were in service before CY2001, their observation window is from their earliest 
date of entry from records in the DEERS data to 48 months later or the last date 
of service, whichever is earlier.  
Section B will present the demographic and service information regarding 
both the enlisted and officer populations, by service and deployment status. 
Section C will present the deployment characteristics of both enlisted and officer 
populations, by service. Section D will present information on mental health 
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disorder diagnosis of both enlisted and officer populations, according to the 
different mental health disorders, by service and deployment location, frequency, 
and duration. Section E summarizes this chapter. 
B. SERVICE AND DEMOGRAPHIC CHARACTERISTICS 
Between 2001 and 2011, 2,800,999 service members served in the U.S. 
military from all four services (Army, Marine Corps, Navy and Air Force). Every 
service member had a unique Electronic Data Interchange Person Number 
(EDIPN). Using the EDIPN, service and demographic information can be 
obtained from the various data sources described in Chapter III. Service and 
demographic characteristics are observed at the start of each service member’s 
observation window. 
1. Enlisted Population 
There were 2,436,266 enlisted personnel from all four services, equivalent 
to approximately 87% of the total number of service members. There were 
984,410 Army, 378,873 Marine, 575,986 Navy and 496,997 Air Force enlisted 
personnel. The proportions of enlisted personnel who had at least one 
deployment in OEF/OIF missions during the observation window were 48% for 
the Army, 49% for the Marine Corps, 42% for the Navy and 40% for the Air 
Force. Table 6 provides the detailed breakdown of enlisted personnel’s service 
and demographic characteristics, by military service branch and deployment 
status from CY2001 to CY2011.   
a. Service Characteristics 
The highest proportions of deployed personnel were those serving 
in combat arms specialty fields in the Army and the Marines (30% and 41%, 





belonged to service support (28% in the Army, 34% in the Marine Corps, and 
45% in the Air Force), except for the Navy where most non-deployed sailors were 
working in other specialty fields.  
The majority of both deployed and non-deployed enlisted personnel 
across all services were in middle pay grades—the percentage of E3 to E5 
service members ranged from 53% to 65%.  
b. Demographic Characteristics 
Enlisted personnel from all four services were comprised mainly of 
males, ranging from 76% to 97%. There were more non-married than married 
enlisted personnel, except among Air Force non-deployed.  
Most of the enlisted personnel were white, ranging from 55% to 
73%. The average age of enlisted personnel ranged between 21 and 27 years. In 
general, deployed personnel were younger than non-deployed enlisted personnel 
across all four services. 
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Table 6. Descriptive statistics of enlisted personnel service and demographic characteristics, by military service 
branch and deployment status from CY2001 to CY2011  
  
Army Enlisted Marine Enlisted Navy Enlisted Air Force Enlisted 
Deployed Not Deployed Deployed Not Deployed Deployed Not Deployed Deployed Not Deployed 
No. % No. % No. % No. % No. % No. % No. % No. % 
Observations 474,051 48% 510,359 52% 185,565 49% 193,308 51% 240,611 42% 335,375 58% 201,245 40% 295,752 60% 984,410 378,873 575,986 496,997 
Service Characteristics 
Military Occupational Specialty (MOS)* 
Combat Arms 142,751 30% 92,978 18% 76,103 41% 39,611 20% 10,766 4% 9,270 3% 22,430 11% 34,444 12% 
Combat Service 57,084 12% 60,079 12% 30,727 17% 26,080 13% 26,345 11% 34,754 10% 46,939 23% 62,137 21% 
Service Support 123,953 26% 144,083 28% 50,767 27% 64,849 34% 10,671 4% 18,337 5% 115,038 57% 134,483 45% 
Aviation 0 0% 0 0% 26,600 14% 34,670 18% 8,806 4% 10,806 3% 0 0% 0 0% 
Medical Service 43,724 9% 35,276 7% 0 0% 0 0% 6,609 3% 12,748 4% 508 0.3% 3,703 1% 
Other MOS 106,539 22% 177,943 35% 1,368 1% 28,098 15% 177,414 74% 249,460 74% 16,330 8% 60,985 21% 
Pay Grade* 
E1 to E2 123,848 26% 142,055 28% 66,409 36% 63,513 33% 75,564 31% 81,262 24% 39,969 20% 58,430 20% 
E3 to E5 306,286 65% 270,529 53% 111,229 60% 110,112 57% 138,897 58% 186,575 56% 134,089 67% 171,301 58% 
E6 to E9 43,917 9% 97,775 19% 7,927 4% 19,683 10% 26,150 11% 67,538 20% 27,187 14% 66,021 22% 
Demographic Characteristics 
Gender 
Male 420,441 89% 398,823 78% 179,360 97% 176,710 91% 211,322 88% 276,766 83% 169,481 84% 224,767 76% 
Female 53,610 11% 111,536 22% 6,205 3% 16,598 9% 29,289 12% 58,609 17% 31,764 16% 70,985 24% 
Marital Status* 
Non-Married 294,002 62% 292,724 57% 147,861 80% 134,829 70% 157,267 65% 194,384 58% 109,890 55% 147,471 50% 
Married 180,049 38% 217,635 43% 37,704 20% 58,479 30% 83,344 35% 140,991 42% 91,355 45% 148,281 50% 
Race 
White 299,277 63% 294,622 58% 133,192 72% 130,296 67% 131,822 55% 200,128 60% 146,130 73% 208,149 70% 
Black 94,984 20% 131,366 26% 17,333 9% 27,314 14% 51,407 21% 65,834 20% 32,110 16% 54,477 18% 
Hispanic 37,965 8% 30,232 6% 17,945 10% 14,232 7% 21,338 9% 24,561 7% 7,195 4% 9,855 3% 
Asian 15,635 3% 15,397 3% 5,403 3% 5,125 3% 14,558 6% 17,163 5% 5,496 3% 6,777 2% 
Other Race 26,190 6% 38,742 8% 11,692 6% 16,341 8% 21,486 9% 27,689 8% 10,314 5% 16,494 6% 
Age* 24 26 21 23 24 26 25 27 
*Service members’ information is based on the beginning of their individual observation window.  
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2. Officer and Warrant Officer Population 
There were 364,733 officers and warrant officers from all four services, 
which made up about 13% of the total number of service members. For the 
purpose of this thesis, both officers and warrant officers were classified as 
officers. Out of the 364,733 officers, 149,640 were from the Army, 25,734 from 
the Marine Corps, 80,690 from the Navy and 108,669 from the Air Force. During 
the observation window, the proportions of officers who had at least one 
deployment were 37% for the Army, 43% for the Marine Corps, 27% for the Navy 
and 30% for the Air Force. Table 7 provides the detailed breakdown of officers’ 
service and demographic characteristics, by military service branch and 
deployment status from CY2001 to CY2011.  
a. Service Characteristics 
The highest proportions of deployed officers were serving in 
combat arms specialty fields in the Army and the Marine Corps (29% and 30%, 
respectively). As for non-deployed officers, the largest MOS category belonged 
to the other specialty fields in the Army and Air Force (28% and 99.9%, 
respectively). Most non-deployed officers in the Marine Corps and Navy were 
working in aviation and service support, respectively.  
Most of the deployed officers across all services were low-ranked 
officers. The percentage of officers with O1 to O2 pay grades ranged from 38% 
to 42%. As for non-deployed officers across all services, most were in middle pay 
grades, except for the Marine Corps. The percentage of officers with O3 pay 




b. Demographic Characteristics 
Similar to the enlisted population, most officers were males. This is 
the same across all four services, ranging from 78% to 94%. More officers were 
married than non-married across all services.  
The majority of the officers were white, ranging from 73% to 85%. 
The average age of officers ranged between 31 and 35 years. On average, 





Table 7. Descriptive statistics of officer service and demographic characteristics, by military service branch and 
deployment status from CY2001 to CY2011 
  
Army Officers Marine Officers Navy Officers Air Force Officers 
Deployed Not Deployed Deployed Not Deployed Deployed Not Deployed Deployed Not Deployed 
No.  % No.  % No.  % No.  % No.  % No.  % No.  % No.  % 
Observations 56,101 37% 93,539 63% 10,991 43% 14,743 57% 21,882 27% 58,808 73% 32,989 30% 75,680 70% 149,640 25,734 80,690 108,669 
Service Characteristics 
Military Occupational Specialty (MOS)* 
Combat Arms 16,362 29% 19,351 21% 3,331 30% 2,509 17% 1 0% 10 0.02% 15 0.1% 14 0.02% 
Combat Service 9,310 17% 13,031 14% 876 8% 1,023 7% 1,999 9% 3,511 6% 13 0.04% 33 0.04% 
Service Support 11,385 20% 14,810 16% 3,133 29% 4,281 29% 19,864 91% 51,901 88% 34 0.1% 57 0.1% 
Aviation 0 0% 0 0% 3,318 30% 4,791 33% 0 0% 5 0.01% 0 0% 0 0% 
Medical Service 6,892 12% 20,364 22% 0 0% 0 0% 8 0.04% 35 0.1% 0 0% 3 0% 
Other MOS 12,152 22% 25,983 28% 333 3% 2,139 15% 10 0.1% 3,346 6% 32,927 99.8% 75,573 99.9% 
Pay Grade* 
Warrant Officers 9,396 17% 23,215 25% 1,986 18% 2,971 20% 1,133 5% 8,873 15% 988 3% 10,780 14% 
O1 to O2 21,185 38% 15,273 16% 4,648 42% 3,767 26% 8,888 41% 12,522 21% 13,366 41% 18,994 25% 
O3 12,693 23% 23,365 25% 2,173 20% 2,843 19% 6,307 29% 14,921 25% 9,474 29% 19,490 26% 
O4 8,237 15% 16,899 18% 1,325 12% 2,558 17% 3,249 15% 10,611 18% 5,921 18% 13,766 18% 
O5 3,518 6% 10,499 11% 672 6% 1,929 13% 1,803 8% 7,832 13% 2,656 8% 8,919 12% 
O6 to O10 1,060 2% 4,259 5% 186 2% 673 5% 492 2% 3,981 7% 584 2% 3,724 5% 
Demographic Characteristics 
Gender 
Male 48,895 87% 75,328 81% 10,378 94% 13,711 93% 19,055 87% 48,140 82% 28,185 85% 59,212 78% 
Female 7,206 13% 18,211 19% 613 6% 1,032 7% 2,827 13% 10,668 18% 4,804 15% 16,468 22% 
Marital Status* 
Non-Married 22,823 41% 35,743 38% 4,944 45% 4,457 30% 10,499 48% 26,821 46% 13,061 40% 30,202 40% 
Married 33,278 59% 57,796 62% 6,047 55% 10,286 70% 11,383 52% 31,987 54% 19,928 60% 45,478 60% 
Race 
White 43,665 78% 68,704 73% 9,264 84% 12,102 82% 17,817 81% 47,871 81% 28,042 85% 61,508 81% 
Black 6,432 11% 11,744 13% 565 5% 1,098 7% 1,575 7% 3,654 6% 1,578 5% 4,906 6% 
Hispanic 1,356 2% 1,984 2% 348 3% 378 3% 891 4% 2,058 4% 585 2% 1,160 2% 
Asian 1,730 3% 3,376 4% 233 2% 222 2% 790 4% 2,076 4% 740 2% 2,060 3% 
Other Race 2,918 5% 7,731 8% 581 5% 943 6% 809 4% 3,149 5% 2,044 6% 6,046 8% 
Age* 32 35 31 34 32 33 32 32 




C. DEPLOYMENT CHARACTERISTICS 
OEF/OIF deployment characteristics are observed during the observation 
window. Out of the 2,800,999 service members, 1,223,435 (44%) of them had 
been deployed in OEF/OIF missions. Tables 8 and 9 provide the detailed 
breakdown of deployment characteristics for the enlisted and officer populations, 
respectively, by military service branch from CY2001 to CY2011.  
1. Enlisted Population 
Out of the 2,436,266 enlisted personnel, 1,101,472 (45%) had been 
deployed in OEF/OIF missions at least once during the observation window. 
Among the four services, the proportions of deployed enlisted personnel were 
48% for the Army, 49% for the Marine Corps, 42% for the Navy and 40% for the 
Air Force.   
Deployed location varied noticeably across services: the majority of Army 
and Marine enlisted personnel were deployed to Iraq (41% and 57% among the 
deployed population, respectively), while a large share of Navy enlisted was 
deployed to unknown locations (44%) and two-thirds of Air Force was deployed 
to known locations other than Afghanistan and Iraq. 
Among deployed enlisted personnel, a large proportion had only one 
deployment in OEF/OIF missions during the observation window. This 
corresponded to 82% of Army enlisted personnel, 69% of Marine enlisted 
personnel, 73% of Navy enlisted personnel and 67% of Air Force enlisted 
personnel. 
With regard to the total deployed days during the observation window, with 
the exception of Navy, the majority of enlisted personnel from the other three 





were deployed in OEF/OIF missions for fewer than 120 days. A large proportion 
of Navy enlisted personnel (60%) were deployed in OEF/OIF missions for more 
than 180 days.  
Most of deployed personnel were sent for their first deployment in 
OEF/OIF missions before CY2006. This corresponded to 61% for the Army, 56% 
for the Marine Corps, 71% for the Navy and 75% for the Air Force.  
The majority of the Navy enlisted personnel (59%) had at least one shore-
based deployment in OEF/OIF missions during the observation window. 
2. Officer and Warrant Officer Population 
Among the 364,733 officers observed, 121,963 (33%) had at least one 
deployment in OEF/OIF missions during the observation window. The 
proportions of deployed officers out of the total officer population were 63% for 
the Army, 57% for the Marine Corps, 73% for the Navy and 70% for the Air 
Force.   
Like the enlisted personnel, there was also a distinct variation in deployed 
location among the four services. Most Army, Marine and Air Force officers were 
deployed to known locations other than Afghanistan and Iraq (59%, 54% and 
64% among the deployed population, respectively), while a large share of Navy 
officers was deployed to Afghanistan (46%).  
Among deployed officers, the majority were only deployed once in 
OEF/OIF missions during the observation window. This corresponded to 80% of 
Army officers, 73% of Marine officers, 76% of Navy officers and 62% of Air Force 
officers. 
With the exception of Navy, the majority of officers from the other three 
services (45% for the Army, 42% for the Marine Corps and 49% for the Air Force) 
were deployed for fewer than 120 days. As for the Navy officers, a large 
proportion (47%) were deployed for more than 180 days.  
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Similar to enlisted personnel, large proportions of deployed personnel 
were first deployed before CY2006 (77% for the Army, 83% for the Marine Corps, 
86% for the Navy and 83% for the Air Force). 
Among Navy deployed officers, the majority (79%) were deployed on 
shore at least once during the observation window. This proportion was higher 




Table 8. Descriptive statistics of enlisted personnel deployment characteristics, by military service branch from 
CY2001 to CY2011 
  
Army Enlisted Marine Enlisted Navy Enlisted Air Force Enlisted 
No. % No. % No. % No. % 
Deployment Status 
Not deployed 510,359 52% 193,308 51% 335,375 58% 295,752 60% 
Deployed 474,051 48% 185,565 49% 240,611 42% 201,245 40% 
Deployment Characteristics of Deployed Population 
Location of deployment* 
Ever deployed to Afghanistan 62,154 13% 30,105 16% 99,236 41% 37,159 18% 
Ever deployed to Iraq 196,422 41% 104,985 57% 14,969 6% 44,936 22% 
Ever deployed to an unknown/classified country 9,580 2% 8,319 4% 105,157 44% 23,528 12% 
Ever deployed to another OEF/OIF country 258,801 55% 73,679 40% 51,210 21% 132,817 66% 
Frequency of deployment 
Deployed once 389,208 82% 127,864 69% 176,193 73% 134,175 67% 
Deployed more than once 84,843 18% 57,701 31% 64,418 27% 67,070 33% 
Total days deployed 
Short duration (less than 120 days) 230,551 49% 99,046 53% 49,720 21% 83,946 42% 
Medium duration (120–180 days) 69,341 15% 28,037 15% 47,579 20% 57,663 29% 
Long duration (more than 180 days) 174,159 37% 58,482 32% 143,312 60% 59,636 30% 
Deployment period 
First deployment occurred in CY2005 and prior 288,984 61% 104,723 56% 170,530 71% 150,411 75% 
First deployment occurred in CY2006 and after 185,067 39% 80,842 44% 70,081 29% 50,834 25% 
Type of Deployment (for Navy only)* 
Shore 
  141,157 
59% 
  
Ship 118,371 49% 
Observations 984,410 378,873 575,986 496,997 
*Location and type of deployment will sum up to more than 100% because some service members have multiple deployments within the observation window. 
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Table 9. Descriptive statistics of officer deployment characteristics, by military service branch from CY2001 to 
CY2011 
  
Army Officer Marine Officer Navy Officer Air Force Officer 
No. % No. % No. % No. % 
Deployment Status 
Not deployed 93,539 63% 14,743 57% 58,808 73% 75,680 70% 
Deployed 56,101 37% 10,991 43% 21,882 27% 32,989 30% 
Deployment Characteristics of Deployed Population 
Location of deployment* 
Ever deployed to Afghanistan 8,848 16% 2,075 19% 10,043 46% 8,062 24% 
Ever deployed to Iraq 18,070 32% 4,103 37% 1,498 7% 5,235 16% 
Ever deployed to an unknown/classified country 3,113 6% 695 6% 6,018 28% 5,955 18% 
Ever deployed to another OEF/OIF country 32,835 59% 5,897 54% 6,792 31% 21,127 64% 
Frequency of deployment 
Deployed once 45,003 80% 8,004 73% 16,714 76% 20,352 62% 
Deployed more than once 11,098 20% 2,987 27% 5,168 24% 12,637 38% 
Total days deployed 
Short duration (less than 120 days) 25,465 45% 4,646 42% 6,954 32% 16,277 49% 
Medium duration (120–180 days) 8,316 15% 2,157 20% 4,662 21% 8,175 25% 
Long duration (more than 180 days) 22,320 40% 4,188 38% 10,266 47% 8,537 26% 
Deployment period 
First deployment occurred in CY2005 and prior 43,332 77% 9,120 83% 18,892 86% 27,348 83% 
First deployment occurred in CY2006 and after 12,769 23% 1,871 17% 2,990 14% 5,641 17% 




  Ship 6,013 27% 
Observations 149,640 25,734 80,690 108,669 





D. MENTAL HEALTH DISORDER DIAGNOSIS CHARACTERISTICS 
This section discusses the prevalence rate of Post-Traumatic Stress 
Disorder (PTSD), schizophrenia and bipolar disorder, with respect to the military 
service branch, OEF/OIF deployment location, frequency and duration from 
CY2001 to CY2011.  
The figures include only diagnoses made after the observation window 
begins until the end of FY2011. Out of the 2,800,999 service members, 110,771 
(0.4%) were diagnosed with PTSD, 4,504 (0.02%) were diagnosed with 
schizophrenia and 25,878 (0.09%) were diagnosed with bipolar disorder, after 
the start of the observation window. 
1. Enlisted Population 
a. PTSD 
Table 10 provides the number and rate of PTSD diagnoses among 
enlisted personnel, by military service branch and OEF/OIF deployment 
characteristics, from CY2001 to CY2011. Among the 2,436,266 enlisted 
personnel, 104,342 (4.28%) were diagnosed with the condition. The PTSD 
prevalence rate was noticeably higher among deployed than non-deployed 
enlisted personnel across all services. The prevalence rates for the deployed and 
non-deployed were 10.61% and 3.45% for the Army, 6.56% and 2.02% for the 
Marine Corps, 2.30% and 1.64% for the Navy, and 2.37% and 1.52% for the Air 
Force, respectively.   
Among the OEF/OIF deployment locations, enlisted personnel’s 
PTSD prevalence rates across the four services were the highest for Iraq, 
ranging from 3.91% to 11.07%. The lowest PTSD prevalence rate was also the 
same across all four services, where deployment to an unknown/classified 
country had the lowest rates ranging from 1.18% to 7.57%.  
PTSD was more prevalent among deployed enlisted personnel with 
multiple deployments (2.51% to 11.37%) than those with a single deployment. 
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PTSD was also more prevalent among enlisted personnel who were deployed for 
more than 180 days (2.41% to 10.94%). These trends were observed across all 
four services.   
All services also showed higher percentages of being diagnosed 
with PTSD among enlisted personnel who had their first deployment in CY2005 
or earlier. The percentage of Navy enlisted personnel diagnosed with PTSD was 
similar between shore-based and ship-based deployments.  
 
Table 10. Actual number and percentage of enlisted personnel with PTSD by 
military service branch, deployment location, frequency and duration from 
CY2001 to CY2011 
  
Army Enlisted Marine Enlisted Navy Enlisted 
Air Force 
Enlisted 
No. % No. % No. % No. % 
Overall diagnosed with PTSD 67,939 6.90% 16,085 4.25% 11,034 1.92% 9,284 1.87% 
Deployment status 
Not deployed 17,625 3.45% 3,907 2.02% 5,506 1.64% 4,505 1.52% 
Deployed 50,314 10.61% 12,178 6.56% 5,528 2.30% 4,779 2.37% 
Location of deployment* 
Ever deployed to Afghanistan 5,224 8.40% 1,751 5.82% 1,697 1.71% 829 2.23% 
Ever deployed to Iraq 21,753 11.07% 7,650 7.29% 1,579 10.55% 1,759 3.91% 
Ever deployed to an unknown/classified country 725 7.57% 469 5.64% 1,246 1.18% 388 1.65% 
Ever deployed to another OEF/OIF country 28,584 11.04% 4,621 6.27% 1,929 3.77% 2,940 2.21% 
Frequency of deployment 
Deployed once 40,667 10.45% 7,475 5.85% 3,914 2.22% 3,023 2.25% 
Deployed more than once 9,647 11.37% 4,703 8.15% 1,614 2.51% 1,756 2.62% 
Total days deployed 
Short duration (less than 120 days) 24,268 10.53% 6,476 6.54% 1,124 2.26% 1,697 2.02% 
Medium duration (120–180 days) 6,985 10.07% 1,592 5.68% 952 2.00% 1,275 2.21% 
Long duration (more than 180 days) 19,061 10.94% 4,110 7.03% 3,452 2.41% 1,807 3.03% 
Deployment period 
First deployment occurred in CY2005 and prior 30,838 10.67% 6,916 6.60% 4,046 2.37% 3,617 2.40% 
First deployment occurred in CY2006 and after 19,476 10.52% 5,262 6.51% 1,482 2.11% 1,162 2.29% 




  Ship 2,671 2.26% 
Observations 984,410 378,873 575,986 496,997 
*Location and type of deployment may sum up to more than total number of service members because some service members have 





Table 11 provides the number and rate of schizophrenia diagnoses 
among enlisted personnel, by military service branch and OEF/OIF deployment 
characteristics, from CY2001 to CY2011. This was a rare condition among 
military personnel. Among the enlisted personnel, 4,290 (0.18%) were diagnosed 
with schizophrenia. Schizophrenia prevalence rate was noticeably lower among 
deployed than non-deployed enlisted personnel across all services. Among the 
deployed and non-deployed, schizophrenia was prevalent among 0.19% and 
0.25% of Army enlisted personnel, 0.09% and 0.19% of Marine enlisted 
personnel, 0.13% and 0.21% of Navy enlisted personnel, and 0.07% and 0.14% 
of Air Force enlisted personnel, respectively.   
Among the OEF/OIF deployment locations, enlisted personnel’s 
schizophrenia prevalence rates were the highest for other OEF/OIF countries for 
the Army and the Marine Corps. It was the highest for Iraq for the Navy. There 
was no distinctive difference for the Air Force.   
In terms of deployment frequency, the schizophrenia prevalence 
rate was lowest among enlisted personnel with more than one deployment 
across all four services, ranging from 0.05% to 0.15%.  
As for deployment duration, with the exception of the Army, enlisted 
personnel who were deployed in OEF/OIF missions for 120 to 180 days had the 
highest prevalence rate of schizophrenia (0.08% to 0.16%). The rate for the Army 
was the highest among those with fewer than 120 days (0.21%).   
With regard to the deployment period, with the exception of the 
Army, schizophrenia was more prevalent among enlisted personnel whose first 
deployment was in CY2005 or earlier (0.08% to 0.14%). Among Navy enlisted 
personnel, the schizophrenia prevalence rate was higher among those with 




Table 11. Actual number and percentage of enlisted personnel with 
schizophrenia by military service branch, deployment location, frequency 
and duration from CY2001 to CY2011 
  
Army Enlisted Marine Enlisted Navy Enlisted 
Air Force 
Enlisted 
No. % No. % No. % No. % 
Overall diagnosed with schizophrenia 2,181 0.22% 546 0.14% 1,007 0.17% 556 0.11% 
Deployment status 
Not deployed 1,271 0.25% 375 0.19% 706 0.21% 413 0.14% 
Deployed 910 0.19% 171 0.09% 301 0.13% 143 0.07% 
Location of deployment* 
Ever deployed to Afghanistan 88 0.14% 20 0.07% 136 0.14% 25 0.07% 
Ever deployed to Iraq 341 0.17% 88 0.08% 22 0.15% 31 0.07% 
Ever deployed to an unknown/classified country 18 0.19% 5 0.06% 112 0.11% 8 0.03% 
Ever deployed to another OEF/OIF country 534 0.21% 81 0.11% 55 0.11% 97 0.07% 
Frequency of deployment 
Deployed once 782 0.20% 126 0.10% 242 0.14% 107 0.08% 
Deployed more than once 128 0.15% 45 0.08% 59 0.09% 36 0.05% 
Total days deployed 
Short duration (less than 120 days) 487 0.21% 88 0.09% 75 0.15% 61 0.07% 
Medium duration (120–180 days) 120 0.17% 40 0.14% 77 0.16% 47 0.08% 
Long duration (more than 180 days) 303 0.17% 43 0.07% 149 0.10% 35 0.06% 
Deployment period 
First deployment occurred in CY2005 and prior 503 0.17% 103 0.10% 235 0.14% 116 0.08% 
First deployment occurred in CY2006 and after 407 0.22% 68 0.08% 66 0.09% 27 0.05% 




  Ship 128 0.11% 
Observations 984,410 378,873 575,986 496,997 
*Location and type of deployment may sum up to more than total number of service members because some service members have 
multiple deployments within the observation window. 
 
c. Bipolar Disorder 
Table 12 provides the number and rate of bipolar disorder 
diagnoses among enlisted personnel, by military service branch and OEF/OIF 
deployment characteristics, from CY2001 to CY2011. Out of all the observed 
enlisted personnel, 24,175 (0.99%) were diagnosed with bipolar disorder. The 
bipolar disorder prevalence rate was noticeably lower among deployed than non-
deployed enlisted personnel across all services. The prevalence rates for the 
deployed and non-deployed were 1.33% and 1.34% for the Army, 0.57% and 
0.74% for the Marine Corps, 0.56% and 0.92% for the Navy, and 0.67% and 
0.93% for the Air Force, respectively. 
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Among the OEF/OIF deployment locations, bipolar disorder was 
most prevalent among Army (1.40%) and Air Force (0.73%) enlisted personnel 
who were deployed to another OEF/OIF country. For Marine enlisted personnel, 
those deployed to an unknown/classified country had the highest bipolar disorder 
prevalence rate (0.65%). As for Navy enlisted personnel, those deployed to Iraq 
had the highest bipolar disorder prevalence rate (0.73%).  
Across all four services, bipolar disorder was more prevalent 
among enlisted personnel with one deployment in OEF/OIF missions, ranging 
from 0.58% to 1.35%. For deployment duration, except for the Marine Corps, 
bipolar disorder was more prevalent (0.66% to 1.45%) among enlisted personnel 
who were deployed for fewer than 120 days. For Marine enlisted personnel, the 
highest bipolar disorder prevalence rate (0.65%) was observed among those who 
were deployed for between 120 and 180 days.  
Similar to schizophrenia, except for Army, bipolar disorder was 
more prevalent (0.58 to 0.73%) among enlisted personnel who were deployed in 
CY2005 and before. For Navy enlisted personnel, bipolar disorder was more 
prevalent among Navy enlisted personnel with shore-based deployment (0.59%), 











Table 12. Actual number and percentage of enlisted personnel with bipolar 
disorder, by military service branch, deployment location, frequency and 
duration from CY2001 to CY2011 
  
Army Enlisted Marine Enlisted Navy Enlisted 
Air Force 
Enlisted 
No. % No. % No. % No. % 
Overall diagnosed with bipolar disorder 13,132 1.33% 2,494 0.66% 4,452 0.77% 4,097 0.82% 
Deployment status 
Not deployed 6,848 1.34% 1,440 0.74% 3,096 0.92% 2,755 0.93% 
Deployed 6,284 1.33% 1,054 0.57% 1,356 0.56% 1,342 0.67% 
Location of deployment* 
Ever deployed to Afghanistan 674 1.08% 131 0.44% 540 0.54% 207 0.56% 
Ever deployed to Iraq 2,506 1.28% 606 0.58% 109 0.73% 254 0.57% 
Ever deployed to an unknown/classified country 101 1.05% 54 0.65% 557 0.53% 114 0.48% 
Ever deployed to another OEF/OIF country 3,636 1.40% 393 0.53% 322 0.63% 963 0.73% 
Frequency of deployment 
Deployed once 5,252 1.35% 795 0.62% 1,030 0.58% 965 0.72% 
Deployed more than once 1,032 1.22% 259 0.45% 326 0.51% 377 0.56% 
Total days deployed 
Short duration (less than 120 days) 3,340 1.45% 596 0.60% 326 0.66% 634 0.76% 
Medium duration (120–180 days) 847 1.22% 181 0.65% 301 0.63% 384 0.67% 
Long duration (more than 180 days) 2,097 1.20% 277 0.47% 729 0.51% 324 0.54% 
Deployment period 
First deployment occurred in CY2005 and prior 3,505 1.21% 606 0.58% 1,045 0.61% 1,092 0.73% 
First deployment occurred in CY2006 and after 2,779 1.50% 448 0.55% 311 0.44% 250 0.49% 




  Ship 635 0.54% 
Observations 984,410 378,873 575,986 496,997 
*Location and type of deployment will sum up to more than total number of service members because some service members have 
multiple deployments within the observation window. 
 
2. Officer and Warrant Officer Population 
a. PTSD 
Table 13 provides the number and rate of PTSD diagnoses among 
officers, by military service branch and OEF/OIF deployment characteristics, from 
CY2001 to CY2011. Results showed that 6,429 (1.76%) out of the 364,733 
officers observed were diagnosed with PTSD. This condition was noticeably 
more prevalent among deployed than non-deployed officers across all services. 




officers, 2.17% and 0.99% of the Marine officers, 1.28% and 0.87% of the Navy 
officers, and 1.32% and 0.86% of the Air Force officers were diagnosed with 
PTSD, respectively. 
PTSD was found to be most prevalent among Army (4.38%) and 
Marine (2.46%) officers who were deployed in another OEF/OIF country. As for 
Navy (3.27%) and Air Force (2.88%), PTSD prevalence rates were highest for 
those deployed in Iraq.  
Unlike enlisted personnel, there was no clear trend in terms of 
deployment frequency in OEF/OIF missions for officers. PTSD was more 
prevalent among Army (4.48%) and Marine (2.51%) officers with multiple 
deployments, and among Navy (1.38%) and Air Force (1.51%) officers with a 
single deployment.  
Other than Army officers, a higher percentage of officers were 
diagnosed with PTSD after they were deployed for a “medium” duration of 120 to 
180 days (1.48% to 2.69%). PTSD was more prevalent among Army officers who 
were deployed for more than 180 days, at 4.51%. 
All services, less the Air Force, showed a higher percentage of 
being diagnosed with PTSD among officers whose first deployment was in 
CY2005 or earlier, ranging from 1.32% to 4.40%. A higher percentage (1.34%) of 
Navy officers who had shore-based deployment was diagnosed with PTSD, 











Table 13. Actual number and percentage of officers with PTSD, by military 
service branch, deployment location, frequency and duration from CY2001 
to CY2011 
  
Army Officer Marine Officer Navy Officer Air Force Officer 
No. % No. % No. % No. % 
Overall diagnosed with PTSD 4,173 2.79% 384 1.49% 789 0.98% 1,083 1.00% 
Deployment status 
Not deployed 1,855 1.98% 146 0.99% 509 0.87% 648 0.86% 
Deployed 2,318 4.13% 238 2.17% 280 1.28% 435 1.32% 
Location of deployment* 
Ever deployed to Afghanistan 288 3.25% 45 2.17% 84 0.84% 97 1.20% 
Ever deployed to Iraq 781 4.32% 88 2.14% 49 3.27% 151 2.88% 
Ever deployed to an unknown/classified country 111 3.57% 13 1.87% 44 0.73% 53 0.89% 
Ever deployed to another OEF/OIF country 1,439 4.38% 145 2.46% 131 1.93% 215 1.02% 
Frequency of deployment 
Deployed once 1,821 4.05% 163 2.04% 230 1.38% 308 1.51% 
Deployed more than once 497 4.48% 75 2.51% 50 0.97% 127 1.00% 
Total days deployed 
Short duration (less than 120 days) 987 3.88% 74 1.59% 80 1.15% 195 1.20% 
Medium duration (120–180 days) 325 3.91% 58 2.69% 69 1.48% 133 1.63% 
Long duration (more than 180 days) 1,006 4.51% 106 2.53% 131 1.28% 107 1.25% 
Deployment period 
First deployment occurred in CY2005 and prior 1,908 4.40% 220 2.41% 249 1.32% 359 1.31% 
First deployment occurred in CY2006 and after 410 3.21% 18 0.96% 31 1.04% 76 1.35% 




  Ship 62 1.03% 
Observations 149,640 25,734 80,690 108,669 
*Location and type of deployment will sum up to more than total number of service members because some service members have 















Table 14 provides the number and rate of schizophrenia diagnoses 
among officers, by military service branch and OEF/OIF deployment 
characteristics, from CY2001 to CY2011. A total of 214 officers were diagnosed 
with schizophrenia. This was equivalent to 0.06% of the total number of officers 
observed. Like enlisted personnel, the schizophrenia prevalence rate was 
noticeably lower among deployed than non-deployed officers across all services. 
Prevalence rates for the deployed and non-deployed were observed to be 0.03% 
and 0.08% for the Army, 0.01% and 0.05% for the Marine Corps, 0.04% and 
0.08% for the Navy, and 0.02% and 0.06% for the Air Force, respectively. 
Schizophrenia was most prevalent among Army (0.05%), Marine 
(0.02%) and Air Force (0.03%) officers who were deployed in another OEF/OIF 
country. For Navy officers, the schizophrenia prevalence rate was highest 
(0.05%) among those deployed to an unknown/classified country.  
With the exception of Air Force, the proportions of officers 
diagnosed with schizophrenia for the other three services were higher for those 
with a single deployment in OEF/OIF missions, ranging from 0.01% to 0.04%, 
compared to those with multiple deployments. 
There was no clear pattern to explain the schizophrenia prevalence 
rate against total number of days deployed.  
Officers from all four services had a higher probability of 
schizophrenia among those with their first deployment in CY2005 or earlier, 
ranging from 0.01% to 0.04%. Schizophrenia was more prevalent among Navy 
officers with ship-based deployment (0.07%), compared to those with shore-








Table 14. Actual number and percentage of officers with schizophrenia, by 
military service branch, deployment location, frequency and duration from 
CY2001 to CY2011 
  
Army Officer Marine Officer Navy Officer Air Force Officer 
No. % No. % No. % No. % 
Overall diagnosed with schizophrenia 96 0.06% 8 0.03% 55 0.07% 55 0.05% 
Deployment status 
Not deployed 77 0.08% 7 0.05% 46 0.08% 47 0.06% 
Deployed 19 0.03% 1 0.01% 9 0.04% 8 0.02% 
Location of deployment* 
Ever deployed to Afghanistan 3 0.03% 0 0% 4 0.04% 1 0.01% 
Ever deployed to Iraq 1 0.01% 0 0% 0 0% 1 0.02% 
Ever deployed to an unknown/classified country 0 0% 0 0% 3 0.05% 1 0.02% 
Ever deployed to another OEF/OIF country 16 0.05% 1 0.02% 2 0.03% 6 0.03% 
Frequency of deployment 
Deployed once 18 0.04% 1 0.01% 9 0.05% 4 0.02% 
Deployed more than once 1 0.01% 0 0% 0 0% 4 0.03% 
Total days deployed 
Short duration (less than 120 days) 10 0.04% 1 0.02% 1 0.01% 5 0.03% 
Medium duration (120–180 days) 4 0.05% 0 0% 3 0.06% 2 0.02% 
Long duration (more than 180 days) 5 0.02% 0 0% 5 0.05% 1 0.01% 
Deployment period 
First deployment occurred in CY2005 and prior 18 0.04% 1 0.01% 8 0.04% 8 0.03% 
First deployment occurred in CY2006 and after 1 0.01% 0 0% 1 0.03% 0 0% 




  Ship 4 0.07% 
Observations 149,640 25,734 80,690 108,669 
*Location and type of deployment will sum up to more than total number of service members because some service members have 








c. Bipolar Disorder 
Table 15 provides the number and rate of bipolar disorder 
diagnoses among officers, by military service branch and OEF/OIF deployment 
characteristics, from CY2001 to CY2011. Among the officers observed in this 
thesis, 1,703 (0.04%) were diagnosed with bipolar disorder. The number of cases 
of bipolar disorder was noticeably lower among deployed than non-deployed 
officers across all services, except for the Marine Corps. Prevalence rates for the 
deployed and non-deployed were 0.52% and 0.63% for the Army, 0.29% and 
0.27% for the Marine Corps, 0.41% and 0.46% for the Navy, and 0.25% and 
0.40% for the Air Force, respectively.  
Bipolar disorder was more prevalent among Army (0.58%) and 
Marine (0.43%) officers who were deployed to an unknown/classified country. 
Bipolar disorder prevalence rates were highest among Navy (0.53%) and Air 
Force (0.36%) officers who were deployed to Iraq.   
Bipolar disorder was observed to be more prevalent among officers 
with a single deployment in OEF/OIF missions across all four services. Among 
officers with a single deployment, 0.29% to 0.53% were diagnosed with bipolar 
disorder, compared to those with multiple deployments (0.19% to 0.49%). 
No distinct pattern explaining the prevalence rate of bipolar disorder 
based on the total number of days deployed was observed. 
Among officers from all four services, bipolar disorder was more 
prevalent for those with first deployment in CY2005 and prior (0.27% to 0.54%), 
compared to first deployment in CY2006 and after (0.14% to 0.48%). However, 
unlike schizophrenia, the bipolar disorder prevalence rate was slightly higher 
among Navy officers with shore-based deployment (0.39%), compared to those 







Table 15. Actual number and percentage of officers with bipolar disorder, by 
military service branch, deployment location, frequency and duration from 
CY2001 to CY2011 
  
Army Officer Marine Officer Navy Officer Air Force Officer 
No. % No. % No. % No. % 
Overall diagnosed with bipolar disorder 882 0.59% 72 0.28% 360 0.45% 389 0.36% 
Deployment status 
Not deployed 588 0.63% 40 0.27% 271 0.46% 306 0.40% 
Deployed 294 0.52% 32 0.29% 89 0.41% 83 0.25% 
Location of deployment* 
Ever deployed to Afghanistan 42 0.47% 7 0.34% 31 0.31% 17 0.21% 
Ever deployed to Iraq 77 0.43% 13 0.32% 8 0.53% 19 0.36% 
Ever deployed to an unknown/classified country 18 0.58% 3 0.43% 22 0.37% 7 0.12% 
Ever deployed to another OEF/OIF country 187 0.57% 17 0.29% 34 0.50% 54 0.26% 
Frequency of deployment 
Deployed once 240 0.53% 24 0.30% 77 0.46% 59 0.29% 
Deployed more than once 54 0.49% 8 0.27% 12 0.23% 24 0.19% 
Total days deployed 
Short duration (less than 120 days) 119 0.47% 11 0.24% 36 0.52% 43 0.26% 
Medium duration (120–180 days) 49 0.59% 7 0.32% 20 0.43% 27 0.33% 
Long duration (more than 180 days) 126 0.56% 14 0.33% 33 0.32% 13 0.15% 
Deployment period 
First deployment occurred in CY2005 and prior 233 0.54% 28 0.31% 81 0.43% 75 0.27% 
First deployment occurred in CY2006 and after 61 0.48% 4 0.21% 8 0.27% 8 0.14% 




  Ship 23 0.38% 
Observations 149,640 25,734 80,690 108,669 
*Location and type of deployment will sum up to more than total number of service members because some service members have 








The descriptive analysis presented in this chapter will facilitate a better 
understanding about the characteristics of both the officer and enlisted 
populations of the four services, with respect to deployment in OEF/OIF missions 
and mental health disorder. Generally, PTSD prevalence rates were higher for 
both deployed officers and enlisted personnel, compared to non-deployed 
service members. On the contrary, schizophrenia and bipolar disorder 
prevalence rates were lower for the deployed groups, compared to non-deployed 
service members. Because schizophrenia is such a rare event in the active duty 
population, as shown in Tables 11 and 14, the authors exclude this condition 
from the multivariate analysis. Chapter VI will next present the results of the 
multivariate analysis models. 
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VI. MULTIVARIATE ANALYSIS RESULTS 
A. INTRODUCTION 
This chapter will present and discuss the results of probit models used to 
examine the effect of Operation Enduring Freedom (OEF) or Operation Iraqi 
Freedom (OIF) deployment characteristics on the probabilities of being 
diagnosed with Post-Traumatic Stress Disorder (PTSD) or bipolar disorder. 
Separate analyses were conducted for enlisted and officer (officer and warrant 
officer) populations across the four services of the U.S. military, and for each of 
the mental health conditions. As shown in Chapter V, schizophrenia was a rare 
event in the active duty population. Thus, schizophrenia was excluded from the 
multivariate analysis.   
This thesis used eight probit models for each mental health condition and 
population, which included four base models and four interaction models. Service 
and demographic variables, such as Military Occupation Specialty (MOS), pay 
grade, gender, race, marital status and age, were held constant in all models. 
Depending on the model, various key variables of interest estimated the effects 
of OEF/OIF deployment characteristics, such as deployment location, 
deployment frequency and days deployed.  
The four base models are summarized below.  
1. Model 1–Overall Effect of Deployment 
The first base model examines the overall effect of deployment in 
OEF/OIF missions on the probabilities of being diagnosed with PTSD or bipolar 
disorder. The key variable of interest is whether the service member had been 
sent for deployment in OEF/OIF missions within the observation window.  
2. Model 2–Effect of Deployment Location 
The second model provides additional details by examining the effect of  
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the deployment location (Afghanistan, Iraq, an unknown/classified country, and 
another OEF/OIF country) on the probabilities of being diagnosed with PTSD or 
bipolar disorder.  
3. Model 3–Effect of Deployment Location and Frequency 
The third base model examines the effect of the OEF/OIF deployment 
location and having multiple OEF/OIF deployments on the probabilities of being 
diagnosed with PTSD or bipolar disorder.  
4. Model 4–Effect of Deployment Location and Duration 
The fourth base model examines the effect of the OEF/OIF deployment 
location and total days deployed within the observation window on the 
probabilities of being diagnosed with PTSD or bipolar disorder. The total days 
deployed within the observation window are divided into three categories: (1) 
Short (less than 120 days), (2) Medium (120 to 180 days), and (3) Long (more 
than 180 days). 
Modifications were made to Models 1 and 2 to study how the interactions 
between various independent variables affected the probabilities of being 
diagnosed with PTSD or bipolar disorder. Four interaction models were used. 
The interaction models and their respective key variables of interest are 
summarized below.   
5. Model 5–Interaction Effect between Deployment and 
Deployment Period 
This model is modified from Model 1 to examine the interactive effect of 
deployment in OEF/OIF missions and deployment period on the probabilities of 
being diagnosed with PTSD or bipolar disorder. With the increase in U.S. military 
efforts, the number of boots on the ground increased between FY2006 and 
FY2010 (U.S. Library of Congress, 2011). This model aims to examine if the 
effect of OEF/OIF deployment differs depending on whether the service member 
was first deployed in CY2005 and prior, or from CY2006 to CY2010. Service 
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members who had been deployed are categorized into “CY2005 and prior” and 
“CY2006 and after” deployment periods, based on their first deployment start 
date within the observation window. A dummy variable is created for each of the 
two periods, to replace the original deployment variable. 
6. Model 6–Interaction Effect between Deployment Location and 
Period 
This model is modified from Model 2 to examine the effect of OEF/OIF 
deployment location and period on the probabilities of being diagnosed with 
PTSD or bipolar disorder. For each location, service members who had been 
deployed to that location are categorized into “CY2005 and prior” and “CY2006 
and after” deployment periods, based on their first deployment start date to that 
location. A dummy variable is created for each of the two periods to replace the 
four original OEF/OIF deployment location variables. A total of eight dummy 
variables are included in the model. 
7. Model 7–Interaction Effect between Deployment and MOS 
Model 1 is further modified to examine the interaction effect between 
deployment in OEF/OIF missions and MOS on the probabilities of being 
diagnosed with PTSD or bipolar disorder. To study the effect of combat arms 
versus other types of MOS, all non-combat arms MOSs are grouped together. 
The interaction variable of deployment and non-combat arms MOSs is then 
generated.  
8. Model 8–Interaction Effect Between Deployment and Gender 
Model 1 is also modified to examine the interaction effect between 
deployment in OEF/OIF missions and gender on the probabilities of being 
diagnosed with PTSD or bipolar disorder. An interaction variable between 
deployment and the female variable is included in the model.  
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B. ARMY ENLISTED POPULATION RESULTS 
Table 16 presents the complete results of Model 1 for both PTSD and 
bipolar disorder among Army enlisted personnel. The key variable of interest was 
a binary variable “Deployed,” which captured whether the service member had 
been sent for deployment related to OEF/OIF within the observation window. The 
abbreviated results of all eight models will be presented, focusing on the key 
deployment variables, in Tables 17 (on PTSD) and 18 (on bipolar disorder). 
The probabilities of being diagnosed with PTSD or bipolar disorder were 
significantly dependent on whether the Army enlisted personnel was deployed as 
part of OEF/OIF missions (p<0.01). A reference Army enlisted personnel’s (single 
white male in E1 to E2 rank, serving in combat arms specialty field) probability of 
being diagnosed with PTSD increased by 5.9 percentage point if deployed, 
compared to those not deployed. On the other hand, a reference Army enlisted 
personnel’s probability of being diagnosed with bipolar disorder decreased by 
0.15 of one percentage point if deployed, compared to those not deployed. The 
opposite effects observed on the deployment variable between PTSD and bipolar 
disorder might reflect the differences in the underlying cause of disease. PTSD is 
triggered by the experience of a traumatic event, while bipolar disorder is 
associated with a genetic disposition. With the genetic disposition, the service 
member might not be selected for OEF/OIF missions.  
Being in combat arms and service support specialty fields generally 
increased an average Army enlisted personnel’s probability of being diagnosed 
with either mental health disorder (all p<0.01, except service support for bipolar 
disorder at p<0.1). Being in junior pay grades (E1 to E2) also increased an 
average Army enlisted personnel’s probability of being diagnosed with either 
mental health disorder (p<0.01).  
Females had higher probabilities of being diagnosed with PTSD or bipolar 
disorder, compared to males, although the practical magnitudes were small. In 
particular, the probabilities of being diagnosed with PTSD or bipolar disorder 
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were 0.1 and 0.77 of one percentage point higher, respectively, for females 
(p<0.05 and p<0.01, respectively). Whites had higher probabilities of being 
diagnosed with PTSD or bipolar disorder, compared to the other racial groups 
(p<0.01). Married personnel had higher probability of being diagnosed with PTSD 
(2.5 percentage point) and bipolar disorder (0.31 of one percentage point), 
compared to non-married personnel (both p<0.01).  
The next two sections provide regression results of all models separately 
for PTSD and bipolar disorder. 
Table 16. Model 1: Marginal effect of deployment on probability of being 
diagnosed with PTSD and bipolar disorder (Army enlisted population) 
Variable PTSD Bipolar Disorder 
Deployment Characteristics     
Deployed in OEF/OIF missions 0.059*** -0.0015*** 
  (0.001) (0.000) 
Service Characteristics (Combat Arms MOSs and E1 to E2 are the reference groups) 
Combat Service -0.024*** -0.0016*** 
  (0.001) (0.000) 
Service Support -0.018*** 0.0006* 
  (0.001) (0.000) 
Medical -0.020*** -0.0000 
  (0.001) (0.000) 
Other MOSS -0.023*** -0.0014*** 
  (0.001) (0.000) 
E3 to E5 -0.005*** -0.0019*** 
  (0.001) (0.000) 
E6 to E9 -0.019*** -0.0068*** 
  (0.001) (0.000) 
Demographic Characteristics (Male, White, and non-married with no missing age information are the 
reference groups) 
Female 0.001** 0.0077*** 
  (0.001) (0.000) 
Black -0.008*** -0.0056*** 
  (0.001) (0.000) 
Hispanic -0.004*** -0.0055*** 
  (0.001) (0.000) 
Asian -0.015*** -0.0045*** 
  (0.001) (0.000) 
Other Race 0.000 -0.0051*** 
  (0.001) (0.000) 
Married 0.025*** 0.0031*** 
  (0.001) (0.000) 
Age 0.000*** -0.0000 
  (0.000) (0.000) 
Missing age indicator -0.048*** -0.0074*** 
  (0.001) (0.000) 
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Variable PTSD Bipolar Disorder 
Calendar Year of Observation (CY2000 is the reference group) 
CY2001 -0.008*** -0.0017*** 
  (0.001) (0.000) 
CY2002 -0.004*** -0.0013*** 
  (0.001) (0.000) 
CY2003 -0.004*** -0.0027*** 
  (0.001) (0.000) 
CY2004 -0.001 -0.0013*** 
  (0.001) (0.000) 
CY2005 0.003*** 0.0009* 
  (0.001) (0.000) 
CY2006 0.000 0.0021*** 
  (0.001) (0.001) 
CY2007 -0.017*** 0.0014*** 
  (0.001) (0.000) 
CY2008 -0.027*** -0.0011* 
  (0.001) (0.001) 
Observed Probability 0.069 0.0133 
Predicted Probability 0.056 0.0122 
Observations 984,410 984,410 
Standard errors in parentheses 




Table 17 presents the marginal effects of key variables of interest on the 
probability of being diagnosed with PTSD. Results of Model 1 shown in the first 
column of Table 16 are reproduced for comparison purposes.  
Model 2 investigated the effect of OEF/OIF deployment location on the 
probability of being diagnosed with PTSD. Deployment to any OEF/OIF location 
(Afghanistan, Iraq, an unknown/classified country or another OEF/OIF country) 
increased the probability of being diagnosed with PTSD, compared to non-
deployed (p<0.01). The magnitude of increase was the highest at 5.4 percentage 
point if deployed to another OEF/OIF country. This was followed by an increase 
of 5.2 percentage points if deployed to Iraq, 1.9 percentage points if deployed to 
Afghanistan, and the lowest increase of 0.9 of one percentage point if deployed 
to an unknown/classified country. All of the pairwise location coefficient 
comparisons were significant (p< 0.01). 
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Model 3 investigated whether there was a difference in the deployment 
effect between those with a single deployment, and those with multiple 
deployments within the observation window. Results showed that having multiple 
deployments decreased the probability of being diagnosed with PTSD by 1.9 
percentage point, compared to an average Army enlisted personnel with a single 
deployment (p< 0.01).   
Model 4 investigated the relationship between days deployed and the 
probability of being diagnosed with PTSD. The probability of being diagnosed 
with PTSD increased by 0.3 of one percentage point for Army enlisted personnel 
with 120 to 180 days of deployment in OEF/OIF missions, and by 0.5 of one 
percentage point if deployed more than 180 days within the observation window, 
compared to those with fewer than 120 days (both p<0.01).    
Model 5 investigated whether there were differences in the deployment 
effect between those whose first deployment in OEF/OIF missions occurred in 
CY2005 and prior, and those who were deployed for the first time in CY2006 and 
after. The probability of being diagnosed with PTSD increased by 6.4 percentage 
points for Army enlisted personnel whose first deployment in OEF/OIF missions 
occurred in CY2005 and prior, and 8.4 percentage points for those whose first 
deployment in OEF/OIF missions occurred in CY2006 and after, compared to 
those not deployed. The coefficient estimates for the two periods were found to 
be statistically different from each other (p<0.01).   
Model 6 refined Model 5’s specification by comparing the coefficient 
estimates of deployed locations by periods. In general, the OEF/OIF deployment 
location effects were higher among those whose first deployment in OEF/OIF 
missions to a given location occurred in CY2006 and after. The differences 
between the two periods for all locations were statistically significant (p< 0.01).  
Model 7 expanded Model 1 and investigated whether the deployment 
effect was magnified or moderated by MOS categories. The results showed that 
the interaction effect between deployment in OEF/OIF missions and non-combat 
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arms MOSs was statistically significant (p<0.01). This meant that the probability 
of being diagnosed with PTSD significantly decreased by 0.4 of one percentage 
point if the deployed Army enlisted personnel was from non-combat arms MOSs, 
compared to those deployed and from combat arms MOSs.  
Model 8 expanded Model 1 and investigated whether there was differential 
effect by gender. Results showed that the interaction effect between deployment 
in OEF/OIF missions and being female was negative (p<0.01). The coefficient 
estimates suggested that the probability of being diagnosed with PTSD 
decreased by 1.6 percentage points if the deployed Army enlisted personnel was 
female, compared to male counterparts.  
2. Bipolar Disorder 
Table 18 presents the marginal effects of key variables of interest on the 
probability of being diagnosed with bipolar disorder. Results of Model 1 shown in 
the second column of Table 16 are reproduced for comparison purposes.  
Model 2 investigated the effect of OEF/OIF deployment location on the 
probability of being diagnosed with bipolar disorder. Deployment to Afghanistan, 
Iraq or an unknown/classified country was associated with reduced probability of 
being diagnosed with bipolar disorder, compared to non-deployed (p<0.01 for 
Afghanistan and Iraq, p<0.1 for an unknown/classified country). An average Army 
enlisted personnel’s probability of being diagnosed with bipolar disorder 
decreased by 0.31 of one percentage point if deployed to Afghanistan, by 0.18 of 
one percentage point if deployed to Iraq, and by 0.20 of one percentage point if 
deployed to an unknown/classified country. Similar to PTSD, the probability of 
being diagnosed with bipolar disorder was significantly higher if he was ever 
deployed to Iraq, as compared to Afghanistan (p<0.01).  
Model 3 investigated whether there was a difference in the deployment 
effect between those with a single deployment in OEF/OIF missions, and those 
with multiple deployments within the observation window. Results showed that  
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having multiple deployments was not associated with significantly different 
probability of being diagnosed with bipolar disorder for Army enlisted personnel 
(p<0.1).  
Model 4 investigated the relationship between days deployed and the 
probability of being diagnosed with bipolar disorder. More days deployed was 
associated with reduced probability of being diagnosed with bipolar disorder. The 
probability of being diagnosed with bipolar disorder decreased by 0.12 of one 
percentage point for Army enlisted personnel with 120 to 180 days of deployment 
in OEF/OIF missions (p<0.01), and by 0.07 of one percentage point if the service 
member was deployed for more than 180 days within the observation window, 
compared to those with fewer than 120 days (p<0.05). 
Model 5 investigated whether the association between deployment in 
OEF/OIF missions and the probability of being diagnosed with bipolar disorder 
differed between those whose first deployment in OEF/OIF missions occurred in 
CY2005 and prior, and those who were deployed for the first time in CY2006 and 
after. No statistically significant difference between the two periods was found. 
Model 6 refined Model 5’s specification by comparing the coefficient 
estimates of deployed locations by periods. Those whose first deployment to Iraq 
in CY2005 and prior were associated with a higher probability of being diagnosed 
with bipolar disorder, compared to those whose first deployment to Iraq occurred 
in CY2006 and after (p<0.01). The reverse trend was observed for an 
unknown/classified country, where lower probability of being diagnosed with 
bipolar disorder was associated with those whose first deployment to an 
unknown/classified country occurred in CY2005 and prior (p<0.01).  
Model 7 expanded Model 1 and investigated whether the deployment 
effect was magnified or moderated by MOS categories. The results showed that 
the interaction effect between deployment in OEF/OIF missions and non-combat 
arms MOSs was associated with a higher probability of bipolar disorder (p<0.01). 
This meant that the probability of being diagnosed with bipolar disorder increased 
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by 0.09 of one percentage point if the deployed Army enlisted personnel was 
from non–combat arms MOSs, compared to those deployed and from combat 
arms MOSs. 
Model 8 expanded Model 1 and investigated whether there was differential 
effect by gender. The results showed that the interaction effect between 
deployment in OEF/OIF missions and being female was not statistically 
significant.    
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Table 17. Marginal effect of key variables of interest on probability of being diagnosed with PTSD  
(Army enlisted population) 
Variable Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 8 
Deployment                 
Deployed in OEF/OIF missions 0.059*** -   -  - -  -  0.062*** 0.062*** 
  (0.001)           (0.001) (0.001) 
Interaction between Deployment and Deployment Period             
First deployment occurred in CY2005 and prior  -  -  -  - 0.064***  -  -  - 
          (0.001)       
First deployment occurred n CY2006 and after  -  -  -  - 0.084***  -  -  - 
          (0.001)       
Deployment Location                 
Ever deployed to Afghanistan  - 0.019*** 0.030*** 0.017***  -  -  -  - 
    (0.001) (0.001) (0.001)         
Ever deployed to Iraq  - 0.052*** 0.061*** 0.049***  -  -  -  - 
    (0.001) (0.001) (0.001)         
Ever deployed to an unknown/classified country  - 0.009*** 0.021*** 0.009***  -  -  -  - 
  (0.003) (0.003) (0.002)         
Ever deployed to another OEF/OIF country -  0.054*** 0.063*** 0.052*** -  -  -  -  
  (0.001) (0.001) (0.001)         
Deployment Frequency                 
Deployed more than once  -  - -0.019*** -  -   - -   - 
      (0.001)           
Total Days Deployed                 
Short duration (less than 120 days) - - - reference - - - - 
                  
Medium duration (120 to 180 days)  -  -  - 0.003***  -  -  -  - 
        (0.001)         
Long duration (more than 180 days)  -  -  - 0.005***  -  -  -  - 
        (0.001)         
Interaction between Deployment Location and Period             
Deployed to Afghanistan in CY2005 and prior  -  -  -  -  - 0.010***  -  - 
          (0.001)     
Deployed to Afghanistan in CY2006 and after -  -  -  -  -  0.038*** -  -  
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Variable Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 8 
          (0.002)     
Deployed to Iraq in CY2005 and prior -  -  -  -  -  0.053*** -  -  
          (0.001)     
Deployed to Iraq in CY2006 and after  -  -  -  -  - 0.060***  -  - 
          (0.001)     
Deployed to an unknown/classified country in 
CY2005 and prior 
 -  -  -  -  - 0.004*  -  - 
          (0.003)     
Deployed to an unknown/classified country in 
CY2006 and after 
-  -  -  -  -  0.049*** -  -  
          (0.009)     
Deployed to another OEF/OIF country in 
CY2005 and prior 
 -  -  -  -  - 0.055***  -  - 
          (0.001)     
Deployed to another OEF/OIF country in 
CY2006 and after 
-  -  -  -  -  0.067*** -  -  
          (0.001)     
Interaction between Deployment and Non-Combat Arms MOS             
Deployed*Non-Combat Arms MOS -   - -   - -  -  -0.004***  - 
              (0.001)   
Interaction between Deployment and Female               
Deployed*Female -   - -   - -  -   - -0.016*** 
                (0.001) 
Observed Probability 0.069 0.069 0.069 0.069 0.069 0.069 0.069 0.069 
Predicted Probability 0.056 0.057 0.057 0.057 0.056 0.057 0.056 0.056 
Observations 984,410 984,410 984,410 984,410 984,410 984,410 984,410 984,410 
Standard errors in parentheses  
*** p<0.01, ** p<0.05, * p<0.1  
Note: Service characteristics (such as MOS and pay grade), demographic characteristics (such as gender, race, marital status and age), and the start year of observation window have 
been controlled for in all models. 
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Table 18. Marginal effect of key variables of interest on probability of being diagnosed with bipolar disorder  
(Army enlisted population) 
Variable Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 8 
Deployment                 
Deployed in OEF/OIF missions -0.0015*** -   -  - -   -  -0.0022*** -0.0016*** 
  (0.000)           (0.000) (0.000) 
Interaction between Deployment and Deployment Period             
First deployment occurred in CY2005 and prior - - - - -0.0014*** - - - 
          (0.000)       
First deployment occurred n CY2006 and after  -  -  -  - -0.0017***  -  -  - 
          (0.000)       
Deployment Location                 
Ever deployed to Afghanistan  - -0.0031*** -0.0031*** -0.0027***  -  -  -  - 
    (0.000) (0.000) (0.000)         
Ever deployed to Iraq  - -0.0018*** -0.0018*** -0.0013***  -  -  -  - 
    (0.000) (0.000) (0.000)         
Ever deployed to an unknown/classified country  - -0.0020* -0.0020* -0.0019*  -  -  -  - 
  (0.001) (0.001) (0.001)         
Ever deployed to another OEF/OIF country  - -0.0003 -0.0003 0.0000  -  -  -  - 
  (0.000) (0.000) (0.000)         
Deployment Frequency                 
Deployed more than once -   - 0.0000 -   -  - -    -  
      (0.000)           
Total Days Deployed                 
Short duration (less than 120 days) - - - reference - - - - 
                  
Medium duration (120 to 180 days)  -  -  - -0.0012***  -  -  -  - 
        (0.000)         
Long duration (more than 180 days)  -  -  - -0.0007**  -  -  -  - 
        (0.000)         
Interaction between Deployment Location and Period             
Deployed to Afghanistan in CY2005 and prior -  -  -  -  -  -0.0028*** -  -  
          (0.001)     
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Variable Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 8 
Deployed to Afghanistan in CY2006 and after  -  -  -  -  - -0.0035***  -  - 
          (0.001)     
Deployed to Iraq in CY2005 and prior  -  -  -  -  - -0.0011***  -  - 
          (0.000)     
Deployed to Iraq in CY2006 and after  -  -  -  -  - -0.0026***  -  - 
          (0.000)     
Deployed to an unknown/classified country in 
CY2005 and prior 
 -  -  -  -  - -0.0028***  -  - 
          (0.001)     
Deployed to an unknown/classified country in 
CY2006 and after 
 -  -  -  -  - 0.0029  -  - 
          (0.003)     
Deployed to another OEF/OIF country in 
CY2005 and prior 
 -  -  -  -  - -0.0004  -  - 
          (0.000)     
Deployed to another OEF/OIF country in 
CY2006 and after 
 -  -  -  -  - -0.0003  -  - 
          (0.000)     
Interaction between Deployment and Non-Combat Arms MOS             
Deployed*Non-Combat Arms MOS -   -  - -  -  -  0.0009* -  
              (0.001)   
Interaction between Deployment and Female               
Deployed*Female -   -  - -  -   -  - 0.0002 
                (0.001) 
Observed Probability 0.013 0.013 0.013 0.013 0.013 0.013 0.013 0.013 
Predicted Probability 0.012 0.012 0.012 0.012 0.012 0.012 0.012 0.012 
Observations 984,410 984,410 984,410 984,410 984,410 984,410 984,410 984,410 
Standard errors in parentheses  
*** p<0.01, ** p<0.05, * p<0.1  
Note: Service characteristics (such as MOS and pay grade), demographic characteristics (such as gender, race, marital status and age), and the start year of observation window have 
been controlled for in all models. 
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C. ARMY OFFICER POPULATION RESULTS 
Table 19 presents the complete results of Model 1 for both PTSD and 
bipolar disorder among Army officers. The key variable of interest was whether 
the service member was deployed on OEF/OIF missions within the observation 
window. 
The probabilities of being diagnosed with PTSD or bipolar disorder were 
significantly dependent on whether an Army officer was deployed as part of 
OEF/OIF missions (p<0.01 and p<0.05, respectively). A reference Army officer’s 
(single white male warrant officer who served in combat arms specialty field) 
probability of being diagnosed with PTSD increased by 1.9 percentage points if 
deployed, compared to those not deployed. On the other hand, a reference Army 
officer’s probability of being diagnosed with bipolar disorder decreased by 0.09 of 
one percentage point among the deployed population, compared to those not 
deployed.  
Being in a combat arms specialty fields increased an average Army 
officer’s probability of being diagnosed with PTSD, compared to those in combat 
service or other MOSs (p<0.1 and p<0.05, respectively). Army officers in medical 
specialty fields had higher probability of being diagnosed with PTSD compared to 
combat arms (p<0.1). As for bipolar disorder, the probabilities were higher for 
Army officers in service support or medical specialty fields, compared to those in 
combat arms (p<0.05 and p<0.01, respectively).  
Being in middle and senior pay grades (O3 to O10) generally decreased 
an average Army officer’s probability of being diagnosed with PTSD, compared 
to those in junior pay grades (W1 to O2) (p<0.01). As for bipolar disorder, the 
probabilities were higher for Army officers in O1 to O2, and O3 pay grades 
(p<0.01 and p<0.05, respectively). The probability of being diagnosed with 
bipolar disorder was lower for those in senior pay grades (O5 to O10) (p<0.01). 
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Females had higher probabilities of being diagnosed with PTSD or bipolar 
disorder, compared to males. The probabilities of being diagnosed with PTSD or 
bipolar disorder were 0.7 and 0.44 of one percentage point higher, respectively, 
for females (both p<0.01). Married personnel had higher probability of being 
diagnosed with PTSD by 0.3 of one percentage point, compared to non-married 
personnel (p<0.01).  
In terms of race, the probabilities of being diagnosed with PTSD for 
blacks, Hispanics and other races were 1.0, 1.4 and 0.5 of one percentage point 
higher respectively, compared to whites (p<0.01). As for bipolar disorder, whites 
had higher probability of being diagnosed with bipolar disorder by 0.11 of one 
percentage point, compared to blacks (p<0.05). Hispanics had the highest 
probability of being diagnosed with bipolar disorder of 0.36 of one percentage 
point higher than whites (p<0.05).  
The next two sections provide regression results of all models separately 
for PTSD and bipolar disorder. 
Table 19. Model 1: Marginal effect of deployment on probability of being 
diagnosed with PTSD and bipolar disorder (Army officer population) 
Variable PTSD Bipolar Disorder 
Deployment Characteristics   
Deployed in OEF/OIF missions 0.019*** -0.0009** 
  (0.001) (0.000) 
Service Characteristics (Combat Arms MOSs and W1 to W5 are the reference groups) 
Combat Service -0.002* 0.0004 
  (0.001) (0.001) 
Service Support 0.002 0.0014** 
  (0.001) (0.001) 
Medical 0.002* 0.0025*** 
  (0.001) (0.001) 
Other MOS -0.003** -0.0004 
  (0.001) (0.001) 
O1 to O2 0.001 0.0018*** 
  (0.001) (0.001) 
O3 -0.005*** 0.0016** 
  (0.001) (0.001) 
O4 -0.008*** 0.0005 
  (0.001) (0.001) 
O5 -0.016*** -0.0023*** 
  (0.001) (0.001) 
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Variable PTSD Bipolar Disorder 
O6 to O10 -0.019*** -0.0025*** 
  (0.001) (0.001) 
Demographic Characteristics (Male, White, and non-married with no missing age information are the 
reference groups) 
Female 0.007*** 0.0044*** 
  (0.001) (0.001) 
Black 0.010*** -0.0011** 
  (0.001) (0.000) 
Hispanic 0.014*** 0.0036** 
  (0.003) (0.002) 
Asian -0.003* -0.0001 
  (0.002) (0.001) 
Other Race 0.005*** -0.0000 
  (0.002) (0.001) 
Married 0.003*** 0.0000 
  (0.001) (0.000) 
Age 0.001*** 0.0001*** 
  (0.000) (0.000) 
Missing age indicator -0.021*** -0.0038*** 
  (0.001) (0.000) 
Calendar Year of Observation (CY2000 is the reference group) 
CY2001 0.000 0.0004 
  (0.001) (0.001) 
CY2002 -0.000 -0.0004 
  (0.001) (0.001) 
CY2003 -0.006*** -0.0025*** 
  (0.001) (0.000) 
CY2004 -0.008*** -0.0015** 
  (0.001) (0.001) 
CY2005 -0.007*** -0.0014** 
  (0.001) (0.001) 
CY2006 -0.012*** -0.0027*** 
  (0.001) (0.001) 
CY2007 -0.014*** -0.0030*** 
  (0.001) (0.001) 
CY2008 -0.018*** -0.0044*** 
  (0.001) (0.000) 
Observed Probability 0.028 0.0059 
Predicted Probability 0.023 0.0050 
Observations 149,640 149,640 
Standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
 
1. PTSD 
Table 20 presents the marginal effects of key variables of interest on the 
probability of being diagnosed with PTSD. Results of Model 1 shown in the first 
column of Table 19 were reproduced for comparison purposes.  
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Model 2 showed that deployment to any OEF/OIF location (Afghanistan, 
Iraq, an unknown/classified country or another OEF/OIF country) increased the 
probability of being diagnosed with PTSD, compared to non-deployed (p<0.01 for 
Afghanistan, Iraq and another OEF/OIF country, p<0.1 for an unknown/classified 
country). The magnitude of increase was the highest at 1.8 percentage point if 
deployed to Iraq or another OEF/OIF country, followed by an increase of 0.5 of 
one percentage point if deployed to Afghanistan or an unknown/classified 
country. The pairwise location coefficient comparisons were significant (p<0.01). 
Model 3 showed that having multiple deployments in OEF/OIF missions 
decreased the probability of an average Army officer being diagnosed with PTSD 
by 0.4 of one percentage point, compared to those with a single deployment 
(p<0.01).    
Model 5 showed stronger effect of deployment in OEF/OIF missions on 
PTSD for those who were deployed after CY2005. The probability of being 
diagnosed with PTSD increased by 1.8 percentage points for Army officers 
whose first deployment in OEF/OIF missions occurred in CY2005 and prior, and 
3.4 percentage points for those whose first deployment in OEF/OIF missions 
occurred in CY2006 and after. The difference between the coefficient estimates 
of the two periods was found to be statistically significant (p<0.01).   
Model 6 showed that the OEF/OIF deployment location effects were 
higher among those whose first deployment to any OEF/OIF location occurred in 
CY2006 and after, compared to those whose first deployment to the same 
location occurred in CY2005 and before (all p<0.05, except for Iraq at p<0.01).  
Model 7 showed that the interaction effect between deployment in 
OEF/OIF missions and non-combat arms MOSs was statistically significant 
(p<0.05). This meant that the probability of being diagnosed with PTSD 
significantly increased by 0.5 percentage point if the deployed Army officer was 
from a non-combat arms MOS, compared to those deployed and from combat 
arms MOSs.  
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Models 4 and 8 showed that the number of days deployed and the 
interaction effect between gender and deployment in OEF/OIF missions had no 
significant effects on the probability of being diagnosed with PTSD for the Army 
officer population.  
2. Bipolar Disorder 
Table 21 presents the marginal effects of key variables of interests on the 
probability of being diagnosed with bipolar disorder. Results of Model 1 shown in 
the second column of Table 19 are reproduced for comparison purposes.  
Model 2 showed that deployment to Iraq was associated with a lower 
probability of being diagnosed with bipolar disorder for Army officers by 0.14 of 
one percentage point, compared to those not deployed (p<0.01).  
Model 5 showed that first deployment in OEF/OIF missions in CY2005 and 
prior was associated with a lower probability of being diagnosed with bipolar 
disorder. The probability of being diagnosed with bipolar disorder was 
significantly lower by 0.12 of one percentage point for those whose first 
deployment in OEF/OIF missions occurred in CY2005 and prior, compared to 
those not deployed (p<0.01). The coefficient estimate for those whose first 
deployment in OEF/OIF missions occurred in CY2006 and after was not 
significant. The difference between the coefficient estimates of the two periods 
was found to be statistically significant (p<0.01).  
Model 6 showed that first deployment to Iraq in CY2005 and prior was 
associated with a lower probability of being diagnosed with bipolar disorder, 
compared to first deployment to the same location in CY2006 and after (p<0.01).  
Models 3 and 4 also showed that deployment frequency and the number 
of days deployed were not associated with the probability of being diagnosed 
with bipolar disorder for Army officers. Models 7 and 8 also indicated that the 
interaction effects between deployment in OEF/OIF missions and non-combat 
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arms MOSs, and deployment in OEF/OIF missions and female, were not 




Table 20. Marginal effect of key variables of Interest on probability of being diagnosed with PTSD (Army officer 
population) 
Variable Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 8 
Deployment                 
Deployed in OEF/OIF missions 0.019*** -   -  - -  -  0.014*** 0.018*** 
  (0.001)           (0.002) (0.001) 
Interaction between Deployment and Deployment Period             
First deployment occurred in CY2005 and prior - - - - 0.018*** - - - 
          (0.001)       
First deployment occurred in CY2006 and after  -  -  -  - 0.034***  -  -  - 
          (0.003)       
Deployment Location                 
Ever deployed to Afghanistan  - 0.005*** 0.006*** 0.004**  -  -  -  - 
    (0.002) (0.002) (0.002)         
Ever deployed to Iraq  - 0.018*** 0.020*** 0.018***  -  -  -  - 
    (0.002) (0.002) (0.002)         
Ever deployed to an unknown/classified country  - 0.005* 0.007** 0.005*  -  -  -  - 
  (0.003) (0.003) (0.003)         
Ever deployed to another OEF/OIF country  - 0.018*** 0.019*** 0.018***  -  -  -  - 
  (0.001) (0.001) (0.001)         
Deployment Frequency                 
Deployed more than once -   - -0.004*** -   - -   - -  
      (0.001)           
Total Days Deployed                 
Short duration (less than 120 days) - - - reference - - - - 
                  
Medium duration (120 to 180 days)  -  -  - -0.001  -  -  -  - 
        (0.002)         
Long duration (more than 180 days)  -  -  - 0.000  -  -  -  - 
        (0.001)         
Interaction between Deployment Location and Period             
Deployed to Afghanistan in CY2005 and prior -  -  -  -  -  0.003* -  -  
          (0.002)     
Deployed to Afghanistan in CY2006 and after  -  -  -  -  - 0.015**  -  - 
          (0.006)     
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Variable Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 8 
Deployed to Iraq in CY2005 and prior  -  -  -  -  - 0.016***  -  - 
          (0.002)     
Deployed to Iraq in CY2006 and after  -  -  -  -  - 0.031***  -  - 
          (0.004)     
Deployed to an unknown/classified country in 
CY2005 and prior 
 -  -  -  -  - 0.002  -  - 
          (0.003)     
Deployed to an unknown/classified country in 
CY2006 and after 
 -  -  -  -  - 0.024**  -  - 
          (0.010)     
Deployed to another OEF/OIF country in 
CY2005 and prior 
 -  -  -  -  - 0.017***  -  - 
          (0.001)     
Deployed to another OEF/OIF country in 
CY2006 and after 
 -  -  -  -  - 0.025***  -  - 
          (0.003)     
Interaction between Deployment and Non-Combat Arms MOS             
Deployed*Non-Combat Arms MOS -   -  - -  -  -  0.005**  - 
              (0.002)   
Interaction between Deployment and Female               
Deployed*Female -   -  - -  -  -  -  0.001 
                (0.002) 
Observed Probability 0.028 0.028 0.028 0.028 0.028 0.028 0.028 0.028 
Predicted Probability 0.023 0.023 0.023 0.023 0.023 0.023 0.023 0.023 
Observations 149,640 149,640 149,640 149,640 149,640 149,640 149,640 149,640 
Standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
Note: Service characteristics (such as MOS and pay grade), demographic characteristics (such as gender, race, marital status and age), and the start year of observation window have 
been controlled for in all models 
  
 91
Table 21. Marginal effect of key variables of Interest on probability of being diagnosed with bipolar disorder (Army 
officer population) 
Variable Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 8 
Deployment               
Deployed in OEF/OIF missions -0.0009** -   -  - -  -  -0.0015** -0.0008* 
  (0.000)           (0.001) (0.000) 
Interaction between Deployment and Deployment Period         
First deployment occurred in CY2005 and prior - - - - -0.0012*** - - - 
          (0.000)       
First deployment occurred in CY2006 and after  -  -  -  - 0.0016  -  -  - 
          (0.001)       
Deployment Location               
Ever deployed to Afghanistan  - -0.0009 -0.0009 -0.0012*  -  -  -  - 
    (0.001) (0.001) (0.001)         
Ever deployed to Iraq  - -0.0014*** -0.0014*** -0.0017***  -  -  -  - 
    (0.000) (0.001) (0.001)         
Ever deployed to an unknown/classified country  - 0.0003 0.0003 0.0002  -  -  -  - 
  (0.001) (0.001) (0.001)         
Ever deployed to another OEF/OIF country  - -0.0005 -0.0004 -0.0007  -  -  -  - 
  (0.000) (0.000) (0.000)         
Deployment Frequency             
Deployed more than once  - -  -0.0000 -   -  - -   
 -  
      (0.001)           
Total Days Deployed               
Short duration (less than 120 days) - - - reference - - - - 
                  
Medium duration (120 to 180 days)  -  -  - 0.0008  -  -  -  - 
        (0.001)         
Long duration (more than 180 days)  -  -  - 0.0006  -  -  -  - 
        (0.001)         
Interaction between Deployment Location and Period         
Deployed to Afghanistan in CY2005 and prior -  -  -  -  -  -0.0012* -  -  
          (0.001)     
Deployed to Afghanistan in CY2006 and after  -  -  -  -  - 0.0015  -  - 
          (0.002)     
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Variable Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 8 
Deployed to Iraq in CY2005 and prior  -  -  -  -  - -0.0022***  -  - 
          (0.000)     
Deployed to Iraq in CY2006 and after  -  -  -  -  - 0.0018  -  - 
          (0.001)     
Deployed to an unknown/classified country in 
CY2005 and prior 
 -  -  -  -  - 0.0003  -  - 
          (0.001)     
Deployed to an unknown/classified country in 
CY2006 and after 
 -  -  -  -  - 0.0005  -  - 
          (0.004)     
Deployed to another OEF/OIF country in 
CY2005 and prior 
 -  -  -  -  - -0.0006  -  - 
          (0.000)     
Deployed to another OEF/OIF country in 
CY2006 and after 
 -  -  -  -  - 0.0008  -  - 
          (0.001)     
Interaction between Deployment and Non-Combat Arms MOS         
Deployed*Non-Combat Arms MOS -   -  - -  -  -  0.0010  - 
              (0.001)   
Interaction between Deployment and Female           
Deployed*Female -   -  - -  -  -  -  -0.0002 
                (0.001) 
Observed Probability 0.006 0.006 0.006 0.006 0.006 0.006 0.006 0.006 
Predicted Probability 0.005 0.005 0.005 0.005 0.005 0.005 0.005 0.005 
Observations 149,640 149,640 149,640 149,640 149,640 149,640 149,640 149,640 
Standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
Note: Service characteristics (such as MOS and pay grade), demographic characteristics (such as gender, race, marital status and age), and the start year of observation window have 




D. MARINE ENLISTED POPULATION RESULTS  
Table 22 presents the complete results of Model 1 for both PTSD and 
bipolar disorder among Marine enlisted personnel. The key variable of interest 
was whether the service member had been sent for OEF/OIF deployment within 
the observation window. 
There were many parallels between the Army and Marine enlisted results. 
The probabilities of being diagnosed with PTSD and bipolar disorder were 
significantly dependent on whether the Marine enlisted personnel was sent for 
deployment in OEF/OIF missions (both p<0.01). A reference Marine enlisted 
personnel’s (single white male in E1 to E2 rank, serving in combat arms specialty 
field) probability of being diagnosed with PTSD increased by 3.5 percentage 
points if deployed, compared to those not deployed. On the other hand, a 
reference Marine enlisted personnel’s probability of being diagnosed with bipolar 
disorder decreased by 0.21 of one percentage point among the deployed 
population, compared to those not deployed.  
Being in a combat arms specialty fields generally increased an average 
Marine enlisted personnel’s probability of being diagnosed with PTSD (p<0.01). 
As for bipolar disorder, Marine enlisted personnel in combat service and service 
support fields had higher probability of being diagnosed with bipolar disorder, 
compared to all other specialty fields (p<0.01).  
Being in middle and senior pay grades (E3 to E9) generally decreased an 
average Marine enlisted personnel’s probability of being diagnosed with bipolar 
disorder, compared to those in junior pay grades (p<0.01). 
In terms of demographics, females had higher probabilities of being 
diagnosed with PTSD or bipolar disorder by 2.3 and 0.86 of one percentage 
point, respectively, compared to males (p<0.01). Whites had higher probabilities 
of being diagnosed with PTSD or bipolar disorder compared to the other racial 
minority groups (all p<0.01, except for other race, p<0.05). Married personnel  
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had higher probabilities of being diagnosed with PTSD or bipolar disorder, 
compared to non-married personnel (2.1 and 0.19 of one percentage point, 
respectively, both p<0.01).   
The next two sections provide regression results of all models separately 
for PTSD and bipolar disorder. 
Table 22. Model 1: Marginal effect of deployment on probability of being 
diagnosed with PTSD and bipolar disorder (Marine enlisted population) 
Variable PTSD Bipolar Disorder 
Deployment Characteristics   
Deployed in OEF/OIF missions 0.035*** -0.0021*** 
  (0.001) (0.000) 
Service Characteristics (Combat Arms MOSs and E1 to E2 are the reference groups) 
Combat Service -0.013*** 0.0017*** 
  (0.001) (0.000) 
Service Support -0.011*** 0.0011*** 
  (0.001) (0.000) 
Aviation -0.026*** 0.0004 
  (0.001) (0.000) 
Other MOS -0.014*** -0.0002 
  (0.001) (0.001) 
E3 to E5 0.001 -0.0009*** 
  (0.001) (0.000) 
E to E9 -0.001 -0.0025*** 
  (0.002) (0.001) 
Demographic Characteristics (Male, White, and non-married with no missing age information are the 
reference groups) 
Female 0.023*** 0.0086*** 
  (0.002) (0.001) 
Black -0.002*** -0.0019*** 
  (0.001) (0.000) 
Hispanic -0.003*** -0.0028*** 
  (0.001) (0.000) 
Asian -0.008*** -0.0033*** 
  (0.001) (0.000) 
Other Race -0.003** -0.0025*** 
  (0.001) (0.000) 
Married 0.021*** 0.0019*** 
  (0.001) (0.000) 
Age 0.000 -0.0001** 
  (0.000) (0.000) 
Missing age indicator -0.027*** -0.0039*** 
  (0.001) (0.000) 
Calendar Year of Observation (CY2000 is the reference group) 
CY2001 -0.003** 0.0001 
  (0.001) (0.000) 
CY2002 0.006*** 0.0009 
  (0.001) (0.001) 
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Variable PTSD Bipolar Disorder 
CY2003 0.007*** -0.0000 
  (0.001) (0.001) 
CY2004 0.017*** 0.0008 
  (0.001) (0.001) 
CY2005 0.014*** 0.0014** 
  (0.001) (0.001) 
CY2006 0.007*** 0.0014** 
  (0.001) (0.001) 
CY2007 -0.002* 0.0021*** 
  (0.001) (0.001) 
CY2008 -0.006*** 0.0019** 
  (0.001) (0.001) 
Observed Probability 0.042 0.0066 
Predicted Probability 0.033 0.0059 
Observations 378,873 378,873 
Standard errors in parentheses 




Table 23 presents the marginal effects of key variables of interests on the 
probability of being diagnosed with PTSD. Results of Model 1 shown in the first 
column of Table 22 are reproduced for comparison purposes.  
Model 2 showed that deployment to any OEF/OIF location (Afghanistan, 
Iraq, an unknown/classified country or another OEF/OIF country) was associated 
with a higher probability of being diagnosed with PTSD, compared to non-
deployed (p<0.01). The magnitude of increase was the greatest at 2.9 
percentage points if deployed to Iraq. This was followed by an increase of 2.5 
percentage points if deployed to another OEF/OIF country, and by 2.1 
percentage points if deployed to Afghanistan or an unknown/classified country. 
All of the pairwise location coefficient comparisons were significant (p<0.01), 
except between Afghanistan and an unknown/classified country. 
Model 3 showed that having multiple deployments in OEF/OIF missions 
was associated with a higher probability of being diagnosed with PTSD by 0.2 of 
one percentage point, compared to an average Marine enlisted personnel with a 
single deployment (p<0.1).    
 96
Model 4 showed that the probability of being diagnosed with PTSD 
increased by 0.4 of one percentage point for Marine enlisted personnel with 120 
to 180 days of deployment, and by 0.8 of one percentage point if deployed more 
than 180 days within the observation window, compared to those with fewer than 
120 days (both p<0.01).    
Model 5 showed that the probability of being diagnosed with PTSD 
increased by 4.4 percentage points for Marine enlisted personnel whose first 
deployment in OEF/OIF missions occurred in CY2005 and prior, and 3.8 
percentage points for those whose first deployment in OEF/OIF missions 
occurred in CY2006 and after. The coefficient estimates for the two periods were 
found to be statistically different (p<0.01).   
Model 6 showed that the OEF/OIF deployment location effect was higher 
among those whose first deployment to Afghanistan occurred in CY2006 and 
after, compared to those whose first deployment to Afghanistan occurred in 
CY2005 and prior (p<0.01). The findings were opposite for Iraq and another 
OEF/OIF country (both p<0.01).  
Model 7 showed that the probability of being diagnosed with PTSD 
significantly decreased by 0.5 of one percentage point if the deployed Marine 
enlisted personnel was from a non-combat arms MOS, compared to those 
deployed and from combat arms MOSs (p<0.01).  
Model 8 suggested that the probability of being diagnosed with PTSD 
decreased by 1.5 percentage points if the deployed Marine enlisted personnel 
was female, compared to male counterparts (p<0.01).  
2. Bipolar Disorder  
Table 24 presents the marginal effects of key variables of interests on the 
probability of being diagnosed with bipolar disorder. Results of Model 1 shown in 
the second column of Table 22 are reproduced for comparison purposes.  
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Model 2 showed that deployment to Afghanistan, Iraq or another OEF/OIF 
country was associated with a lower probability of being diagnosed with bipolar 
disorder, compared to non-deployed. In particular, the probability of being 
diagnosed with bipolar disorder decreased by 0.23, 0.18 and 0.16 of one 
percentage point if deployed to Afghanistan, Iraq and another OEF/OIF country, 
respectively, compared to non-deployed (all p<0.01). The location coefficient 
comparisons for Afghanistan and an unknown/classified country, Afghanistan 
and another OEF/OIF country, and Iraq and another OEF/OIF country were 
significant (p<0.01, p<0.1 and p<0.01, respectively). 
Model 3 showed that having multiple deployments to OEF/OIF missions 
was associated with a lower probability of being diagnosed with bipolar disorder 
by 0.09 of one percentage point, compared to an average Marine enlisted 
personnel with a single deployment in OEF/OIF missions (p<0.05).  
Model 4 showed that being deployed for 120 to 180 days was associated 
with a higher probability of being diagnosed with bipolar disorder, by 0.15 of one 
percentage point, compared to those being deployed for fewer than 120 days 
(p<0.05).    
Results of Model 5 showed that the probability of being diagnosed with 
bipolar disorder was reduced by 0.09 of one percentage point for Marine enlisted 
personnel whose first deployment in OEF/OIF missions occurred in CY2005 and 
prior, and 0.32 of one percentage point for those whose first deployment in 
OEF/OIF missions occurred in CY2006 and after. The coefficient estimates for 
the two periods were found to be significantly different (p<0.01).  
Model 6 showed that the first deployment to Afghanistan, Iraq, and 
another OEF/OIF country occurring in CY2006 and after was associated with a 
higher probability of being diagnosed with bipolar disorder, compared to those 
whose first deployment to the same locations occurred in CY2005 and prior 
(p<0.01 for Afghanistan and Iraq, p<0.05 for another OEF/OIF country). 
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Models 7 and 8 showed that the interaction effects between deployment in 
OEF/OIF missions and non-combat arms MOSs, and deployment in OEF/OIF 
missions and female, were not statistically significant.   
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Table 23. Marginal effect of key variables of Interest on probability of being diagnosed with PTSD (Marine enlisted 
population) 
Variable Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 8 
Deployment                 
Deployed in OEF/OIF missions 0.035*** -   -  - -  -  0.038*** 0.036*** 
  (0.001)           (0.001) (0.001) 
Interaction between Deployment and Deployment Period             
First deployment occurred in CY2005 and prior - - - - 0.044*** - - - 
          (0.001)       
First deployment occurred in CY2006 and after  -  -  -  - 0.038***  -  -  - 
          (0.001)       
Deployment Location                 
Ever deployed to Afghanistan  - 0.021*** 0.019*** 0.016***  -  -  -  - 
    (0.001) (0.001) (0.001)         
Ever deployed to Iraq  - 0.029*** 0.028*** 0.027***  -  -  -  - 
    (0.001) (0.001) (0.001)         
Ever deployed to an unknown/classified country  - 0.021*** 0.020*** 0.019***  -  -  -  - 
  (0.003) (0.003) (0.002)         
Ever deployed to another OEF/OIF country  - 0.025*** 0.024*** 0.021***  -  -  -  - 
  (0.001) (0.001) (0.001)         
Deployment Frequency                 
Deployed more than once -   - 0.002* -   - -   - -  
      (0.001)           
Total Days Deployed                 
Short duration (less than 120 days) - - - reference - - - - 
                  
Medium duration (120 to 180 days)  -  -  - 0.004***  -  -  -  - 
        (0.001)         
Long duration (more than 180 days)  -  -  - 0.008***  -  -  -  - 
        (0.001)         
Interaction between Deployment Location and Period             
Deployed to Afghanistan in CY2005 and prior -  -  -  -  -  0.017*** -  -  
          (0.002)     
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Variable Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 8 
Deployed to Afghanistan in CY2006 and after  -  -  -  -  - 0.029***  -  - 
          (0.002)     
Deployed to Iraq in CY2005 and prior  -  -  -  -  - 0.036***  -  - 
          (0.001)     
Deployed to Iraq in CY2006 and after  -  -  -  -  - 0.027***  -  - 
          (0.001)     
Deployed to an unknown/classified country in 
CY2005 and prior 
 -  -  -  -  - 0.019***  -  - 
          (0.003)     
Deployed to an unknown/classified country in 
CY2006 and after 
 -  -  -  -  - 0.027***  -  - 
          (0.005)     
Deployed to another OEF/OIF country in 
CY2005 and prior 
 -  -  -  -  - 0.033***  -  - 
          (0.001)     
Deployed to another OEF/OIF country in 
CY2006 and after 
 -  -  -  -  - 0.010***  -  - 
          (0.002)     
Interaction between Deployment and Non-Combat Arms MOS             
Deployed*Non-Combat Arms MOS -   -  - -  -  -  -0.005***  - 
              (0.001)   
Interaction between Deployment and Female               
Deployed*Female -   -  - -  -  -   - -0.015*** 
                (0.001) 
Observed Probability 0.042 0.042 0.042 0.042 0.042 0.042 0.042 0.042 
Predicted Probability 0.033 0.033 0.033 0.033 0.033 0.033 0.033 0.033 
Observations 378,873 378,873 378,873 378,873 378,873 378,873 378,873 378,873 
Standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
Note: Service characteristics (such as MOS and pay grade), demographic characteristics (such as gender, race, marital status and age), and the start year of observation window have 




Table 24. Marginal effect of key variables of Interest on probability of being diagnosed with bipolar disorder (Marine 
enlisted population) 
Variable Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 8 
Deployment               
Deployed in OEF/OIF missions -0.0021*** -   -  - -  -  -0.0024*** -0.0021*** 
  (0.000)           (0.000) (0.000) 
Interaction between  Deployment and Deployment Period         
First deployment occurred in CY2005 and prior - - - - -0.0009*** - - - 
          (0.000)       
First deployment occurred in CY2006 and after  -  -  -  - -0.0032***  -  -  - 
          (0.000)       
Deployment Location               
Ever deployed to Afghanistan  - -0.0023*** -0.0021*** -0.0025***  -  -  -  - 
    (0.000) (0.000) (0.000)         
Ever deployed to Iraq  - -0.0018*** -0.0015*** -0.0018***  -  -  -  - 
    (0.000) (0.000) (0.000)         
Ever deployed to an unknown/classified country  - -0.0002 0.0000 -0.0005  -  -  -  - 
  (0.001) (0.001) (0.001)         
Ever deployed to another OEF/OIF country  - -0.0016*** -0.0013*** -0.0017***  -  -  -  - 
  (0.000) (0.000) (0.000)         
Deployment Frequency             
Deployed more than once -   - -0.0009** -   - -   -  - 
      (0.000)           
Total Days Deployed               
Short duration (less than 120 days) - - - reference - - - - 
                  
Medium duration (120 to 180 days)  -  -  - 0.0015**  -  -  -  - 
        (0.001)         
Long duration (more than 180 days)  -  -  - -0.0001  -  -  -  - 
        (0.000)         
Interaction between Deployment Location and Period         
Deployed to Afghanistan in CY2005 and prior -  -  -  -  -  -0.0008 -  -  
          (0.001)     
Deployed to Afghanistan in CY2006 and after  -  -  -  -  - -0.0041***  -  - 
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Variable Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 8 
          (0.000)     
Deployed to Iraq in CY2005 and prior  -  -  -  -  - -0.0004  -  - 
          (0.000)     
Deployed to Iraq in CY2006 and after  -  -  -  -  - -0.0026***  -  - 
          (0.000)     
Deployed to an unknown/classified country in 
CY2005 and prior 
 -  -  -  -  - 0.0005  -  - 
          (0.001)     
Deployed to an unknown/classified country in 
CY2006 and after 
 -  -  -  -  - -0.0019  -  - 
          (0.001)     
Deployed to another OEF/OIF country in CY2005 
and prior 
 -  -  -  -  - -0.0011***  -  - 
          (0.000)     
Deployed to another OEF/OIF country in CY2006 
and after 
 -  -  -  -  - -0.0024***  -  - 
          (0.000)     
Interaction between Deployment and Non-Combat Arms MOS         
Deployed*Non-Combat Arms MOS -   -  - -  -  -  0.0004  - 
              (0.001)   
Interaction between Deployment and Female           
Deployed*Female -   -  - -  -  -   - -0.0004 
                (0.001) 
Observed Probability 0.007 0.007 0.007 0.007 0.007 0.007 0.007 0.007 
Predicted Probability 0.006 0.006 0.006 0.006 0.006 0.006 0.006 0.006 
Observations 378,873 378,873 378,873 378,873 378,873 378,873 378,873 378,873 
Standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
Note: Service characteristics (such as MOS and pay grade), demographic characteristics (such as gender, race, marital status and age), and the start year of observation window have 




E. MARINE OFFICER POPULATION RESULTS 
Table 25 presents the complete results of Model 1 for both PTSD and 
bipolar disorder among Marine officers. The key variable of interest was whether 
the service member had been deployed in OEF/OIF missions within the 
observation window. 
The probability of a reference Marine officer (single white male warrant 
officer who served in combat arms specialty field) being diagnosed with PTSD 
increased by 1.0 percentage point if deployed, compared to those not deployed 
(p<0.01). On the other hand, deployment in OEF/OIF missions was also not 
associated with the probability of being diagnosed with bipolar disorder. 
Marine officers in combat arms specialty fields had higher probability of 
being diagnosed with PTSD, compared to aviation and other MOSs (p<0.01). 
Higher pay grades were associated with a lower probability of being diagnosed 
with PTSD (p<0.01 for O3 and O4, p<0.10 for O6, with the reference pay grade 
being warrant officer). There was no significant effect of MOS and pay grade on 
the probability of being diagnosed with bipolar disorder. 
In terms of demographics, females had higher probabilities of being 
diagnosed with PTSD or bipolar disorder by 1.4 and 0.54 of one percentage 
point, respectively, compared to males (p<0.01 and p<0.05, respectively). Asians 
had the lowest probability of being diagnosed with PTSD, compared to the other 
racial groups (p<0.01). Race was not a significant predictor of bipolar disorder. 
The next two sections provide regression results of all models separately 






Table 25. Model 1: Marginal effect of deployment on probability of being 
diagnosed with PTSD and bipolar disorder (Marine officer population) 
Variable PTSD Bipolar Disorder 
Deployment Characteristics   
Deployed in OEF/OIF missions 0.010*** -0.0000 
  (0.002) (0.001) 
Service Characteristics (Combat Arms MOSs and W1 to W5 are the reference groups) 
Combat Service 0.001 0.0017 
  (0.002) (0.002) 
Service Support -0.000 0.0004 
  (0.002) (0.001) 
Aviation -0.007*** -0.0001 
  (0.001) (0.001) 
Other MOS -0.009*** 0.0006 
  (0.002) (0.002) 
O1 to O2 0.004 0.0021 
  (0.002) (0.001) 
O3 -0.002 0.0014 
  (0.002) (0.001) 
O4 -0.007*** 0.0021 
  (0.001) (0.002) 
O5 -0.008*** 0.0009 
  (0.002) (0.002) 
O6 to O10 -0.006* - 
  (0.003) - 
Demographic Characteristics (Male, White, and non-married with no missing age information are the 
reference groups) 
Female 0.014*** 0.0054** 
  (0.004) (0.002) 
Black -0.002 -0.0006 
  (0.002) (0.001) 
Hispanic 0.003 - 
  (0.004) - 
Asian -0.010*** -0.0009 
  (0.002) (0.002) 
Other Race 0.003 0.0007 
  (0.003) (0.001) 
Married 0.002 -0.0000 
  (0.001) (0.001) 
Age 0.001*** -0.0000 
  (0.000) (0.000) 
Missing age indicator -0.007*** -0.0022*** 
  (0.003) (0.001) 
Calendar Year of Observation (CY2000 is the reference group) 
CY2001 -0.003* -0.0006 
  (0.002) (0.001) 
CY2002 -0.004* -0.0021*** 
  (0.002) (0.001) 
CY2003 -0.005** -0.0014* 
  (0.002) (0.001) 
CY2004 -0.004 -0.0011 
  (0.002) (0.001) 
CY2005 -0.006** -0.0021*** 
  (0.002) (0.001) 
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Variable PTSD Bipolar Disorder 
CY2006 -0.009*** -0.0009 
  (0.002) (0.001) 
CY2007 -0.009*** -0.0015 
  (0.002) (0.001) 
CY2008 - - 
  - - 
Observed Probability 0.015 0.0031 
Predicted Probability 0.011 0.0025 
Observations 25,317 23,570 
Standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
 
1. PTSD 
Table 26 presents the marginal effects of key variables of interest on the 
probability of being diagnosed with PTSD. Results of Model 1 shown in the first 
column of Table 25 are reproduced for comparison purposes.  
Model 2 showed that deployment to Afghanistan, Iraq or another known 
OEF/OIF country increased the probability of being diagnosed with PTSD, 
compared to non-deployed population (all p<0.01).  
Model 4 indicated the probability of being diagnosed with PTSD increased 
by 0.5 of one percentage point for Marine officers with 120 to 180 days of 
deployment, compared to those with fewer than 120 days (p<0.1).    
Model 8 showed that the probability of being diagnosed with PTSD 
decreased by 0.7 of one percentage point if the deployed Marine officer was 
female, compared to male counterparts (p<0.01).  
Model 3 suggested that there was no statistical significant relationship 
between having multiple deployments to OEF/OIF missions and the probability of 
being diagnosed with PTSD. The difference in deployment effects between the 
two periods in general as well as for all locations was not statistically significant, 
as shown in Models 5 and 6. Model 7 also showed that the interaction effect 
between deployment in OEF/OIF missions and non-combat arms MOSs was not 
statistically significant.  
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2. Bipolar Disorder 
Table 27 presents the marginal effects of key variables of interests on the 
probability of being diagnosed with bipolar disorder. Results of Model 1 shown in 
the second column of Table 25 are reproduced for comparison purposes.  
Results of all eight models showed that none of the deployment-related 
variables of interest were associated with the probability of being diagnosed with 




Table 26. Marginal effect of key variables of Interest on probability of being diagnosed with PTSD (Marine officer 
population) 
Variable Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 8 
Deployment                 
Deployed in OEF/OIF missions 0.010*** -   -  - -  -  0.011*** 0.011*** 
  (0.002)           (0.003) (0.002) 
Interaction between Deployment and Deployment Period             
First deployment occurred in CY2005 and prior - - - - 0.011*** - - - 
          (0.002)       
First deployment occurred in CY2006 and after  -  -  -  - 0.004  -  -  - 
          (0.005)       
Deployment Location                 
Ever deployed to Afghanistan  - 0.009*** 0.010*** 0.006*  -  -  -  - 
    (0.003) (0.004) (0.003)         
Ever deployed to Iraq  - 0.009*** 0.010*** 0.007***  -  -  -  - 
    (0.002) (0.003) (0.002)         
Ever deployed to an unknown/classified country  - 0.005 0.006 0.003  -  -  -  - 
  (0.005) (0.005) (0.004)         
Ever deployed to another OEF/OIF country  - 0.009*** 0.009*** 0.006***  -  -  -  - 
  (0.002) (0.002) (0.002)         
Deployment Frequency                 
Deployed more than once -   - -0.002 -   - -   - -  
      (0.002)           
Total Days Deployed                 
Short duration (less than 120 days) - - - reference - - - - 
                  
Medium duration (120 to 180 days)  -  -  - 0.005*  -  -  -  - 
        (0.003)         
Long duration (more than 180 days)  -  -  - 0.003  -  -  -  - 
        (0.002)         
Interaction between Deployment Location and Period             
Deployed to Afghanistan in CY2005 and prior -  -  -  -  -  0.009*** -  -  
          (0.003)     
Deployed to Afghanistan in CY2006 and after  -  -  -  -  - 0.005  -  - 
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Variable Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 8 
          (0.012)     
Deployed to Iraq in CY2005 and prior  -  -  -  -  - 0.010***  -  - 
          (0.003)     
Deployed to Iraq in CY2006 and after  -  -  -  -  - 0.002  -  - 
          (0.004)     
Deployed to an unknown/classified country in 
CY2005 and prior 
 -  -  -  -  - 0.005  -  - 
          (0.005)     
Deployed to an unknown/classified country in 
CY2006 and after 
 -  -  -  -  - 0.008  -  - 
          (0.021)     
Deployed to another OEF/OIF country in 
CY2005 and prior 
 -  -  -  -  - 0.009***  -  - 
          (0.002)     
Deployed to another OEF/OIF country in 
CY2006 and after 
 -  -  -  -  - 0.005  -  - 
          (0.008)     
Interaction between Deployment and Non-Combat Arms MOS             
Deployed*Non-Combat Arms MOS -   -  - -  -  -  -0.002  - 
              (0.003)   
Interaction between Deployment and Female               
Deployed*Female -   -  - -  -  -  -  -0.007*** 
                (0.002) 
Observed Probability 0.015 0.015 0.015 0.015 0.015 0.015 0.015 0.015 
Predicted Probability 0.011 0.011 0.011 0.011 0.011 0.011 0.011 0.011 
Observations 25,317 25,317 25,317 25,317 25,317 25,317 25,317 25,317 
Standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
Note: Service characteristics (such as MOS and pay grade), demographic characteristics (such as gender, race, marital status and age), and the start year of observation window have 





Table 27. Marginal effect of key variables of Interest on probability of being diagnosed with bipolar disorder (Marine 
officer population) 
Variable Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 8 
Deployment               
Deployed in OEF/OIF missions -0.0000 -   -  - -  -  0.0000 -0.0002 
  (0.001)           (0.001) (0.001) 
Interaction between Deployment and Deployment Period         
First deployment occurred in CY2005 and prior - - - - -0.0001 - - - 
          (0.001)       
First deployment occurred in CY2006 and after  -  -  -  - 0.0006  -  -  - 
          (0.002)       
Deployment Location               
Ever deployed to Afghanistan  - 0.0004 0.0007 0.0002  -  -  -  - 
    (0.001) (0.001) (0.001)         
Ever deployed to Iraq  - 0.0010 0.0014 0.0009  -  -  -  - 
    (0.001) (0.001) (0.001)         
Ever deployed to an unknown/classified country  - 0.0011 0.0015 0.0010  -  -  -  - 
  (0.002) (0.002) (0.002)         
Ever deployed to another OEF/OIF country  - -0.0003 -0.0000 -0.0004  -  -  -  - 
  (0.001) (0.001) (0.001)         
Deployment Frequency             
Deployed more than once -   - -0.0008 -   - -   - -  
      (0.001)           
Total Days Deployed               
Short duration (less than 120 days) - - - reference - - - - 
                  
Medium duration (120 to 180 days)  -  -  - 0.0000  -  -  -  - 
        (0.001)         
Long duration (more than 180 days)  -  -  - 0.0003  -  -  -  - 
        (0.001)         
Interaction between Deployment Location and Period         
Deployed to Afghanistan in CY2005 and prior -  -  -  -  -  0.0008 -  -  
          (0.001)     
Deployed to Afghanistan in CY2006 and after  -  -  -  -  - -  -  - 
          -     
Deployed to Iraq in CY2005 and prior  -  -  -  -  - 0.0009  -  - 
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          (0.001)     
Deployed to Iraq in CY2006 and after  -  -  -  -  - 0.0005  -  - 
          (0.002)     
Deployed to an unknown/classified country in 
CY2005 and prior 
 -  -  -  -  - -0.0002  -  - 
          (0.002)     
Deployed to an unknown/classified country in 
CY2006 and after 
 -  -  -  -  - 0.0421  -  - 
          (0.042)     
Deployed to another OEF/OIF country in 
CY2005 and prior 
 -  -  -  -  - -0.0003  -  - 
          (0.001)     
Deployed to another OEF/OIF country in 
CY2006 and after 
 -  -  -  -  - -0.0006  -  - 
          (0.002)     
Interaction between Deployment and Non-Combat Arms MOS         
Deployed*Non-Combat Arms MOS -   -  - -  -  -  -0.0000  - 
              (0.002)   
Interaction between Deployment and Female           
Deployed*Female -   -  - -  -  -  -  0.0013 
                (0.003) 
Observed Probability 0.003 0.003 0.003 0.003 0.003 0.003 0.003 0.003 
Predicted Probability 0.003 0.002 0.002 0.002 0.003 0.002 0.003 0.003 
Observations 23,570 23,570 23,570 23,570 23,570 23,308 23,570 23,570 
Standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
Note: Service characteristics (such as MOS and pay grade), demographic characteristics (such as gender, race, marital status and age), and the start year of observation window have 




F. NAVY ENLISTED POPULATION RESULTS 
Table 28 presents the complete results of Model 1 for both PTSD and 
bipolar disorder among Navy enlisted personnel. The key variable of interest was 
whether the service member had been sent for deployment in OEF/OIF missions 
within the observation window. 
For a reference sailor (single white male in E1 to E2 rank, serving in 
combat arms specialty field), his probability of being diagnosed with PTSD 
increased by 0.4 of one percentage point if deployed, compared to those not 
deployed (p<0.01). On the other hand, deployment in OEF/OIF missions was 
associated with a lower probability of being diagnosed with bipolar disorder by 
0.39 of one percentage point (p<0.01).  
The probabilities of being diagnosed with PTSD or bipolar disorder were 
generally higher if an average Navy enlisted personnel was sent for a shore-
based deployment, compared to ship-based deployment. A sailor’s probabilities 
of being diagnosed with PTSD or bipolar disorder increased by 0.2 and 0.1 of 
one percentage point, respectively, if deployed on shore (p<0.01 and p<0.05, 
respectively). 
Unlike the results seen with the Army, being in service support, medical or 
other MOSs generally increased the probability of being diagnosed with PTSD 
compared to combat arms. As for bipolar disorder, Navy enlisted personnel in 
medical specialty fields had a higher probability of being diagnosed with the 
condition, compared to all other specialty fields (p<0.01).  
Being in middle pay grades (E3 to E5) generally increased an average 
Navy enlisted personnel’s probability of being diagnosed with either mental 
health disorder, compared to junior pay grades (E1 to E2) (p<0.01 for PTSD and 
p<0.1 for bipolar disorder). The opposite effects were observed for those in 
senior pay grades (E6 to E9) (both p<0.01). 
 Females had higher probabilities of being diagnosed with PTSD or bipolar 
disorder, compared to males (1.8 and 0.8 of one percentage point, respectively, 
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both p<0.01). Hispanics and personnel in “other race” had higher probabilities of 
being diagnosed with PTSD, compared to whites (p<0.1 and p<0.01, 
respectively). Blacks and Asians generally had lower probabilities of being 
diagnosed with PTSD, as compared to whites (both p<0.01). As for bipolar 
disorder, whites had higher probability of being diagnosed with the condition, 
compared to all other races (p<0.01). Married personnel had higher probabilities 
of being diagnosed with PTSD or bipolar disorder, compared to non-married 
personnel (0.6 and 0.16 of one percentage point, respectively, both p<0.01).   
The next two sections provide regression results of all models separately 
for PTSD and bipolar disorder. 
Table 28. Model 1: Marginal effect of deployment on probability of being 
diagnosed with PTSD and bipolar disorder (Navy enlisted population) 
Variable PTSD Bipolar Disorder 
Deployment Characteristics   
Deployed in OEF/OIF missions 0.004*** -0.0039*** 
  (0.000) (0.000) 
Shore-based Deployment 0.002*** 0.0010** 
  (0.001) (0.000) 
Service Characteristics (Combat Arms MOSs and E1 to E2 are the reference groups) 
Combat Service -0.004*** -0.0006 
  (0.001) (0.001) 
Service Support 0.008*** -0.0003 
  (0.002) (0.001) 
Aviation -0.002 -0.0010 
  (0.001) (0.001) 
Medical 0.070*** 0.0028*** 
  (0.004) (0.001) 
Other MOS 0.005*** 0.0004 
  (0.001) (0.001) 
E3 to E5 0.001*** 0.0004* 
  (0.000) (0.000) 
E6 to E9 -0.007*** -0.0025*** 
  (0.001) (0.000) 
Demographic Characteristics (Male, White, and non-married with no missing age information are the 
reference groups) 
Female 0.018*** 0.0080*** 
  (0.001) (0.000) 
Black -0.004*** -0.0038*** 
  (0.000) (0.000) 
Hispanic 0.001* -0.0030*** 
  (0.001) (0.000) 
Asian -0.003*** -0.0046*** 
  (0.001) (0.000) 
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Variable PTSD Bipolar Disorder 
Other Race 0.002*** -0.0009*** 
  (0.001) (0.000) 
Married 0.006*** 0.0016*** 
  (0.000) (0.000) 
Age 0.000 -0.0001*** 
  (0.000) (0.000) 
Missing age indicator -0.013*** -0.0043*** 
  (0.000) (0.000) 
Calendar Year of Observation (CY2000 is the reference group) 
CY2001 0.002*** 0.0008** 
  (0.001) (0.000) 
CY2002 0.002*** 0.0008* 
  (0.001) (0.000) 
CY2003 0.003*** -0.0003 
  (0.001) (0.000) 
CY2004 0.003*** -0.0001 
  (0.001) (0.000) 
CY2005 0.002*** -0.0003 
  (0.001) (0.000) 
CY2006 0.000 0.0005 
  (0.001) (0.000) 
CY2007 -0.002*** -0.0003 
  (0.001) (0.000) 
CY2008 -0.003*** -0.0000 
  (0.001) (0.001) 
Observed Probability 0.019 0.0077 
Predicted Probability 0.016 0.0066 
Observations 575,986 575,986 
Standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
 
1. PTSD 
Table 29 presents the marginal effects of key variables of interests on the 
probability of being diagnosed with PTSD. Results of Model 1 shown in the first 
column of Table 28 are reproduced for comparison purposes.  
Model 2 results indicated that deployment to Iraq or another OEF/OIF 
country increased the probability of being diagnosed with PTSD, compared to 
those not deployed (7.2 and 1.2 percentage points, respectively, both p<0.01). 
Deployment to an unknown/classified country decreased the probability of being 
diagnosed with PTSD by 0.5 of one percentage point (p<0.01). The location 
coefficient comparisons were statistically significantly different (p<0.01). 
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Model 3 showed that having multiple deployments to OEF/OIF missions 
increased an average Navy enlisted personnel’s probability of being diagnosed 
with PTSD by 0.1 of one percentage point, compared to those with a single 
deployment in OEF/OIF missions (p<0.05).  
Model 4 showed that deployment duration was not a significant predictor 
of the probability of being diagnosed with PTSD. Model 5 also indicated that the 
difference in the coefficient estimates between the two periods was not 
statistically significant. 
There were mixed results regarding differential deployment effects by 
period when the authors analyzed each location category separately. Model 6 
suggested that deployment in OEF/OIF missions had greater effects in the earlier 
period (CY2005 and prior) for all locations (p<0.01), except for Afghanistan.  
Model 7 showed the deployment effect was greater for those sailors in 
non-combat arms specialty fields, compared to those in combat arms specialty 
fields, by 0.9 of one percentage point (p<0.01).   
Results of Model 8 suggested that the probability of being diagnosed with 
PTSD was lower by 0.8 of one percentage point if a deployed Navy enlisted 
personnel was female, compared to male counterparts (p<0.01).  
2. Bipolar Disorder 
Table 30 presents the marginal effects of key variables of interests on the 
probability of being diagnosed with bipolar disorder. Results of Model 1 shown in 
the second column of Table 28 are reproduced for comparison purposes.  
Model 2 showed that the deployment effect varied somewhat across 
locations, but all coefficient estimates were of very small practical magnitude. No 
significant difference in the bipolar disorder rates between those with a single 
and multiple deployments was found, as shown in Model 3. From Model 4, Navy 
enlisted personnel with 120 to 180 days, and more than 180 days of deployment, 
were associated with reduced probability of being diagnosed with bipolar 
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disorder, as compared to those deployed less than 120 days (0.11 and 0.22 of 
one percentage point, p<0.05 and p<0.01, respectively).  
Model 5 showed that the probability of being diagnosed with bipolar 
disorder was associated with a decrease of 0.24 of one percentage point for 
those whose first deployment in OEF/OIF missions occurred in CY2005 and 
prior, and 0.42 of one percentage point for those whose first deployment in 
OEF/OIF missions occurred in CY2006 and after (both p<0.01). The differential 
effect between the two periods was statistically significant (p<0.01).  
Results of Model 6 showed having a first deployment to Iraq, an 
unknown/classified country or another OEF/OIF country occurred in CY2006 and 
after was associated with a lower probability of being diagnosed with bipolar 
disorder, compared to CY2005 and prior (p<0.01 for Iraq and an 
unknown/classified country, p<0.05 for another OEF/OIF country).  
Model 7 showed that being deployed and from non-combat arms MOSs 
was associated with a lower probability of being diagnosed with bipolar disorder, 
by 0.21 of one percentage point, compared to those deployed and from combat 
arms MOSs (p<0.1). Lastly, Model 8 showed no significant association between 
the interaction of gender and deployment in OEF/OIF missions and the 
probability of being diagnosed with bipolar disorder. 
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Table 29. Marginal effect of key variables of Interest on probability of being diagnosed with PTSD (Navy enlisted 
population) 
Variable Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 8 
Deployment               
Deployed in OEF/OIF missions 0.004*** -   -  - -  -  -0.004** 0.007*** 
  (0.000)           (0.002) (0.001) 
Interaction between Deployment and Deployment Period         
First deployment occurred in CY2005 and prior - - - - 0.004*** - - - 
          (0.001)       
First deployment occurred in CY2006 and after  -  -  -  - 0.005***  -  -  - 
          (0.001)       
Deployment Location               
Ever deployed to Afghanistan  - 0.000 -0.000 0.000  -  -  -  - 
    (0.001) (0.001) (0.001)         
Ever deployed to Iraq  - 0.072*** 0.071*** 0.072***  -  -  -  - 
    (0.002) (0.003) (0.003)         
Ever deployed to an unknown/classified country  - -0.005*** -0.005*** -0.005***  -  -  -  - 
  (0.000) (0.000) (0.000)         
Ever deployed to another OEF/OIF country  - 0.012*** 0.012*** 0.012***  -  -  -  - 
  (0.001) (0.001) (0.001)         
Deployment Frequency                 
Deployed more than once -   - 0.001** -   -  - -   
 -  
      (0.001)           
Total Days Deployed               
Short duration (less than 120 days) - - - reference - - - - 
                  
Medium duration (120 to 180 days)  -  -  - -0.000  -  -  -  - 
        (0.001)         
Long duration (more than 180 days)  -  -  - 0.000  -  -  -  - 
        (0.001)         
Interaction between Deployment Location and Period         
Deployed to Afghanistan in CY2005 and prior -  -  -  -  -  -0.003*** -  -  
          (0.001)     
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Variable Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 8 
Deployed to Afghanistan in CY2006 and after  -  -  -  -  - 0.037***  -  - 
          (0.003)     
Deployed to Iraq in CY2005 and prior  -  -  -  -  - 0.097***  -  - 
          (0.004)     
Deployed to Iraq in CY2006 and after  -  -  -  -  - 0.050***  -  - 
          (0.003)     
Deployed to an unknown/classified country in 
CY2005 and prior 
 -  -  -  -  - -0.003***  -  - 
          (0.000)     
Deployed to an unknown/classified country in 
CY2006 and after 
 -  -  -  -  - -0.006***  -  - 
          (0.000)     
Deployed to another OEF/OIF country in 
CY2005 and prior 
 -  -  -  -  - 0.014***  -  - 
          (0.001)     
Deployed to another OEF/OIF country in 
CY2006 and after 
 -  -  -  -  - 0.002*  -  - 
          (0.001)     
Interaction between Deployment and Non-Combat Arms MOS         
Deployed*Non-Combat Arms MOS -   -  - -  -  -  0.009***  - 
              (0.002)   
Interaction between Deployment and Female           
Deployed*Female -   -  - -  -  -  -  -0.008*** 
                (0.000) 
Observed Probability 0.019 0.019 0.019 0.019 0.019 0.019 0.019 0.019 
Predicted Probability 0.016 0.014 0.014 0.014 0.016 0.014 0.016 0.015 
Observations 575,986 575,986 575,986 575,986 575,986 575,986 575,986 575,986 
Standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
Note: Service characteristics (such as MOS and pay grade), demographic characteristics (such as gender, race, marital status and age), and the start year of observation window have 




Table 30. Marginal effect of key variables of Interest on probability of being diagnosed with bipolar disorder (Navy 
enlisted population) 
Variable Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 8 
Deployment               
Deployed in OEF/OIF missions -0.0039*** -   -  - -  -  -0.0019 -0.0040*** 
  (0.000)           (0.001) (0.000) 
Interaction between Deployment and Deployment Period         
First deployment occurred in CY2005 and prior - - - - -0.0024*** - - - 
          (0.000)       
First deployment occurred in CY2006 and after  -  -  -  - -0.0042***  -  -  - 
          (0.000)       
Deployment Location               
Ever deployed to Afghanistan  - -0.0028*** -0.0029*** -0.0018***  -  -  -  - 
    (0.000) (0.000) (0.000)         
Ever deployed to Iraq  - -0.0010* -0.0010* 0.0003  -  -  -  - 
    (0.001) (0.001) (0.001)         
Ever deployed to an unknown/classified country  - -0.0029*** -0.0030*** -0.0019***  -  -  -  - 
  (0.000) (0.000) (0.000)         
Ever deployed to another OEF/OIF country  - -0.0021*** -0.0022*** -0.0012***  -  -  -  - 
  (0.000) (0.000) (0.000)         
Deployment Frequency                 
Deployed more than once -   - 0.0002 -   -  - -   
 -  
      (0.000)           
Total Days Deployed               
Short duration (less than 120 days) - - - reference - - - - 
                  
Medium duration (120 to 180 days)  -  -  - -0.0011**  -  -  -  - 
        (0.000)         
Long duration (more than 180 days)  -  -  - -0.0022***  -  -  -  - 
        (0.000)         
Interaction between Deployment Location and Period         
Deployed to Afghanistan in CY2005 and prior -  -  -  -  -  -0.0021*** -  -  
          (0.000)     
Deployed to Afghanistan in CY2006 and after  -  -  -  -  - -0.0032***  -  - 
          (0.001)     
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Variable Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 8 
Deployed to Iraq in CY2005 and prior  -  -  -  -  - 0.0019  -  - 
          (0.001)     
Deployed to Iraq in CY2006 and after  -  -  -  -  - -0.0024***  -  - 
          (0.001)     
Deployed to an unknown/classified country in 
CY2005 and prior 
 -  -  -  -  - -0.0017***  -  - 
          (0.000)     
Deployed to an unknown/classified country in 
CY2006 and after 
 -  -  -  -  - -0.0041***  -  - 
          (0.000)     
Deployed to another OEF/OIF country in 
CY2005 and prior 
 -  -  -  -  - -0.0012**  -  - 
          (0.001)     
Deployed to another OEF/OIF country in 
CY2006 and after 
 -  -  -  -  - -0.0028***  -  - 
          (0.000)     
Interaction between Deployment and Non-Combat Arms MOS         
Deployed*Non-Combat Arms MOS -   -  - -  -  -  -0.0021*  - 
              (0.001)   
Interaction between Deployment and Female           
Deployed*Female -   -  - -  -  -   - 0.0004 
                (0.001) 
Observed Probability 0.008 0.008 0.008 0.008 0.008 0.008 0.008 0.008 
Predicted Probability 0.007 0.007 0.007 0.007 0.007 0.007 0.007 0.007 
Observations 575,986 575,986 575,986 575,986 575,986 575,986 575,986 575,986 
Standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
Note: Service characteristics (such as MOS and pay grade), demographic characteristics (such as gender, race, marital status and age), and the start year of observation window have 







G. NAVY OFFICER POPULATION RESULTS 
Table 31 presents the complete results of Model 1 for both PTSD and 
bipolar disorder among Navy officers. The key variable of interest was whether 
the Navy officer had been sent for deployment in OEF/OIF missions within the 
observation window. 
There was a small but statistically significant effect of deployment in 
OEF/OIF missions on PTSD. The probability of being diagnosed with PTSD was 
higher by 0.3 of one percentage point for a reference Navy Officer (single white 
male warrant officer who served in a combat arms specialty field) if deployed, 
compared to those not deployed (p<0.01). The probability of being diagnosed 
with bipolar disorder was not associated with deployment in OEF/OIF missions.  
Whether a Navy officer was deployed on shore or in ship had no effect on 
the probabilities of being diagnosed with the two mental health conditions. 
However, being in a combat arms specialty field, and middle and senior pay 
grades (O4 to O10) generally lowered the probabilities for both conditions (both 
p<0.01).  
Females had higher probabilities of being diagnosed with PTSD or bipolar 
disorder, compared to males, by 1.1 and 0.59 of one percentage point, 
respectively (both p<0.01). In terms of race, only the coefficient estimate for 
Asians was statistically significant (p<0.01), at 0.20 of one percentage point lower 
than whites. Married personnel had higher probabilities of being diagnosed with 
PTSD or bipolar disorder, by 0.2 and 0.11 of one percentage point, respectively, 
compared to non-married personnel (p<0.01 and p<0.05, respectively).   
The next two sections provide regression results of all models separately 





Table 31. Model 1: Marginal effect of deployment on probability of being 
diagnosed with PTSD and bipolar disorder (Navy officer population) 
Variable PTSD Bipolar Disorder 
Deployment Characteristics   
Deployed in OEF/OIF missions 0.003** 0.0002 
  (0.001) (0.001) 
Shore-based Deployment 0.000 -0.0012 
  (0.001) (0.001) 
Service Characteristics (Combat Arms MOSs and W1 to W5 are the reference groups) 
Combat Service 0.776*** 0.7613*** 
  (0.094) (0.190) 
Service Support 0.021*** 0.0113*** 
  (0.002) (0.002) 
Aviation 0.992*** 0.9946*** 
  (0.003) (0.000) 
Medical 0.984*** - 
  (0.000) - 
Other MOS 0.740*** 0.7767*** 
  (0.114) (0.190) 
O1 to O2 0.001 0.0011 
  (0.001) (0.001) 
O3 -0.001 -0.0005 
  (0.001) (0.001) 
O4 -0.006*** -0.0022*** 
  (0.001) (0.001) 
O5 -0.007*** -0.0022*** 
  (0.001) (0.001) 
O6 to O10 -0.008*** -0.0032*** 
  (0.000) (0.000) 
Demographic Characteristics (Male, White, and non-married with no missing age information are the 
reference groups) 
Female 0.011*** 0.0059*** 
  (0.001) (0.001) 
Black 0.001 0.0001 
  (0.001) (0.001) 
Hispanic 0.002 0.0003 
  (0.002) (0.001) 
Asian 0.000 -0.0020*** 
  (0.001) (0.001) 
Other Race -0.001 -0.0006 
  (0.001) (0.001) 
Married 0.002*** 0.0011** 
  (0.001) (0.000) 
Age 0.001*** 0.0001** 
  (0.000) (0.000) 
Missing age indicator -0.006*** -0.0011 
  (0.001) (0.001) 
Calendar Year of Observation (CY2000 is the reference group) 
CY2001 -0.000 -0.0005 
  (0.001) (0.001) 
CY2002 -0.000 -0.0019*** 
  (0.001) (0.001) 
CY2003 -0.000 -0.0012 
  (0.001) (0.001) 
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Variable PTSD Bipolar Disorder 
CY2004 -0.002 -0.0008 
  (0.001) (0.001) 
CY2005 -0.001 -0.0009 
  (0.001) (0.001) 
CY2006 -0.002** -0.0017** 
  (0.001) (0.001) 
CY2007 -0.005*** -0.0027*** 
  (0.001) (0.001) 
CY2008 -0.003* -0.0035*** 
  (0.001) (0.000) 
Observed Probability 0.010 0.0045 
Predicted Probability 0.007 0.0035 
Observations 80,690 80,647 
Standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
 
1. PTSD 
Table 32 presents the marginal effects of key variables of interest on the 
probability of being diagnosed with PTSD. Results of Model 1 shown in the first 
column of Table 31 are reproduced for comparison purposes.  
Model 2 showed that deployment to Iraq or another OEF/OIF country 
increased the probability of being diagnosed with PTSD by 1.8 percentage 
points, compared to non-deployed (p<0.01). Deployment to Afghanistan 
decreased the probability of being diagnosed with PTSD by 0.2 of one 
percentage point (p<0.01). Most of the pairwise location coefficient comparisons 
were significant (p<0.01), except for Afghanistan and an unknown/classified 
country. 
Results of Model 3 showed that having multiple deployments to OEF/OIF 
missions was associated with a lower probability of being diagnosed with PTSD, 
by 0.2 of one percentage point, compared to those with a single deployment in 
OEF/OIF missions (p<0.05).    
From Model 4, an average Navy officer’s probability of being diagnosed 
with PTSD increased by 0.3 of one percentage point when deployed for 120 to 
180 days, compared to one who was deployed for fewer than 120 days (p<0.1).    
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Results of Model 7 showed that the probability of being diagnosed with 
PTSD significantly decreased by 0.2 of one percentage point if the deployed 
Navy officer was from a non-combat arms MOS, compared to those deployed 
and from combat arms MOSs (p<0.01).  
Models 5 and 6 showed no statistically significant differential deployment 
effects, either in general or by locations, between the two periods (CY2005 and 
before, and CY2006 and after). Likewise, Model 8 showed no significant 
interactive effect between gender and deployment in OEF/OIF missions. 
2. Bipolar Disorder 
Table 33 presents the marginal effects of key variables of interest on the 
probability of being diagnosed with bipolar disorder. Results of Model 1 shown in 
the second column of Table 31 are reproduced for comparison purposes. 
Model 2 showed that deployment to Afghanistan was associated with 
reduced probability of being diagnosed with bipolar disorder by 0.17 of one 
percentage point, compared to non-deployed (p<0.05).  
Model 3 showed that an average Navy officer with multiple deployments to 
OEF/OIF missions  was associated with a lower probability of being diagnosed 
with bipolar disorder by 0.18 of one percentage point, compared to those with a 
single deployment in OEF/OIF missions (p<0.05).   
Results of Model 7 showed that the interactive effect of being deployed 
and from non-combat arms MOSs was associated with a lower probability of 
being diagnosed with bipolar disorder, by 0.47 of one percentage point, 
compared to those deployed and from combat arms MOSs (p<0.01).  
Model 8 showed that the probability of being diagnosed with bipolar 
disorder was associated with a decrease of 0.15 of one percentage point if a 
deployed Navy officer was female, compared to a deployed male officer (p<0.05).   
Model 4 indicated that the number of days of deployment in OEF/OIF 
missions had no significant effect on the probability of being diagnosed with 
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bipolar disorder. The probability of being diagnosed with bipolar disorder was 
also not affected by the time of deployment in OEF/OIF missions, as shown in 
Model 5. Likewise for Model 6, there were no statistical differences between the 
two periods for all four locations.  
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Table 32. Marginal effect of key variables of Interest on probability of being diagnosed with PTSD (Navy officer 
population) 
Variable Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 8 
Deployment                 
Deployed in OEF/OIF missions 0.003** -   -  - -  -  0.006*** 0.003** 
  (0.001)           (0.002) (0.001) 
Interaction between Deployment and Deployment Period             
First deployment occurred in CY2005 and prior - - - - 0.002 - - - 
          (0.001)       
First deployment occurred in CY2006 and after  -  -  -  - 0.004  -  -  - 
          (0.003)       
Deployment Location                 
Ever deployed to Afghanistan  - -0.002* -0.001 -0.003**  -  -  -  - 
    (0.001) (0.001) (0.001)         
Ever deployed to Iraq  - 0.018*** 0.021*** 0.016***  -  -  -  - 
    (0.004) (0.005) (0.004)         
Ever deployed to an unknown/classified country  - -0.002 -0.001 -0.002**  -  -  -  - 
  (0.001) (0.001) (0.001)         
Ever deployed to another OEF/OIF country  - 0.005*** 0.007*** 0.004**  -  -  -  - 
  (0.002) (0.002) (0.002)         
Deployment Frequency                 
Deployed more than once -   - -0.002** -   - -   - -  
      (0.001)           
Total Days Deployed                 
Short duration (less than 120 days) - - - reference - - - - 
                  
Medium duration (120 to 180 days)  -  -  - 0.003*  -  -  -  - 
        (0.002)         
Long duration (more than 180 days)  -  -  - 0.002  -  -  -  - 
        (0.001)         
Interaction between Deployment Location and Period             
Deployed to Afghanistan in CY2005 and prior -  -  -  -  -  -0.002* -  -  
          (0.001)     
Deployed to Afghanistan in CY2006 and after  -  -  -  -  - 0.005  -  - 
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Variable Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 8 
          (0.006)     
Deployed to Iraq in CY2005 and prior  -  -  -  -  - 0.022***  -  - 
          (0.006)     
Deployed to Iraq in CY2006 and after  -  -  -  -  - 0.011**  -  - 
          (0.006)     
Deployed to an unknown/classified country in 
CY2005 and prior 
 -  -  -  -  - -0.001  -  - 
          (0.001)     
Deployed to an unknown/classified country in 
CY2006 and after 
 -  -  -  -  - -0.004**  -  - 
          (0.002)     
Deployed to another OEF/OIF country in 
CY2005 and prior 
 -  -  -  -  - 0.006***  -  - 
          (0.002)     
Deployed to another OEF/OIF country in 
CY2006 and after 
 -  -  -  -  - 0.002  -  - 
          (0.003)     
Interaction between Deployment and Non-Combat Arms MOS             
Deployed*Non-Combat Arms MOS -   -  - -  -  -  -0.002***  - 
              (0.000)   
Interaction between Deployment and Female               
Deployed*Female -   -  - -  -  -   - -0.001 
                (0.001) 
Observed Probability 0.010 0.010 0.010 0.010 0.010 0.010 0.010 0.010 
Predicted Probability 0.007 0.007 0.007 0.007 0.007 0.007 0.007 0.007 
Observations 80,690 80,690 80,690 80,690 80,690 80,690 80,690 80,690 
Standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
Note: Service characteristics (such as MOS and pay grade), demographic characteristics (such as gender, race, marital status and age), and the start year of observation window have 




Table 33. Marginal effect of key variables of Interest on probability of being diagnosed with bipolar disorder (Navy 
officer population) 
Variable Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 8 
Deployment                 
Deployed in OEF/OIF missions 0.0002 -   -  - -  -  0.0099*** 0.0007 
  (0.001)           (0.002) (0.001) 
Interaction between Deployment and Deployment Period               
First deployment occurred in CY2005 and prior - - - - 0.0003 - - - 
          (0.001)       
First deployment occurred in CY2006 and after  -  -  -  - -0.0002  -  -  - 
          (0.001)       
Deployment Location                 
Ever deployed to Afghanistan  - -0.0017** -0.0010 -0.0013  -  -  -  - 
    (0.001) (0.001) (0.001)         
Ever deployed to Iraq  - 0.0017 0.0026 0.0025  -  -  -  - 
    (0.002) (0.002) (0.002)         
Ever deployed to an unknown/classified country  - -0.0005 0.0001 -0.0002  -  -  -  - 
  (0.001) (0.001) (0.001)         
Ever deployed to another OEF/OIF country  - 0.0002 0.0011 0.0006  -  -  -  - 
  (0.001) (0.001) (0.001)         
Deployment Frequency                 
Deployed more than once -   - -0.0018** -   - -   -  - 
      (0.001)           
Total Days Deployed                 
Short duration (less than 120 days) - - - reference - - - - 
                  
Medium duration (120 to 180 days)  -  -  - -0.0002  -  -  -  - 
        (0.001)         
Long duration (more than 180 days)  -  -  - -0.0011  -  -  -  - 
        (0.001)         
Interaction between Deployment Location and Period               
Deployed to Afghanistan in CY2005 and prior -  -  -  -  -  -0.0016* -  -  
          (0.001)     
Deployed to Afghanistan in CY2006 and after  -  -  -  -  - -  -  - 
          -     
Deployed to Iraq in CY2005 and prior  -  -  -  -  - 0.0018  -  - 
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Variable Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 8 
          (0.003)     
Deployed to Iraq in CY2006 and after  -  -  -  -  - 0.0016  -  - 
          (0.003)     
Deployed to an unknown/classified country in 
CY2005 and prior 
 -  -  -  -  - -0.0008  -  - 
          (0.001)     
Deployed to an unknown/classified country in 
CY2006 and after 
 -  -  -  -  - 0.0012  -  - 
          (0.002)     
Deployed to another OEF/OIF country in 
CY2005 and prior 
 -  -  -  -  - 0.0005  -  - 
          (0.001)     
Deployed to another OEF/OIF country in 
CY2006 and after 
 -  -  -  -  - -0.0015  -  - 
          (0.002)     
Interaction between Deployment and Non-Combat Arms MOS             
Deployed*Non-Combat Arms MOS -   -  - -  -  -  -0.0047***  - 
              (0.000)   
Interaction between Deployment and Female               
Deployed*Female -   -  - -  -  -  -  -0.0015** 
                (0.001) 
Observed Probability 0.004 0.004 0.004 0.004 0.004 0.004 0.004 0.004 
Predicted Probability 0.004 0.003 0.003 0.003 0.004 0.004 0.004 0.004 
Observations 80,647 80,647 80,647 80,647 80,647 80,344 80,647 80,647 
Standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
Note: Service characteristics (such as MOS and pay grade), demographic characteristics (such as gender, race, marital status and age), and the start year of observation window have 
been controlled for in all models. 
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H. AIR FORCE ENLISTED POPULATION RESULTS 
Table 34 presents the complete results of Model 1 for both PTSD and 
bipolar disorder among Air Force enlisted personnel. The key variable of interest 
was whether the service member had been sent for deployment in OEF/OIF 
missions within the observation window. 
The probabilities of being diagnosed with PTSD or bipolar disorder were 
significantly dependent on whether an Air Force enlisted personnel was sent for 
deployment in OEF/OIF missions (p<0.01). A reference Air Force enlisted 
personnel’s (single white male in E1 to E2 rank, serving in a combat arms 
specialty field) probability of being diagnosed with PTSD increased by 0.8 of one 
percentage point if deployed, compared to those not deployed (p<0.01). On the 
other hand, the probability of being diagnosed with bipolar disorder was lowered 
by 0.25 of one percentage point among the deployed population, compared to 
those not deployed (p<0.01).  
Being in a combat arms specialty fields was associated with a lower 
probability of being diagnosed with PTSD, compared to other specialty fields, 
except medical (p<0.01). Being in middle pay grades (E3 to E5) generally 
increased an average Air Force enlisted personnel’s probability of being 
diagnosed with either mental health disorder, compared to being in junior pay 
grades (E1 to E2) (p<0.01 for PTSD and p<0.1 for bipolar disorder). Being in 
senior pay grades (E6 to E9) generally decreased his probability, compared to 
being in junior pay grades (E1 to E2) (both p<0.01).  
Females had higher probabilities of being diagnosed with PTSD or bipolar 
disorder, by 1.9 and 0.76 of one percentage point higher, respectively, compared 
to males, (both p<0.01). Hispanics had higher probability of being diagnosed with 
PTSD, compared to whites (p<0.05). Blacks and Asians had lower probabilities of 
being diagnosed with the same condition, compared to whites (both p<0.01). As 
for bipolar disorder, whites had higher probability of being diagnosed with the 
condition than the other race minority groups (p<0.01).  
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Married personnel had higher probability of being diagnosed with PTSD 
(0.5 of one percentage point) and bipolar disorder (0.12 of one percentage point), 
compared to non-married personnel (both p<0.01).   
The next two sections provide regression results of all models separately 
for PTSD and bipolar disorder. 
Table 34. Model 1: Marginal effect of deployment on probability of being 
diagnosed with PTSD and bipolar disorder (Air Force enlisted population) 
Variable PTSD Bipolar Disorder 
Deployment Characteristics 
Deployed in OEF/OIF missions 0.008*** -0.0025*** 
  (0.000) (0.000) 
Service Characteristics (Combat Arms MOSs and E1 to E2 are the reference groups) 
Combat Service 0.002*** 0.0006 
  (0.001) (0.000) 
Service Support 0.004*** 0.0004 
  (0.001) (0.000) 
Medical 0.002 0.0014 
  (0.002) (0.001) 
Other MOS 0.011*** 0.0002 
  (0.001) (0.000) 
E3 to E5 0.002*** 0.0005* 
  (0.000) (0.000) 
E6 to E9 -0.008*** -0.0033*** 
  (0.001) (0.000) 
Demographic Characteristics (Male, White, and non-married with no missing age information are the reference 
groups) 
Female 0.019*** 0.0076*** 
  (0.001) (0.000) 
Black -0.004*** -0.0035*** 
  (0.000) (0.000) 
Hispanic 0.002** -0.0032*** 
  (0.001) (0.000) 
Asian -0.005*** -0.0036*** 
  (0.001) (0.000) 
Other Race -0.001 -0.0030*** 
  (0.001) (0.000) 
Married 0.005*** 0.0012*** 
  (0.000) (0.000) 
Age -0.000*** -0.0002*** 
  (0.000) (0.000) 
Missing age indicator -0.013*** -0.0044*** 
  (0.000) (0.000) 
Calendar Year of Observation (CY2000 is the reference group) 
CY2001 -0.001 0.0004 
  (0.001) (0.000) 
CY2002 -0.001** -0.0007* 
  (0.001) (0.000) 
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Variable PTSD Bipolar Disorder 
CY2003 -0.002*** -0.0011*** 
  (0.001) (0.000) 
CY2004 -0.002*** -0.0018*** 
  (0.001) (0.000) 
CY2005 -0.001 -0.0023*** 
  (0.001) (0.000) 
CY2006 -0.003*** -0.0022*** 
  (0.001) (0.000) 
CY2007 -0.005*** -0.0024*** 
  (0.001) (0.000) 
CY2008 -0.007*** -0.0033*** 
  (0.001) (0.001) 
Observed Probability 0.019 0.0082 
Predicted Probability 0.016 0.0071 
Observations 496,997 496,997 
Standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
 
1. PTSD 
Table 35 presents the marginal effects of key variables of interest on the 
probability of being diagnosed with PTSD. Results of Model 1 shown in the first 
column of Table 34 are reproduced for comparison purposes.   
Model 2 showed that deployment to Afghanistan, Iraq or another known 
OEF/OIF country increased the probability of being diagnosed with PTSD, 
compared to non-deployed (all p<0.01). The magnitude of increase was the 
highest at 2.3 percentage points if deployed to Iraq, followed by 0.5 of one 
percentage point if deployed to Afghanistan, and 0.4 of one percentage point if 
deployed to another known OEF/OIF country.  
Results of Model 3 showed that there was no association between 
frequency of deployments and the probability of being diagnosed with PTSD. 
From Model 4, the probability of being diagnosed with PTSD increased by 0.1 of 
one percentage point for Air Force enlisted personnel with 120 to 180 days of 
deployment in OEF/OIF missions, and by 0.7 of one percentage point if deployed 
for more than 180 days, compared to those with fewer than 120 days (p<0.05 
and p<0.01, respectively).     
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The probability of being diagnosed with PTSD increased by 0.8 of one 
percentage point for an average Air Force enlisted personnel whose first 
deployment in OEF/OIF missions occurred in CY2005 and prior, and 1.2 
percentage points whose first deployment in OEF/OIF missions occurred in 
CY2006 and after, as shown in Model 5 (both p<0.01). The coefficient estimates 
for the two periods were statistically different (p<0.01).   
Model 6 showed that Air Force enlisted personnel who were first deployed 
to Afghanistan in CY2005 and prior had lower probability of being diagnosed with 
PTSD, than those who were first deployed to the same location in CY2006 and 
after (p<0.01). The opposite was true for Iraq (p<0.01). 
The results of Model 7 showed that the probability of being diagnosed with 
PTSD significantly increased by 0.4 of one percentage point if the deployed Air 
Force enlisted personnel was from a non-combat arms MOS, compared to those 
deployed and from combat arms MOSs (p<0.01).  
Model 8 showed that the probability of being diagnosed with PTSD 
decreased by 0.6 of one percentage point if the deployed Air Force enlisted 
personnel was female, compared to male counterparts (p<0.01).  
2. Bipolar Disorder 
Table 36 presents the marginal effects of key variables of interest on the 
probability of being diagnosed with bipolar disorder. Results of Model 1 shown in 
the second column of Table 34 are reproduced for comparison purposes.  
As shown in Model 2, deployment to any OEF/OIF location (Afghanistan, 
Iraq, an unknown/classified country or another OEF/OIF country) was associated 
with a lower probability of being diagnosed with bipolar disorder, compared to 
non-deployed (by 0.22, 0.24, 0.25, and 0.15 of one percentage point, 
respectively, all p<0.01). All pairwise location coefficient comparison were 
significant except between Afghanistan and another OEF/OIF country (p<0.01).  
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Model 4 showed that a higher number of days deployed was associated 
with a reduced probability of being diagnosed with bipolar disorder. The 
probability was decreased by 0.09 of one percentage point for Air Force enlisted 
personnel with 120 to 180 days of deployment in OEF/OIF missions, and by 0.17 
percentage point if deployed more than 180 days, compared to those with fewer 
than 120 days (p<0.05 and p<0.01, respectively). 
Model 5 indicated that the probability of being diagnosed with bipolar 
disorder decreased by 0.21 of one percentage point for those whose first 
deployment in OEF/OIF missions occurred in CY2005 and prior, and by 0.34 of 
one percentage point for those whose first deployment in OEF/OIF missions 
occurred in CY2006 and after (both p<0.01). The coefficient estimates for both 
periods were found to be statistically different (p<0.01). Model 6 also showed that 
statistical differences were found between the two periods for first deployment to 
Afghanistan or another OEF/OIF country (p<0.01 and p<0.05, respectively). 
Model 3 showed that there was no association between deployment 
frequency and the probability of being diagnosed with bipolar disorder for Air 
Force enlisted personnel. Models 7 and 8 also suggested that there were no 
association between the interactive effects of deployment in OEF/OIF missions 
and MOS, and deployment in OEF/OIF missions and female with the probability 
of being diagnosed with bipolar disorder. 
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Table 35. Marginal effect of key variables of Interest on probability of being diagnosed with PTSD (Air Force enlisted 
population) 
Variable Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 8 
Deployment               
Deployed in OEF/OIF missions 0.008*** -   -  - -   -  0.004*** 0.011*** 
  (0.000)           (0.001) (0.000) 
Interaction between Deployment and Deployment Period         
First deployment occurred in CY2005 and prior - - - - 0.008*** - - - 
          (0.000)       
First deployment occurred in CY2006 and after  -  -  -  - 0.012***  -  -  - 
          (0.001)       
Deployment Location               
Ever deployed to Afghanistan  - 0.005*** 0.004*** 0.002***  -  -  -  - 
    (0.001) (0.001) (0.001)         
Ever deployed to Iraq  - 0.023*** 0.023*** 0.019***  -  -  -  - 
    (0.001) (0.001) (0.001)         
Ever deployed to an unknown/classified country  - -0.001 -0.001 -0.002***  -  -  -  - 
  (0.001) (0.001) (0.001)         
Ever deployed to another OEF/OIF country  - 0.004*** 0.004*** 0.002***  -  -  -  - 
  (0.000) (0.000) (0.000)         
Deployment Frequency                 
Deployed more than once -   - 0.001 -   - -   - -  
      (0.001)           
Total Days Deployed               
Short duration (less than 120 days) - - - reference - - - - 
                  
Medium duration (120 to 180 days)  -  -  - 0.001**  -  -  -  - 
        (0.001)         
Long duration (more than 180 days)  -  -  - 0.007***  -  -  -  - 
        (0.001)         
Interaction between Deployment Location and Period         
Deployed to Afghanistan in CY2005 and prior -  -  -  -  -  0.002** -  -  
          (0.001)     
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Variable Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 8 
Deployed to Afghanistan in CY2006 and after  -  -  -  -  - 0.013***  -  - 
          (0.002)     
Deployed to Iraq in CY2005 and prior  -  -  -  -  - 0.027***  -  - 
          (0.001)     
Deployed to Iraq in CY2006 and after  -  -  -  -  - 0.020***  -  - 
          (0.001)     
Deployed to an unknown/classified country in 
CY2005 and prior 
 -  -  -  -  - -0.000  -  - 
          (0.001)     
Deployed to an unknown/classified country in 
CY2006 and after 
 -  -  -  -  - -0.002  -  - 
          (0.002)     
Deployed to another OEF/OIF country in 
CY2005 and prior 
 -  -  -  -  - 0.004***  -  - 
          (0.000)     
Deployed to another OEF/OIF country in 
CY2006 and after 
 -  -  -  -  - 0.005***  -  - 
          (0.001)     
Interaction between Deployment and Non-Combat Arms MOS         
Deployed*Non-Combat Arms MOS -   -  - -  -  -  0.004***  - 
              (0.001)   
Interaction between Deployment and Female           
Deployed*Female -   -  - -  -  -   - -0.006*** 
                (0.001) 
Observed Probability 0.019 0.019 0.019 0.019 0.019 0.019 0.019 0.019 
Predicted Probability 0.016 0.015 0.015 0.015 0.016 0.015 0.016 0.015 
Observations 496,997 496,997 496,997 496,997 496,997 496,997 496,997 496,997 
Standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
Note: Service characteristics (such as MOS and pay grade), demographic characteristics (such as gender, race, marital status and age), and the start year of observation window have 
been controlled for in all models. 
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Table 36. Marginal effect of key variables of Interest on probability of being diagnosed with bipolar disorder (Air Force 
enlisted population) 
Variable Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 8 
Deployment               
Deployed in OEF/OIF missions -0.0025*** -   -  - -  -  -0.0029*** -0.0027*** 
  (0.000)           (0.001) (0.000) 
Interaction between Deployment and Deployment Period         
First deployment occurred in CY2005 and prior - - - - -0.0021*** - - - 
          (0.000)       
First deployment occurred in CY2006 and after  -  -  -  - -0.0034***  -  -  - 
          (0.000)       
Deployment Location               
Ever deployed to Afghanistan  - -0.0022*** -0.0021*** -0.0018***  -  -  -  - 
    (0.000) (0.000) (0.000)         
Ever deployed to Iraq  - -0.0024*** -0.0022*** -0.0018***  -  -  -  - 
    (0.000) (0.000) (0.000)         
Ever deployed to an unknown/classified country  - -0.0025*** -0.0023*** -0.0022***  -  -  -  - 
  (0.000) (0.001) (0.000)         
Ever deployed to another OEF/OIF country  - -0.0015*** -0.0013*** -0.0009***  -  -  -  - 
  (0.000) (0.000) (0.000)         
Deployment Frequency                 
Deployed more than once -   - -0.0007 -   -  - -  -  
      (0.000)           
Total Days Deployed               
Short duration (less than 120 days) - - - reference - - - -  
                  
Medium duration (120 to 180 days)  -  -  - -0.0009**  -  -  - -  
        (0.000)         
Long duration (more than 180 days)  -  -  - -0.0017***  -  -  - -  
        (0.000)         
Interaction between Deployment Location and Period         
Deployed to Afghanistan in CY2005 and prior -  -  -  -  -  -0.0014*** -  -  
          (0.000)     
Deployed to Afghanistan in CY2006 and after  -  -  -  -  - -0.0048***  -  - 
          (0.001)     
Deployed to Iraq in CY2005 and prior  -  -  -  -  - -0.0023***  -  - 
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Variable Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 8 
          (0.000)     
Deployed to Iraq in CY2006 and after  -  -  -  -  - -0.0025***  -  - 
          (0.000)     
Deployed to an unknown/classified country in 
CY2005 and prior 
 -  -  -  -  - -0.0026***  -  - 
          (0.001)     
Deployed to an unknown/classified country in 
CY2006 and after 
 -  -  -  -  - -0.0021**  -  - 
          (0.001)     
Deployed to another OEF/OIF country in 
CY2005 and prior 
 -  -  -  -  - -0.0013***  -  - 
          (0.000)     
Deployed to another OEF/OIF country in 
CY2006 and after 
 -  -  -  -  - -0.0025***  -  - 
          (0.000)     
Interaction between Deployment and Non-Combat Arms MOS         
Deployed*Non-Combat Arms MOS -   -  - -  -  -  0.0004  - 
              (0.001)   
Interaction between Deployment and Female           
Deployed*Female -   -  - -  -  -   - 0.0007 
                (0.001) 
Observed Probability 0.008 0.008 0.008 0.008 0.008 0.008 0.008 0.008 
Predicted Probability 0.007 0.007 0.007 0.007 0.007 0.007 0.007 0.007 
Observations 496,997 496,997 496,997 496,997 496,997 496,997 496,997 496,997 
Standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
Note: Service characteristics (such as MOS and pay grade), demographic characteristics (such as gender, race, marital status and age), and the start year of observation window have 






I. AIR FORCE OFFICER POPULATION RESULTS 
Table 37 presents the complete results of Model 1 for both PTSD and 
bipolar disorder among Air Force officers. The key variable of interest was 
whether the service member was sent for deployment in OEF/OIF missions 
within the observation window. 
A reference Air Force officer’s (single white male officer in O1 or O2 pay 
grade, and served in a combat arms specialty field) probability of being 
diagnosed with PTSD increased by 0.4 of one percentage point if deployed, 
compared to those not deployed (p<0.01). On the other hand, deployment in 
OEF/OIF missions was associated with a lower probability of being diagnosed 
with bipolar disorder, by 0.13 of one percentage point, compared to those not 
deployed (p<0.01).  
Being in a combat arms specialty field, and middle or senior pay grades 
(O4 to O10) were generally associated with a reduced probability of being 
diagnosed with either mental health disorder (both p<0.01).  
In terms of demographics, females had higher probabilities of being 
diagnosed with PTSD or bipolar disorder, compared to males, (by 1.3 and 0.37 of 
one percentage point, respectively, both p<0.01). Hispanics and officers of “other 
race” had higher probabilities of being diagnosed with PTSD by 1.0 and 0.2 of 
one percentage point, respectively, compared to whites (p<0.01 and p<0.05, 
respectively). Married personnel had higher probability by 0.1 of one percentage 
point of being diagnosed with PTSD, compared to non-married personnel 
(p<0.05).   
The next two sections provide regression results of all models separately 





Table 37. Model 1: Marginal effect of deployment on probability of being 
diagnosed with PTSD and bipolar disorder (Air Force officer population) 
Variable PTSD Bipolar Disorder 
Deployment Characteristics   
Deployed in OEF/OIF missions 0.004*** -0.0013*** 
  (0.001) (0.000) 
Service Characteristics (Combat Arms MOSs and O1 to O2 are the reference groups) 
Combat Service 0.980*** 0.9660*** 
  (0.014) (0.030) 
Service Support - - 
  - - 
Medical - - 
  - - 
Other MOS 0.008*** 0.0030*** 
  (0.000) (0.000) 
O3 -0.000 0.0002 
  (0.001) (0.000) 
O4 -0.005*** -0.0014*** 
  (0.001) (0.000) 
O5 -0.006*** -0.0021*** 
  (0.001) (0.000) 
O6 to O10 -0.007*** -0.0024*** 
  (0.000) (0.000) 
Demographic Characteristics (Male, White, and non-married with no missing age information are the reference 
groups) 
Female 0.013*** 0.0037*** 
  (0.001) (0.001) 
Black 0.002 -0.0006 
  (0.001) (0.001) 
Hispanic 0.010*** -0.0009 
  (0.003) (0.001) 
Asian -0.001 -0.0005 
  (0.001) (0.001) 
Other Race 0.002** 0.0005 
  (0.001) (0.001) 
Married 0.001** -0.0001 
  (0.001) (0.000) 
Age 0.000*** 0.0001*** 
  (0.000) (0.000) 
Missing age indicator -0.007*** -0.0019*** 
  (0.001) (0.000) 
Calendar Year of Observation (CY2000 is the reference group) 
CY2001 0.000 -0.0005 
  (0.001) (0.000) 
CY2002 -0.000 -0.0003 
  (0.001) (0.001) 
CY2003 -0.003*** -0.0010** 
  (0.001) (0.001) 
CY2004 -0.001 -0.0001 
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Variable PTSD Bipolar Disorder 
  (0.001) (0.001) 
CY2005 -0.002 -0.0015*** 
  (0.001) (0.001) 
CY2006 -0.001 -0.0014** 
  (0.001) (0.001) 
CY2007 -0.003*** -0.0019*** 
  (0.001) (0.000) 
CY2008 -0.003** -0.0017*** 
  (0.001) (0.001) 
Observed Probability 0.010 0.0036 
Predicted Probability 0.008 0.0029 
Observations 108,575 108,575 
Standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
 
1. PTSD 
Table 38 presents the marginal effects of key variables of interest on the 
probability of being diagnosed with PTSD. Results of Model 1 shown in the first 
column of Table 37 are included for comparison purposes.   
Model 2 indicated that deployment to Afghanistan or Iraq increased the 
probability of being diagnosed with PTSD by 0.2 and 1.6 percentage points, 
respectively, compared to those not deployed (p<0.05 and p<0.01, respectively). 
Deployment to an unknown/classified country decreased the probability of being 
diagnosed with PTSD by 0.2 of one percentage point, compared to those not 
deployed (p<0.05). Pairwise location coefficient comparisons showed significant 
differences between Iraq and the other three locations (p<0.01), as well as 
between Afghanistan and an unknown/classified country (p<0.05).  
In terms of deployment frequency, Model 3 showed that having multiple 
deployments in OEF/OIF missions decreased the probability of being diagnosed 
with PTSD by 0.2 of one percentage point, compared to an average Air Force 
officer with a single deployment in OEF/OIF missions (p<0.01). From Model 4, an 
average Air Force officer’s probability of being diagnosed with PTSD decreased 
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by 0.3 of one percentage point when deployed for between 120 to 180 days, 
compared to those deployed for fewer than 120 days (p<0.05).   
Model 5 showed that there was no significant difference between the 
coefficient estimates of the two deployment periods on the probability of being 
diagnosed with PTSD. However, Model 6 showed that an average Air Force 
officer’s probability of being diagnosed with PTSD was higher when first 
deployed to Afghanistan in CY2006 and after, as compared to those whose first 
deployment to the same location occurred in CY2005 and prior (p<0.01).  
Model 7 showed that the probability of being diagnosed with PTSD 
significantly decreased by 0.1 of one percentage point if a deployed Air Force 
officer was from a non-combat arms MOS, compared to those deployed and from 
combat arms MOSs (p<0.01).  
Results of Model 8 suggested that the interaction effect between 
deployment in OEF/OIF missions and gender did not have a significant effect on 
the probability of being diagnosed with PTSD.  
2. Bipolar Disorder 
Table 39 presents the marginal effects of key variables of interest on the 
probability of being diagnosed with bipolar disorder. Results of Model 1 shown in 
the second column of Table 37 are reproduced for comparison purposes.  
As shown in Model 2, deployment to Afghanistan, an unknown/classified 
country or another OEF/OIF country was associated with a reduced probability of 
being diagnosed with bipolar disorder by 0.09, 0.19 and 0.1 of one percentage 
point, respectively, compared to non-deployed (p<0.1, p<0.01 and p<0.01, 
respectively). The coefficient estimates of Iraq and an unknown/classified country 
were statistically different (p<0.05). 
Results of Model 3 showed that OEF/OIF deployment frequency was not 
associated with the probability of being diagnosed with bipolar disorder for Air 
Force officers. Model 4 showed that being deployed for more than 180 days was 
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associated with the probability of being diagnosed with bipolar disorder. The 
probability was lowered by 0.11 of one percentage point when an average Air 
Force officer was deployed in OEF/OIF missions for more than 180 days, 
compared to those who were deployed for 180 days and less (p<0.1).  
The results of Model 7 showed that the interactive effect of being deployed 
and from non-combat arms MOSs was associated with a lower probability of 
being diagnosed with bipolar disorder, by 0.23 of one percentage point, 
compared to those deployed and from combat arms MOSs (p<0.01).  
Models 5 and 6 showed that there were no statistical differences between 
the coefficient effects of deployment in OEF/OIF missions in CY2005 and prior, 
and CY2006 and after, in general, as well as for all locations. Model 8 also 
showed that the interaction effect between deployment in OEF/OIF missions and 




Table 38. Marginal effect of key variables of Interest on probability of being diagnosed with PTSD (Air Force officer 
population) 
Variable Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 8 
Deployment                 
Deployed in OEF/OIF missions 0.004*** -   -  - -   -  0.006*** 0.004*** 
  (0.001)           (0.001) (0.001) 
Interaction between Deployment and Deployment Period             
First deployment occurred in CY2005 and prior - - - - 0.004*** - - - 
          (0.001)       
First deployment occurred in CY2006 and after  -  -  -  - 0.007***  -  -  - 
          (0.002)       
Deployment Location                 
Ever deployed to Afghanistan  - 0.002** 0.003*** 0.001  -  -  -  - 
    (0.001) (0.001) (0.001)         
Ever deployed to Iraq  - 0.016*** 0.018*** 0.014***  -  -  -  - 
    (0.002) (0.002) (0.002)         
Ever deployed to an unknown/classified country  - -0.002** -0.001 -0.002**  -  -  -  - 
  (0.001) (0.001) (0.001)         
Ever deployed to another OEF/OIF country  - 0.000 0.001* -0.000  -  -  -  - 
  (0.001) (0.001) (0.001)         
Deployment Frequency                 
Deployed more than once -   - -0.002*** -   - -   -  - 
      (0.001)           
Total Days Deployed                 
Short duration (less than 120 days) - - - reference - - - - 
                  
Medium duration (120 to 180 days)  -  -  - 0.003**  -  -  -  - 
        (0.001)         
Long duration (more than 180 days)  -  -  - 0.001  -  -  -  - 
        (0.001)         
Interaction between Deployment Location and Period             
Deployed to Afghanistan in CY2005 and prior -  -  -  -  -  -0.000 -  -  
          (0.001)     
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Variable Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 8 
Deployed to Afghanistan in CY2006 and after  -  -  -  -  - 0.017***  -  - 
          (0.005)     
Deployed to Iraq in CY2005 and prior  -  -  -  -  - 0.019***  -  - 
          (0.003)     
Deployed to Iraq in CY2006 and after  -  -  -  -  - 0.012***  -  - 
          (0.003)     
Deployed to an unknown/classified country in 
CY2005 and prior 
 -  -  -  -  - -0.001  -  - 
          (0.001)     
Deployed to an unknown/classified country in 
CY2006 and after 
 -  -  -  -  - -0.003  -  - 
          (0.002)     
Deployed to another OEF/OIF country in 
CY2005 and prior 
 -  -  -  -  - 0.001  -  - 
          (0.001)     
Deployed to another OEF/OIF country in 
CY2006 and after 
 -  -  -  -  - -0.002  -  - 
          (0.001)     
Interaction between Deployment and Non-Combat Arms MOS             
Deployed*Non-Combat Arms MOS -   -  - -  -  -  -0.001***  - 
              (0.000)   
Interaction between Deployment and Female               
Deployed*Female -   -  - -  -  -   - -0.001 
                (0.001) 
Observed Probability 0.010 0.010 0.010 0.010 0.010 0.010 0.010 0.010 
Predicted Probability 0.008 0.007 0.007 0.007 0.007 0.007 0.008 0.007 
Observations 108,575 108,575 108,575 108,575 108,575 108,575 108,575 108,575 
Standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
Note: Service characteristics (such as MOS and pay grade), demographic characteristics (such as gender, race, marital status and age), and the start year of observation window have 




Table 39. Marginal effect of key variables of Interest on probability of being diagnosed with bipolar disorder (Air Force 
officer population) 
Variable Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 8 
Deployment               
Deployed in OEF/OIF missions -
0.0013*** 
-   -  - -   -  0.0013*** -0.0011*** 
  (0.000)           (0.000) (0.000) 
Interaction between Deployment and Deployment Period         
First deployment occurred in CY2005 and prior - - -  - -0.0012*** - - - 
          (0.000)       
First deployment occurred in CY2006 and after  -  -  -  - -0.0016***  -  -  - 
          (0.001)       
Deployment Location               
Ever deployed to Afghanistan  - -0.0009* -0.0009 -0.0008  -  -  -  - 
    (0.001) (0.001) (0.001)         
Ever deployed to Iraq  - 0.0002 0.0003 0.0003  -  -  -  - 
    (0.001) (0.001) (0.001)         
Ever deployed to an unknown/classified country  - -0.0019*** -0.0019*** -0.0019***  -  -  -  - 
  (0.000) (0.001) (0.000)         
Ever deployed to another OEF/OIF country  - -0.0010*** -0.0009** -0.0008*  -  -  -  - 
  (0.000) (0.000) (0.000)         
Deployment Frequency             
Deployed more than once -   - -0.0004 -   -  - -   
 -  
      (0.001)           
Total Days Deployed               
Short duration (less than 120 days) - - - reference - - - - 
                  
Medium duration (120 to 180 days)  -  -  - 0.0004  -  -  -  - 
        (0.001)         
Long duration (more than 180 days)  -  -  - -0.0011*  -  -  -  - 
        (0.001)         
Interaction between Deployment Location and Period         
Deployed to Afghanistan in CY2005 and prior -  -  -  -  -  -0.0013** -  -  
          (0.001)     
Deployed to Afghanistan in CY2006 and after  -  -  -  -  - 0.0013  -  - 
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Variable Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 8 
          (0.002)     
Deployed to Iraq in CY2005 and prior  -  -  -  -  - 0.0007  -  - 
          (0.001)     
Deployed to Iraq in CY2006 and after  -  -  -  -  - -0.0010  -  - 
          (0.001)     
Deployed to an unknown/classified country in 
CY2005 and prior 
 -  -  -  -  - -0.0020***  -  - 
          (0.001)     
Deployed to an unknown/classified country in 
CY2006 and after 
 -  -  -  -  - -0.0018  -  - 
          (0.001)     
Deployed to another OEF/OIF country in 
CY2005 and prior 
 -  -  -  -  - -0.0007*  -  - 
          (0.000)     
Deployed to another OEF/OIF country in 
CY2006 and after 
 -  -  -  -  - -  -  - 
          -     
Interaction between Deployment and Non-Combat Arms MOS         
Deployed*Non-Combat Arms MOS -   -  - -  -  -  -0.0023***  - 
              (0.000)   
Interaction between Deployment and Female           
Deployed*Female -   -  - -  -  -   - -0.0009 
                (0.001) 
Observed Probability 0.004 0.004 0.004 0.004 0.004 0.004 0.004 0.004 
Predicted Probability 0.003 0.003 0.003 0.003 0.003 0.003 0.003 0.003 
Observations 108,575 108,575 108,575 108,575 108,575 105,855 108,575 108,575 
Standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
Note: Service characteristics (such as MOS and pay grade), demographic characteristics (such as gender, race, marital status and age), and the start year of observation window have 





This chapter used multivariate analysis to determine if deployment 
characteristics in OEF/OIF missions were associated with the probabilities of 
being diagnosed with PTSD or bipolar disorder by employing eight probit models. 
Deployment characteristics in OEF/OIF missions included the overall effect of 
deployment, deployment location, frequency and days deployed. Interaction 
effects between deployment and deployment period, deployment location and 
deployment period, deployment and MOS, and deployment and gender were 
also included to study how the interactions between various independent 
variables affected the probabilities of being diagnosed with PTSD or bipolar 
disorder. Separate analyses were conducted for officers and enlisted personnel 
across the four services of the U.S. military, and for each of the two mental 
health conditions. 
In general, the deployment effects were more pronounced among the 
enlisted personnel than the officers who were deployed in OEF/OIF missions. 
These effects were also more pronounced for PTSD than bipolar disorder. 
The multivariate analyses showed that being sent for deployment in 
OEF/OIF missions generally increased the probability of being diagnosed with 
PTSD. This was evident in both enlisted personnel and officer populations, 
across all four branches of service. The reverse was observed for bipolar 
disorder. With the exception of Marine and Navy officers, deployment in OEF/OIF 
missions was associated with a reduced probability of being diagnosed with 
bipolar disorder. Deployment in OEF/OIF missions had no significant effect for 
Marine and Navy officers. These results supported the hypothesis that 
deployment in OEF/OIF missions increased the probability of being diagnosed 
with PTSD, as PTSD is triggered by exposure to traumatic events. However, 
environmental stressors did not appear to be associated with a higher probability 
of being diagnosed with bipolar disorder. This was probably because genetics is 
a stronger determinant of bipolar disorder. 
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The probability of being diagnosed with PTSD was generally higher for 
enlisted personnel and officers deployed to Iraq, compared to those deployed to 
Afghanistan, except for Marine and Air Force officers. With the exception of Air 
Force, the probability of being diagnosed with bipolar disorder was also generally 
higher for enlisted personnel deployed to Iraq, compared to Afghanistan.  
The authors had hypothesized that the probabilities of being diagnosed 
with PTSD or bipolar disorder would increase with multiple deployments to 
OEF/OIF missions, compared to a single deployment. Interestingly, the results 
showed that having multiple deployments either decreased or had no significant 
effect on the probability of being diagnosed with the conditions, with the 
exception of Marine and Navy enlisted personnel for PTSD. 
The probability of being diagnosed with PTSD increased with the number 
of days deployed for both the enlisted personnel and officers, especially for those 
deployed 120 to 180 days. The effects were the opposite for bipolar disorder. 
The number of days deployed was either not associated or associated with 
reduced probability of being diagnosed with bipolar disorder.  
For both Army enlisted personnel and officers, the probability of being 
diagnosed with PTSD was higher for those first deployed in CY2006 and after, 
compared to those first deployed in CY2005 and prior. The differences in 
OEF/OIF deployment location effects between the two periods were evident for 
all OEF/OIF deployment locations. There was no distinctive pattern in the 
OEF/OIF deployment location effects between the two periods on PTSD for the 
other three services, or on bipolar disorder for all populations.  
Army and Marine service members generally had higher probability of 
being diagnosed with PTSD if they were in combat arms specialty fields, 
compared to the other specialty fields. The effect of combat arms MOSs on the 
probability of being diagnosed with PTSD was greater among deployed Army 
and Marine enlisted personnel, compared to officers from the same services. On 
the other hand, Navy and Air Force service members had lower probability of 
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being diagnosed with PTSD if they were in combat arms specialty fields, 
compared to the other specialty fields.  
As for bipolar disorder, Army enlisted personnel in combat arms specialty 
fields was associated with an increase in probability of being diagnosed with the 
condition, compared to the other specialty fields. For Navy and Air Force officers 
and Navy enlisted personnel, being in combat arms specialty fields was 
associated with a reduced probability of being diagnosed with bipolar disorder, 
compared to the other specialty fields.  
Females had higher probabilities of being diagnosed with PTSD or bipolar 
disorder, compared to males. This was consistent across all eight populations. 
Among enlisted personnel across all services, there was a negative interaction 
effect between deployment in OEF/OIF missions and being female on the 
probability of being diagnosed with PTSD.  
Enlisted personnel in junior pay grades had higher probabilities of being 
diagnosed with PTSD or bipolar disorder, compared to those in senior pay 
grades. This was evident for all four services, with the exception of Marine 
enlisted personnel where the effect of pay grade was not significant for PTSD. 
For officers in all four services, being in junior pay grades increased the 
probability of being diagnosed with PTSD, compared to those in middle and 
senior pay grades.  
In terms of race, there were some observable trends on the probability of 
being diagnosed with either mental health condition. Among the enlisted 
personnel, whites across all services had higher probability of being diagnosed 
with PTSD, as compared to blacks. For bipolar disorder, white enlisted personnel 
across all services were also associated with a higher probability of being 
diagnosed with the condition, compared to other racial minority groups. There 
were no distinctive trends among the officers for PTSD and bipolar disorder.  
Generally, married personnel had higher probability of being diagnosed 
with either condition for enlisted personnel for all four services, compared to non-
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married. This was also observed for officers across all four services on the 
probability of being diagnosed with PTSD, except Marine officers.   
Chapter VII will cover an in-depth discussion of the results. Limitations of 







This thesis analyzed the effects of deployment, service, and demographic 
characteristics on the probability of being diagnosed with Post-Traumatic Stress 
Disorder (PTSD), schizophrenia and bipolar disorder between 2001 and 2011. As 
the U.S. military’s efforts in Operation Enduring Freedom (OEF) and Operation 
Iraqi Freedom (OIF) stepped up from FY2006 to FY2010, an in-depth analysis 
was also conducted to determine if there was differential effects of deployments 
on the incidence rates of these costly mental health conditions between service 
members deployed in 2005 and prior, and 2006 and after. 
The discussions in this chapter will largely focus on PTSD and bipolar 
disorder. As described in Chapter V, there was a low schizophrenia occurrence 
rate among both enlisted and officer populations. Thus, this condition was 
removed from the multivariate analysis in Chapter VI.  
    The authors hypothesized that the probability of being diagnosed with 
PTSD and bipolar disorder would increase if a service member were sent for 
deployment in OEF/OIF, compared to non-deployed. For PTSD, the multivariate 
analysis results supported this hypothesis for both enlisted personnel and 
officers, across all four services. This is consistent with the existing literature on 
the relationship between deployment and PTSD prevalence rate among the 
active duty service members in the U.S. military (Hoge et al., 2006; Shen et al., 
2010; Vasterling et al., 2010). Deployed service members had higher chances of 
directly experiencing blasts from improvised explosive devices (IED) or on the 
battlefield, or indirectly experiencing combat stress through seeing or helping 
dead and injured friends. Such factors thus increased the probability of service 
members being diagnosed with PTSD.  
As for bipolar disorder, the results did not support the above-mentioned 
hypothesis. Unlike current studies that showed environmental stressors could 
 152
affect the risk of developing bipolar disorder (Bebbington et al., 1993; Goldberg & 
Gamo, 2005), the results showed that deployment in OEF/OIF missions either 
had no effects or decreased the probability of being diagnosed with the condition, 
for both enlisted personnel and officers. One possible explanation is that, similar 
to schizophrenia, bipolar disorder is largely determined by genetic inheritance. 
Service members who showed symptoms, or assessed to have higher probability 
of developing bipolar disorder, would be filtered out during the selection 
processes for active duty recruitment or overseas deployment.  
The multivariate analysis results also supported the hypothesis that 
deployment to Iraq is associated with higher probability of being diagnosed with 
PTSD or bipolar disorder, relative to other OEF/OIF countries, including 
Afghanistan. The location variables can be considered as proxy for levels of 
combat exposure. The findings were consistent with Hoge et al. (2004), which 
found that service members who deployed to Iraq had a higher frequency of 
contact with enemy and exposure of combat experiences, as compared to those 
deployed to Afghanistan. The chances of experiencing traumatic events should 
be lower in unknown/classified country or other OEF/OIF country as those 
countries are likely to be staging countries, or locations executing administrative 
or logistics support. Therefore, the occurrence of traumatic events should be 
lower.  
The authors hypothesized that the probability of being diagnosed with 
PTSD increased with higher frequency of deployments. For PTSD, this 
hypothesis was supported only in the Marine and Navy enlisted populations. The 
hypothesis was not supported for bipolar disorder. This might reflect a selection 
problem; that is, a service member diagnosed with mental health conditions was 
less likely to be deployed again.  
The results also supported the hypothesis that with more days deployed, 
the probability of being diagnosed with PTSD increased. This was evident among 
service members with 120 to 180 days deployed, compared to those with fewer 
than 120 days, with the exception of Navy enlisted personnel. One reason could 
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be that having more days in deployment increased the chances of being exposed 
to traumatic or stressful events. The results were not consistent for service 
members with more than 180 days deployed, compared to those with fewer than 
120 days. This might again reflect a selection problem—a deployed service 
member diagnosed with PTSD was less likely to be deployed for longer 
durations, or would have been sent home earlier.  
As stated earlier, the U.S. military’s war efforts had stepped up from 
FY2006 to FY2010. The increased tempo in operations was likely to increase 
mental stress on the deployed troops. In addition, the Iraq Study Group reported 
in December 2006 that the situation in Iraq had deteriorated (Tanielian & Jaycox, 
2008). Around the same time, the former Iraqi president, Saddam Hussein, was 
executed, leading to increased instability in the region. This inferred that service 
members deployed in and after CY2006 could have higher chances of 
encountering traumatic events. The results supported the hypothesis for the 
Army, where deployment period had a significant effect on the probability of 
being diagnosed with PTSD among Army service members. The probability of 
being diagnosed with PTSD was higher for Army service members who were first 
deployed in CY2006 and after, compared to CY2005 and prior. Notably, there is 
no significant difference between the two periods for the Marine Corps. This is 
despite both the Army and the Marine Corps being stretched to support the 
OEF/OIF missions, and exposed to similar combat environments due to their 
mode of operations. Many factors could lead to this difference in results. For 
example, the number of PTSD cases diagnosed could be affected by the 
different type of intervention programs available, culture in the service, and the 
level of stigma on service members with PTSD. Other reasons, such as the 
demographic mix of the service members, or changes in specific job operations 
could also play a part. No significant differences between the two periods were 
observed for the other populations for PTSD, as well as for bipolar disorder, for 
all four services.  
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As hypothesized, service members in combat arms specialty fields 
generally had a higher probability of being diagnosed with PTSD, compared to 
other specialty fields. This was evident in the Army and Marine Corps. Due to the 
nature of the job assignments, Army and Marine service members were more 
likely to be involved in direct engagement with enemies or witness injuries or 
deaths up close, than were the Navy and Air Force members. Another reason 
could be data limitations, as large proportions of Navy and Air Force service 
members were identified as having other Military Occupational Specialty (MOS).  
Consistent with prior studies, females had a higher probability of being 
diagnosed with PTSD and bipolar disorder, compared to males (Kennedy et al., 
2002; Krishkan, 2005; Shen et al., 2010; Shippee et al., 2011). This could be 
because females were more willing to actively seek proper medical treatment 
than males, or that females had a higher propensity of acquiring PTSD after 
experiencing a traumatic event.  
Other than the key variables of interest, there were other findings worthy 
of discussion. First, being in junior pay grades generally was associated with a 
higher probability of being diagnosed with PTSD or bipolar disorder. Service 
members in junior pay grades generally had shorter time in service and could 
have fewer combat experiences, and thus lower levels of mental toughness.  
Married service members had a higher probability of being diagnosed with 
PTSD and bipolar disorder, compared to non-married. One reason could be that 
married service members were more likely to actively seek medical help, when 
their spouses noticed the symptoms and encouraged them to seek treatment. 
Conversely, the probability of a close friend or family member to do the same for 




This thesis has several limitations. First, it used the observation window 
approach to reduce selection bias, where only deployment information during the 
first four years of service was tracked (for service members who were already in 
service prior to 2000, the first year of data, we observe them during the first four 
years of data). This meant that the military population studied was generally 
younger than the general U.S. military population. A standard timeframe was also 
used to define the observation window across four services, for both enlisted 
personnel and officers. It might not be suitable for observation of deployment 
characteristics across all populations, as the training cycle and deployment 
patterns differed among the services and pay grades. Although the observation 
window approach had its limitations, it was chosen because of its merits. As 
mentioned in Chapter IV, the observation window allowed for consistent 
reference points across all populations in observing independent variables, and 
ensured that deployment characteristics were independent of the outcomes of 
interest (PTSD and bipolar disorder).  
Second, the medical diagnosis information used for this thesis was limited 
to only information from TRICARE. The number of PTSD, schizophrenia and 
bipolar cases might be understated for two reasons. The first reason is that the 
data did not capture service members who did not seek medical treatment, or 
those who sought treatment from institutes not covered under TRICARE. This 
could be due to fear that their career progression might be affected by their 
conditions. The second reason is that TRICARE only applies to active duty and 
retired service members. After separation from the military under other than 
dishonorable conditions, veterans’ health care is provided by the Department of 
Veterans Affairs (VA) health care system, and not TRICARE. Thus, the number 
of cases might also be understated because mental health conditions diagnosed 
for the veteran population would not be captured in the data, unless they were 
first diagnosed during active duty. 
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Third, the data did not capture information on the specific assignments or 
the level of combat exposure for each deployment. It was difficult to determine 
whether the effect on mental health conditions was due to the deployments or 
higher levels of combat exposure and stress. Instead, Afghanistan and Iraq were 
used as proxies for deployment locations with higher levels of combat stress. 
Military Occupation Specialty (MOS) was also included as a proxy for the 
likelihood of encountering traumatic events, using the combat arms specialty 
fields to represent assignments with higher levels of combat exposure.  
Fourth, there were data limitations as mentioned in Chapter III. Some 
observations had missing information or data entry errors. Due to the 
categorization of MOS used, the majority of Navy and Air Force service members 
were categorized in “other MOS.”  These might have an impact on the precision 
of the analysis. 
C. RECOMMENDATIONS 
Future research can focus on using data with detailed information on the 
actual levels of combat exposure and intensity, and relate that to the probability 
of being diagnosed with mental health conditions. This will help to better identify 
the specific triggers for PTSD, schizophrenia and bipolar disorder, such as the 
types of combat experiences and environment. One possibility is to obtain 
information (such as specific job assignment, level and types of combat 
exposure) through post-deployment questionnaires. Detailed classifications of 
the deployment locations can also be included, as the intensity of combat warfare 
for each area may differ within the same country. 
D. CONCLUSIONS 
Statistics have shown that the number of cases of PTSD and bipolar 
disorder have been on the rise over the years, especially with the increase in 
tempo of the Global War on Terrorism (GWOT) after CY2006. Sustained 
operations have strained the U.S. military. To sustain the requirements in GWOT, 
more service members were deployed with longer deployment durations and 
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multiple deployments (Hosek, Kavanagh, & Miller, 2006). The demands of the 
operations have led to higher incidences of mental health conditions among the 
service members. These mental health disorders, in turn, had a direct impact on 
the service members and their families. Treatment costs, as well as indirect 
costs, could be substantial to both the military and society.  
This thesis used data on almost 100% of the active duty population over 
the ten years of study. This was equivalent to almost three million active duty 
enlisted personnel and officers. While the coefficient estimates from the 
multivariate analyses were small in magnitude, they represented substantial 
numbers on the ground. Military planners can use the information from the 
multivariate analyses and review the personnel planning for future overseas 
deployments. For example, the days deployed for each service member should 
be considered carefully to reduce the probability of developing PTSD.  
The U.S. military can also do more for current active duty service 
members who returned from deployment, or are returning from overseas 
deployment. Instead of passively waiting for affected service members to seek 
treatment of mental health conditions, a more proactive approach can be 
adopted. Periodic mental health screenings can be conducted for all service 
members to better identify symptoms and provide prompt medical treatment.  
It is important for affected service members to seek prompt medical 
treatment. The U.S. military should look into ways to encourage them, such as 
family and friends support programs, and addressing concerns that having 
mental health conditions could affect their career progression. Given the 
continuing U.S. military presence in other parts of the world, the Department of 
Defense (DoD) needs to continually focus on active duty service members’ well-
being, so that the U.S. military can maintain adequate end strength for future 
operations.   
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APPENDIX. MILITARY OCCUPATIONAL SPECIALTY 
CATEGORIES 
The occupational codes for each service are categorized into six groups: 
combat arms, combat service, service support, aviation, medical and others, as 
shown in Table 40. For a detailed description of each code by occupational title, 
refer to the DoD Occupational Conversion Index (DoD 1312. 1-I). 
Table 40. Military occupational specialty code grouping 
Air Force 
Combat Arms 1A, 1B, 1C, 1N, 1T, 1S, 1W 
Combat Service 3C, 3S, 8A, 8R, 2E, 2W, 3E 
Service Support 2A, 2F, 2G, 2M, 2P, 2R, 2S, 2T, 3A, 3H, 3M, 3N, 3P, 3U, 3V, 5J, 5R, 6C, 6F, 7S, 8C 
Medical 4X, 4Y 
Army 
Combat Arms 11, 12, 13, 14, 18, 21 
Combat Service 25, 31, 35, 74 
Service Support 27, 36, 42, 44, 88, 89, 91, 92, 94 
Medical 60, 61, 62, 63, 64, 65, 66, 67 
Marine Corps 
Combat Arms 03, 08, 13, 18 
Combat Service 05, 06, 21, 23, 25, 26, 28, 57 
Service Support 01, 02, 04, 09, 11, 27, 30, 31, 33, 34, 35, 40, 41, 43, 44, 46, 55, 58, 59 
Aviation 60, 61, 62, 63, 64, 65, 66, 68, 70, 72, 73, 75 
Navy 
Combat Arms BM01, FC11, FC13, GM08, MN12, OS03, QM02, TM07, 53, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 
Combat Service 
DC48, EM33, EM46, EN43, EO57, ET14, ET15, ET16, ET17, ET33, 
ET47, FC16, FT11, FT13, GS41, IC47, IS39, MM33, MM42, MM45, 
MR44, MT33, CT091, STG04, STG05, STG06, 60, 61, 62, 63, 64, 65, 
66, 67, 68, 69, 70,71, 72, 73, 74, 75, 76, 77, 78, 79 
Service Support 
BU59, CE56, CM58, DK29, HT49, IT23, IT27, JO32,  LI36, MA20, MS35, 
MU38, NC21, PN26, RP24, SH31, SK28, YN25, 10, 11, 12, 13, 14, 15, 
16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 
35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 
54, 55, 56, 57, 58, 59 
Aviation AZ63, AD64, AO68, AC69, AB70, AE71, AM72, PR73, ABE70, ABF70, ABH70, AME72, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89 
Medical HM84, DT87, 00, 02, 02, 03, 04, 05, 06, 07, 08, 09 
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